Processing 00000000.tx.1: Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews  Mutations in the sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews Ann Nestorowicz, Beth Anne Wilson, Kathleen P. 

Phrase: "Mutations in the sulfonylurea receptor gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with familial hyperinsulinism"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2931834:Hyperinsulinism, familial [Disease or Syndrome]
   770   C0015576:familial [Family Group]
   770   C0020459:Hyperinsulinism [Disease or Syndrome]
   770   C0241888:Familial [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Ashkenazi Jews  Mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0337704:ashkenazi jews [Population Group]

Phrase: "in the sulfonylurea receptor gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "are"

Phrase: "associated with familial hyperinsulinism"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2931834:Hyperinsulinism, familial [Disease or Syndrome]
   770   C0015576:familial [Family Group]
   770   C0020459:Hyperinsulinism [Disease or Syndrome]
   770   C0241888:Familial [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Ashkenazi Jews Ann Nestorowicz,"

Phrase: "Beth Anne Wilson,"

Phrase: "Kathleen P."
Processing 00000000.tx.2: Schoor, Hiroshi Inoue, Benjamin Glaser1, Heddy Landau2, Charles A. 

Phrase: "Schoor,"

Phrase: "Hiroshi Inoue,"

Phrase: "Benjamin Glaser1,"

Phrase: "Heddy Landau2,"

Phrase: "Charles A."
Processing 00000000.tx.3: Stanley3, Paul S. 

Phrase: "Stanley3,"

Phrase: "Paul S."
Processing 00000000.tx.4: Thornton3,+, John P. 

Phrase: "Thornton3,"

Phrase: "+,"

Phrase: "John P."
Processing 00000000.tx.5: Clement IV4, Joseph Bryan4, Lydia Aguilar-Bryan4 and M. 

Phrase: "Clement IV4,"

Phrase: "Joseph Bryan4,"

Phrase: "Lydia Aguilar-Bryan4"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: Alan Permutt* Division of Endocrinology, Diabetes and Metabolism, Washington University School of Medicine, Box 8127, 660 South Euclid Ave., St Louis, MO 63110, USA, 1Department of Endocrinology and Metabolism, The Hebrew University, Hadassah Medical School, Jerusalem, Israel, 2Department of Pediatrics, The Hebrew University, Hadassah Medical School, Jerusalem, Israel, 3Division of Endocrinology/Diabetes, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA and 4Departments of Cell Biology and Medicine, Baylor College of Medicine, Houston, TX 77030, USA Received July 1, 1996; 

Phrase: "Alan Permutt"

Phrase: "* Division of Endocrinology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Washington University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Box 8127,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "660 South Euclid Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO 63110,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "1Department of Endocrinology"

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "The Hebrew University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Hadassah Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Jerusalem,"

Phrase: "Israel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: "2Department of Pediatrics,"

Phrase: "The Hebrew University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Hadassah Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Jerusalem,"

Phrase: "Israel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: "3Division of Endocrinology/Diabetes,"

Phrase: "Department of Pediatrics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587482:department pediatrics [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "University of Pennsylvania School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA 19104,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "4Departments of Cell Biology"

Phrase: "and"

Phrase: "Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Baylor College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "Houston,"

Phrase: "TX 77030,"

Phrase: "USA Received July 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "1996"

Phrase: ";"
Processing 00000000.tx.7: Revised and Accepted August 29, 1996 Familial hyperinsulinism (HI) is a disorder of pancreatic [beta]-cell function characterized by persistent hyperinsulinism despite severe hypoglycemia. 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted August 29,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1996 Familial hyperinsulinism (HI)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2931834:Hyperinsulinism, familial [Disease or Syndrome]
   827   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "is"

Phrase: "a disorder of pancreatic [beta]-cell function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0030286:Pancreatic Disorder [Disease or Syndrome]
   748   C0012634:Disorder [Disease or Syndrome]
   738   C0277785:Functional disorder [Qualitative Concept]

Phrase: "characterized by persistent hyperinsulinism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020459:Hyperinsulinism [Disease or Syndrome]
   770   C0205322:Persistent [Temporal Concept]
   770   C1880022:Characterized [Activity]

Phrase: "despite severe hypoglycemia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0020615:Hypoglycaemia [Disease or Syndrome]
   861   C0205082:Severe [Qualitative Concept]
   789 E C0020616:Hypoglycaemic [Pharmacologic Substance]
Processing 00000000.tx.8: To define the molecular genetic basis of HI in Ashkenazi Jews, 25 probands were screened for mutations in the sulfonylurea receptor (SUR1) gene by single-strand conformation polymorphism (SSCP) analysis of genomic DNA and subsequent nucleotide sequence analyses. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the molecular genetic basis of HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1853126:MOLECULAR BASIS [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "in Ashkenazi Jews,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337704:ashkenazi jews [Population Group]
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]

Phrase: "25 probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "were"

Phrase: "screened for mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the sulfonylurea receptor (SUR1) gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "by single-strand conformation polymorphism (SSCP) analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519159:Single-Strand Conformation Polymorphism Analysis [Molecular Biology Research Technique]
   840   C0796451:polymorphism analysis [Diagnostic Procedure]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0243031:single strand conformation polymorphism [Laboratory or Test Result]

Phrase: "of genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "subsequent nucleotide sequence analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]
Processing 00000000.tx.9: Two common mutations were identified: (i) a novel in-frame deletion of three nucleotides (nt) in exon 34, resulting in deletion of the codon for F1388 ([Delta]F1388) and (ii) a previously described g -> a transition at position -9 of the 3' splice site of intron 32 (designated 3992-9g -> a). 

Phrase: "Two common mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "identified: (i)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a novel in-frame deletion of three nucleotides (nt)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "in exon 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "resulting in deletion of the codon"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332294:Resulting in [Functional Concept]
   753   C0009221:Codon [Nucleotide Sequence]
   753   C0678226:resulting [Functional Concept]
   753   C1095825:Codon [Plant]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "for F1388"

Phrase: "("

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388"

Phrase: ")"

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "a previously described g ->"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "a transition at position -9 of the 3' splice site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0599156:Transition [Cell or Molecular Dysfunction]
   739   C2700061:Transition [Activity]

Phrase: "of intron 32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "3992-9g -"

Phrase: ">"

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.10: Together, these mutations are associated with 88% of the HI chromosomes of the patients studied. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with 88% of the HI chromosomes of the patients"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   739   C0008633:Chromosomes [Cell Component]
   739   C0020459:Hyperinsulinism [Disease or Syndrome]
   739   C0030705:Patients [Patient or Disabled Group]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.11: 86Rb+ efflux measurements of COSm6 cells co-expressing Kir6.2 and either wild-type or [Delta]F1388 SUR1 revealed that the F1388 mutation abolished ATP-sensitive potassium channel (KATP) activity in intact cells. 

Phrase: "86Rb+ efflux measurements of COSm6 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:measurements [Functional Concept]

Phrase: "co-expressing"

Phrase: "Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: "and"

Phrase: "either wild-type or [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0439097:Delta [Intellectual Product]
   812   C1705241:Delta [Quantitative Concept]
   812   C3146239:Delta [Eukaryote]
   812   C3538806:DELTA [Spatial Concept]
   812   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   827   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "abolished"

Phrase: "ATP-sensitive potassium channel"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0001480:Adenosine Triphosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   840   C0032824:Potassium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   804   C0032821:Potassium [Element, Ion, or Isotope]
   804   C0146894:triphosphate [Inorganic Chemical]
   804   C0332324:Sensitive [Functional Concept]
   804   C0439799:Channel [Spatial Concept]
   804   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1550474:sensitive [Idea or Concept]
   804   C1706095:Channel [Conceptual Entity]

Phrase: "(KATP"

Phrase: ")"

Phrase: "activity in intact cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.12: Extended haplotype analyses indicated that the [Delta]F1388 mutation was associated with a single specific haplotype whereas the 3992-9g -> a mutation was primarily associated with a single haplotype but also occurred in the context of several other different haplotypes. 

Phrase: "Extended haplotype analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "associated with a single specific haplotype"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0018591:Haplotype [Organism Attribute]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "whereas"

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "primarily"

Phrase: "associated with a single haplotype"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0018591:Haplotype [Organism Attribute]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "also"

Phrase: "occurred in the context of several"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]
   753   C1709305:Occurred [Activity]
   719 E C2745955:OCCUR [Temporal Concept]

Phrase: "other different haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.13: These data suggest that HI in Ashkenazi Jews is predominantly associated with mutations in the SUR1 gene and provide evidence for the existence of at least two founder HI chromosomes in this population. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that HI in Ashkenazi Jews"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "is"

Phrase: "predominantly"

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the SUR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for the existence of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "at least two founder HI chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0008633:Chromosomes [Cell Component]

Phrase: "in this population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.14: INTRODUCTION Familial hyperinsulinism (HI; 

Phrase: "INTRODUCTION Familial hyperinsulinism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2931834:Hyperinsulinism, familial [Disease or Syndrome]
   827   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "(HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.15: OMIM: 256450) is an autosomal recessive disorder of pancreatic [beta]-cell function and is characterized by inadequate suppression of insulin secretion in the presence of severe, recurrent, fasting hypoglycemia. 

Phrase: "OMIM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950133:OMIM [Intellectual Product]

Phrase: ":"

Phrase: "256450"

Phrase: ")"

Phrase: "is"

Phrase: "an autosomal recessive disorder of pancreatic [beta]-cell function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0030286:Pancreatic Disorder [Disease or Syndrome]
   742   C0012634:Disorder [Disease or Syndrome]
   726   C0277785:Functional disorder [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "characterized by inadequate suppression of insulin secretion"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1256369:insulin secretion [Cell Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205412:Inadequate [Qualitative Concept]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1880022:Characterized [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of severe, recurrent, fasting hypoglycemia."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0271708:Fasting Hypoglycemia [Disease or Syndrome]
   812   C0015663:Fasting [Finding]
   812   C0020615:Hypoglycaemia [Disease or Syndrome]
   812   C1550565:fasting [Intellectual Product]
   779 E C0456962:Fast [Qualitative Concept]
   741 E C0020616:Hypoglycaemic [Pharmacologic Substance]
Processing 00000000.tx.16: Clinical manifestations of HI, which occurs predominantly in neonates and infants under 1 year of age, include seizures, coma and large birth weight for gestational age (1 -3 ). 

Phrase: "Clinical manifestations of HI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   770   C0205319:manifestations [Functional Concept]

Phrase: "which"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "predominantly in neonates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0021289:Neonates [Age Group]
   756 E C2239178:Neonate [Finding]
   756 E C2939425:Neonate, NOS [Temporal Concept]

Phrase: "and"

Phrase: "infants under 1 year of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021270:Infants [Age Group]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "seizures,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0036572:Seizures [Sign or Symptom]
   966 E C1959629:Seizure [Finding]

Phrase: "coma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009421:Coma [Disease or Syndrome]
  1000   C0543874:COMA [Congenital Abnormality]
  1000   C3146279:Coma [Fungus]

Phrase: "and"

Phrase: "large birth weight for gestational age"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0005612:Birth Weight [Organism Attribute]
   753   C0005615:Birth [Organism Function]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1550722:birth [Idea or Concept]
   753   C1705104:Weight [Idea or Concept]
   753   C3245487:birth [Intellectual Product]

Phrase: "(1 -3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: In the absence of treatment, HI may be lethal or result in irreversible neurologic sequelae. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "lethal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3151529:Lethal [Finding]

Phrase: "or"

Phrase: "result in irreversible neurologic sequelae."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
Processing 00000000.tx.18: Estimates for the incidence of this disorder vary from 1/40 000 live births in northern Europe (4 ) to 1/2675 live births in Saudi Arabia, a country in which 51% of all births are from consanguineous marriages (5 ). 

Phrase: "Estimates for the incidence of this disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750572:estimates [Quantitative Concept]

Phrase: "vary from 1/40 000 live births"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C0481667:Live Births [Qualitative Concept]
   774 E C0551755:Births.live [Clinical Attribute]
   748   C0005615:Births [Organism Function]
   748   C0439509:/40 [Temporal Concept]
   748   C1548795:Live [Qualitative Concept]
   748   C1634625:% live [Qualitative Concept]
   748   C2982691:Live [Activity]
   745 E C1317974:live birth [Health Care Activity]
   714 E C1550722:birth [Idea or Concept]
   714 E C3245487:birth [Intellectual Product]

Phrase: "in northern Europe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028413:Northern Europe [Geographic Area]
   861   C0015176:Europe [Geographic Area]

Phrase: "(4"

Phrase: ")"

Phrase: "to 1/2675 live births"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
   861   C0481667:Live Births [Qualitative Concept]
   827 E C1317974:live birth [Health Care Activity]
   812   C0005615:Births [Organism Function]
   812   C1548795:Live [Qualitative Concept]
   812   C1634625:% live [Qualitative Concept]
   812   C2982691:Live [Activity]
   779 E C1550722:birth [Idea or Concept]
   779 E C3245487:birth [Intellectual Product]
   741 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   741 E C0314603:Genetic [Functional Concept]
   741 E C0454729:Natal [Geographic Area]
   719 E C0035150:Reproduction [Organism Function]
   719 E C0079946:origin [Classification]
   719 E C0439659:Origin [Temporal Concept]
   719 E C1550512:origin [Intellectual Product]
   706 E C0559522:Genital [Body System]
   706 E C1546649:Genital [Intellectual Product]
   706 E C1550642:Genital [Body Substance]
   701 E C0205313:Original [Idea or Concept]
   701 E C2347409:Original [Occupational Activity]

Phrase: "in Saudi Arabia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0036243:Saudi Arabia [Geographic Area]
   861   C0003671:Arabia [Geographic Area]
   789 E C0238686:ARABIAN [Finding]

Phrase: "a country in which 51% of all births"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C1300001:Country of birth [Finding]
           Origin - country
   759 E C1549631:Country Of Origin [Idea or Concept]
   759 E C3262211:Country of origin [Clinical Attribute]
   744   C0454664:Country [Geographic Area]

Phrase: "are from consanguineous marriages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024841:Marriages [Finding]
   770   C1551058:Are [Quantitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: The HI locus was initially assigned to the region flanked by the microsatellite markers D11S926 and D11S899 on chromosome 11p14-15.1 by genetic linkage analyses and homozygosity mapping (6 ,7 ). 

Phrase: "The HI locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "assigned to the region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C1516050:Assigned [Functional Concept]
   770   C1552601:assigned [Intellectual Product]

Phrase: "flanked by the microsatellite markers D11S926"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           Microsatellite
   719   C0005516:Marker [Clinical Attribute]
   719   C0230171:Flank [Body Location or Region]

Phrase: "and"

Phrase: "D11S899 on chromosome 11p14-15.1"

Phrase: "by genetic linkage analyses"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0796345:Genetic Linkage Analyses [Laboratory Procedure]
           linkage analysis
   896   C0679560:genetic analysis [Laboratory Procedure]
   896   C0796344:Genetic Analysis [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0023745:genetic linkage [Molecular Function]

Phrase: "and"

Phrase: "homozygosity mapping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1283195:Mapping [Activity]

Phrase: "(6 ,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.20: Subsequent linkage and haplotype studies using additional genetic markers refined the position of the HI locus to the D11S419-D11S1310 interval (8 ). 

Phrase: "Subsequent linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "haplotype studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "additional genetic markers"
Meta Candidates (Total=19; Excluded=14; Pruned=0; Remaining=5)
   901   C0017393:Genetic Markers [Genetic Function]
   901   C0600223:genetic markers [Laboratory Procedure]
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C0005516:Marker [Clinical Attribute]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "refined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   907   C1947930:Cleanse [Activity]
   907   C1998793:Purified [Functional Concept]

Phrase: "the position of the HI locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "to the D11S419-D11S1310 interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.21: Recently, the gene for the sulfonylurea receptor (SUR1), a modulator of insulin secretion, was localized to chromosome 11p15.1 by fluorescence in situ hybridization (FISH) and two separate point mutations were identified in probands with HI by nucleotide sequence analyses of SUR1 cDNA and/or genomic DNA (9 ). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the gene for the sulfonylurea receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1335671:Receptor Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]

Phrase: "(SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "a modulator of insulin secretion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709060:Modulator [Manufactured Object]

Phrase: "was"

Phrase: "localized to chromosome 11p15.1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1520365:11p15.1 [Cell Component]
   797   C0008651:Chromosome 1 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C0392752:Localized [Spatial Concept]
   760   C1520364:11p15 [Cell Component]

Phrase: "by fluorescence in situ hybridization (FISH)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescence in situ hybridisation [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "two separate point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   812   C0026882:Mutations [Genetic Function]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "identified in probands"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C0702111:probands [Organism Attribute]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   756 E C1948021:Proband [Family Group]
   718 E C0702110:Propositus [Organism Attribute]

Phrase: "with HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "by nucleotide sequence analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0004793:Nucleotide Sequence [Nucleotide Sequence]

Phrase: "of SUR1 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and/or"

Phrase: "genomic DNA (9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.22: Both mutations, a g -> a transition in a 5' splice site which results in exon skipping and a g -> a transition in intron 32, postulated to activate cryptic splice sites, are presumed to result in premature truncation of the SUR1 molecule (9 ). 

Phrase: "Both mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "a g -> a transition in a 5' splice site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0599156:Transition [Cell or Molecular Dysfunction]
   742   C2700061:Transition [Activity]

Phrase: "which"

Phrase: "results in exon skipping"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0560435:skipping [Finding]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "a g -> a transition in intron 32,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0599156:Transition [Cell or Molecular Dysfunction]
   748   C2700061:Transition [Activity]

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "cryptic splice sites,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1720838:Cryptic Splice Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in premature truncation of the SUR1 molecule"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   742   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   742   C0205252:Premature [Temporal Concept]
   742   C0567416:Molecule [Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1706395:Truncation [Cell or Molecular Dysfunction]
   742   C2825142:Result [Finding]
   742   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.23: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.24: Schematic representation of the predicted membrane topology of the SUR1 protein. 

Phrase: "Schematic representation of the predicted membrane topology of the SUR1 protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1514861:Representation [Conceptual Entity]
   736   C1882932:Representation [Activity]
Processing 00000000.tx.25: The molecule comprises two nucleotide-binding folds (designated NBF-1 and NBF-2), containing the characteristic Walker A and Walker B consensus sequence motifs (denoted by A and B, respectively), and two membrane spanning domains composed of multiple putative transmembrane segments (10-12). 

Phrase: "The molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "two nucleotide-binding folds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0598153:nucleotide binding fold [Amino Acid Sequence]
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "(designated NBF-1"

Phrase: "and"

Phrase: "NBF-2"

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the characteristic Walker A"

Phrase: "and"

Phrase: "Walker B consensus sequence motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1514562:Motif [Amino Acid Sequence]

Phrase: "("

Phrase: "denoted by A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "two membrane spanning domains"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   779   C1711300:Span [Conceptual Entity]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C2700613:Span [Quantitative Concept]
   779   C3541951:Domain [Intellectual Product]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "composed of multiple putative transmembrane segments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439064:Multiple [Quantitative Concept]
   753   C1167322:transmembrane [Cell Component]
   753   C2752508:transmembrane [Cell Component]
   719   C0441635:Segment [Spatial Concept]

Phrase: "(10-12"

Phrase: ")."
Processing 00000000.tx.26: Locations of putative disease causing mutations identified in Ashkenazi Jewish probands are denoted as: (1) the position where premature truncation of SUR1 due to the intronic mutation, 3992-9g -> a, is postulated to occur (9,10) and (2) [Delta]F1388. 

Phrase: "Locations of putative disease causing mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0450429:locations [Spatial Concept]
   719 E C1515974:Location [Body Location or Region]

Phrase: "identified in Ashkenazi Jewish probands"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0022422:Jewish [Idea or Concept]
   760   C0178443:Jewish [Population Group]
   760   C0205396:Identified [Qualitative Concept]
   760   C0702111:probands [Organism Attribute]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726 E C1948021:Proband [Family Group]

Phrase: "are"

Phrase: "denoted"

Phrase: "as"

Phrase: ":"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "the position where premature truncation of SUR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1706395:Truncation [Cell or Molecular Dysfunction]

Phrase: "due to the intronic mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1881250:Intronic Mutation [Genetic Function]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "3992-9g -"

Phrase: ">"

Phrase: "a,"

Phrase: "is"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: "and ("

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388."
Processing 00000000.tx.27: Adapted from Philipson, L. 

Phrase: "Adapted from Philipson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2937289:adapted [Organic Chemical]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.28: H. and Steiner, D. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Steiner,"

Phrase: "D."
Processing 00000000.tx.29: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.30: Science 268, 372-373. 

Phrase: "Science 268,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "372-373."
Processing 00000000.tx.31: Characterization of the full-length complementary DNA (cDNA) sequence and genomic structure of the human SUR1 homologue indicates that the SUR1 gene comprises 39 exons and spans >100kb of genomic DNA (G. Gonzalez, L. Aguilar-Bryan and J. Bryan, GSDB Accession #L78208; H. Inoue and M. A. Permutt, unpublished data). 

Phrase: "Characterization of the full-length complementary DNA (cDNA) sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "genomic structure of the human SUR1 homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0678594:Structure [Spatial Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the SUR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "39 exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "spans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: ">100kb of genomic DNA (G. Gonzalez,"

Phrase: "L. Aguilar-Bryan"

Phrase: "and"

Phrase: "J. Bryan,"

Phrase: "GSDB Accession #L78208"

Phrase: "; H. Inoue"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "A. Permutt,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.32: The human SUR1 cDNA contains a single open reading frame that encodes a protein of 1581 amino acids and an alternative spliced form of 1582 amino acids (MW [approx] 177 kDa) (G. Gonzalez, L. Aguilar-Bryan and J. Bryan, GSDB accession #L78208; H. Inoue and M. A. Permutt, unpublished data) (10 ). 

Phrase: "The human SUR1 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a single open reading frame"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0079941:Open Reading Frame [Gene or Genome]
   861   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   812   C0034754:Reading [Daily or Recreational Activity]
   812   C0175566:Open [Spatial Concept]
   812   C0180979:Frame [Medical Device]
   812   C1705179:Reading [Finding]
   812   C1705858:Frame [Manufactured Object]
   741 E C0547049:Openness [Spatial Concept]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a protein of 1581 amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "an alternative spliced form of 1582 amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "(MW ["
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024548:MW [Geographic Area]
  1000   C0026385:mw [Quantitative Concept]
  1000   C0556966:mW [Quantitative Concept]

Phrase: "approx"

Phrase: "] 177 kDa) (G. Gonzalez,"

Phrase: "L. Aguilar-Bryan"

Phrase: "and"

Phrase: "J. Bryan,"

Phrase: "GSDB accession #L78208"

Phrase: "; H. Inoue"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "A. Permutt,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.33: Homology analyses of the deduced amino acid sequence revealed that SUR1 is a member of the adenosine triphosphate (ATP)-binding cassette superfamily (11 ,12 ). 

Phrase: "Homology analyses of the deduced amino acid sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C0751970:Sequence Analyses, Amino Acid [Laboratory Procedure,Molecular Biology Research Technique]
   767   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "is"

Phrase: "a member of the adenosine triphosphate (ATP)-binding cassette superfamily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "(11 ,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.34: A model for SUR1 predicts that the molecule contains two nucleotide binding domains (NBF-1 and NBF-2) and two membrane spanning domains, each composed of multiple putative transmembrane regions (Fig. 1 ) (10 ). 

Phrase: "A model for SUR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "predicts"

Phrase: "that"

Phrase: "the molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "two nucleotide binding domains"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1148916:nucleotide binding [Molecular Function]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "(NBF-1"

Phrase: "and"

Phrase: "NBF-2"

Phrase: ")"

Phrase: "and"

Phrase: "two membrane spanning domains,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   779   C1711300:Span [Conceptual Entity]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C2700613:Span [Quantitative Concept]
   779   C3541951:Domain [Intellectual Product]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "each"

Phrase: "composed of multiple putative transmembrane regions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C1519623:Transmembrane Region [Amino Acid Sequence]
   753   C0439064:Multiple [Quantitative Concept]
   753   C1167322:transmembrane [Cell Component]
   753   C2752508:transmembrane [Cell Component]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.35: Evidence for a functional role of SUR1 in the regulation of ATP-sensitive potassium channels (KATP) in pancreatic [beta]-cells has recently been provided by the finding that co-expression of SUR1 and a small [beta]-cell inward rectifier potassium channel subunit (Kir 6.2) in COSm6 or COS-1 cells reconstitutes an inwardly rectifying ATP-sensitive potassium current (IKATP) (13 ). 

Phrase: "Evidence for a functional role of SUR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of ATP-sensitive potassium channels"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0001480:Adenosine Triphosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   840   C0032824:Potassium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   804   C0032821:Potassium [Element, Ion, or Isotope]
   804   C0146894:triphosphate [Inorganic Chemical]
   804   C0332324:Sensitive [Functional Concept]
   804   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1550474:sensitive [Idea or Concept]
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]

Phrase: "(KATP"

Phrase: ")"

Phrase: "in pancreatic [beta]-cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "provided by the finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C1999230:Provided [Activity]
   770   C2825141:Finding [Finding]

Phrase: "that co-expression of SUR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0597360:receptor expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "[beta]-cell inward rectifier potassium channel subunit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   927   C1416578:BETA-CELL INWARD RECTIFIER SUBUNIT [Gene or Genome]
   893   C1264631:Beta subunit [Qualitative Concept]
   795   C1711351:Subunit [Quantitative Concept]
   710   C0214230:inward rectifier potassium channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Kir 6.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017550:KIR [Geographic Area]
   827   C0665952:KIR [Amino Acid, Peptide, or Protein,Receptor]
   827   C1415041:KIR [Gene or Genome]
   827   C3540490:KIR [Gene or Genome]

Phrase: ")"

Phrase: "in COSm6"

Phrase: "or"

Phrase: "COS-1 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1257857:COS-1 Cells [Cell]
   913   C0376702:COS Cells [Cell]
           COS-1
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "reconstitutes"

Phrase: "an inwardly"

Phrase: "rectifying"

Phrase: "ATP-sensitive potassium current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0521116:Current [Temporal Concept]
   804   C1705970:Current [Natural Phenomenon or Process]

Phrase: "(IKATP"

Phrase: ")"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.36: The SUR1 protein is presumed to confer ATP/ADP-sensitivity on IKATP (13 ). 

Phrase: "The SUR1 protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "is"

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "ATP/ADP-sensitivity on IKATP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.37: Current models for glucose-regulated insulin secretion propose that closure of such KATP channels in pancreatic [beta]-cells is required for insulin exocytosis (14 ). 

Phrase: "Current models for glucose-regulated insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Models [Intellectual Product]

Phrase: "propose"

Phrase: "that closure of such KATP channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185003:Closure [Therapeutic or Preventive Procedure]
   753   C1521802:Closure [Research Activity]

Phrase: "in pancreatic [beta]-cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "required for insulin exocytosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0015283:Exocytosis [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1514873:Required [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.38: Elevations in blood glucose concentration lead to increased rates of glucose metabolism in [beta]-cells and consequent alterations in the intracellular ratio of ATP/ADP, resulting in inhibition of KATP channels. 

Phrase: "Elevations in blood glucose concentration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0702240:elevations [Spatial Concept]
   726 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "lead to increased rates of glucose metabolism in [beta]-cells"
Meta Candidates (Total=24; Excluded=3; Pruned=0; Remaining=21)
   760   C0596620:glucose metabolism [Molecular Function]
   757   C0860803:glucose increased [Finding]
   757   C0861064:increased lead [Finding]
   739   C0007634:Cells [Cell]
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   739   C0025519:Metabolism [Organism Function]
   739   C0025520:metabolism [Functional Concept]
   739   C0205217:Increased [Quantitative Concept]
   739   C0330390:Beta [Plant]
   739   C0439096:Beta [Intellectual Product]
   739   C0442805:Increased [Functional Concept]
   739   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   739   C1522538:Lead [Functional Concept]
   739   C2004068:Beta [Qualitative Concept]
   739   C2348269:Lead [Element, Ion, or Isotope]
   739   C3275067:LEAD [Therapeutic or Preventive Procedure]
   739   C3282337:Cells [Cell]
   726   C0030281:Beta cell [Cell]
   706   C0871208:Rate [Activity]
   706 E C1269647:Cell [Cell]
   706   C1521828:Rate [Quantitative Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "consequent alterations in the intracellular ratio of ATP/ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1515926:Alteration [Idea or Concept]

Phrase: "resulting in inhibition of KATP channels."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0332294:Resulting in [Functional Concept]
   790   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0678226:resulting [Functional Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   719   C0439799:Channel [Spatial Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719   C1706095:Channel [Conceptual Entity]
   719 E C2825142:Result [Finding]
Processing 00000000.tx.39: The subsequent depolarization of the [beta]-cell plasma membrane activates voltage-sensitive Ca2+ channels and the ensuing influx of Ca2+ initiates insulin secretion. 

Phrase: "The subsequent depolarization of the [beta]-cell plasma membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1816453:membrane depolarization [Cell Function]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "voltage-sensitive Ca2+ channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0598352:Voltage [Quantitative Concept]
   812   C1550474:sensitive [Idea or Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "the ensuing influx of Ca2+"

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.40: Absence of KATP channel activity in HI has been demonstrated by patch-clamp studies on islet [beta]-cells obtained from affected individuals (15 ,16 ), a finding consistent with the identification of mutations in the SUR1 gene associated with HI (9 ,17 ). 

Phrase: "Absence of KATP channel activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated by patch-clamp studies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0920630:patch clamp [Research Activity]
   760   C0175721:Clamp [Medical Device]
   760   C0332461:Patch [Finding]
   760   C0445403:Patch [Biomedical or Dental Material]
   760   C0947630:studies [Laboratory Procedure]
   760   C0991556:Patch [Medical Device]
   760   C1305400:Patch [Medical Device]
   760   C1533128:Patch [Biomedical or Dental Material]
   760   C1705942:Clamp [Manufactured Object]
   760   C1706366:{Patch} [Quantitative Concept]
   760   C1707974:Patch [Biomedical or Dental Material]
   760   C1883710:Clamp [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "on islet"

Phrase: "[beta]-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "obtained from affected individuals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0392760:Affected [Functional Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]
   737 E C1706701:Obtain [Activity]

Phrase: "(15 ,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "consistent with the identification of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the SUR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "associated with HI"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0020459:Hyperinsulinism [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(9 ,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.41: We previously demonstrated a founder effect for HI in Ashkenazi Jews by extended haplotype analyses of 21 kindreds (8 ). 

Phrase: "We previously"

Phrase: "demonstrated"

Phrase: "a founder effect for HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0242918:Founder Effect [Phenomenon or Process]
   760   C0263541:Founder [Disease or Syndrome]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in Ashkenazi Jews"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337704:ashkenazi jews [Population Group]
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]

Phrase: "by extended haplotype analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "of 21 kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindreds [Qualitative Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.42: In this report, probands from these and an additional four families of Ashkenazi Jewish descent were screened for mutations in the SUR1 gene by single-strand conformation polymorphism (SSCP) analysis of genomic DNA. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "probands from these"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0702111:probands [Organism Attribute]
   756 E C1948021:Proband [Family Group]
   718 E C0702110:Propositus [Organism Attribute]

Phrase: "and"

Phrase: "an additional four families of Ashkenazi Jewish descent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: "were"

Phrase: "screened for mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the SUR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "by single-strand conformation polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243031:single strand conformation polymorphism [Laboratory or Test Result]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(SSCP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: ")"

Phrase: "analysis of genomic DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0200898:DNA analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.43: Two common mutations, deletion of F1388 ([Delta]F1388) and a g -> a transition at position -9 of the 3' splice site of intron 32, were identified. 

Phrase: "Two common mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "deletion of F1388 ([Delta]F1388)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442161:Deletion [Cell or Molecular Dysfunction]
   790   C1511760:Deletion [Genetic Function]
   790   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "a g -> a transition at position -9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0599156:Transition [Cell or Molecular Dysfunction]
   748   C2700061:Transition [Activity]

Phrase: "of the 3' splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887918:3' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "of intron 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.44: The effects of the [Delta]F1388 mutation upon KATP channel activity were examined by 86RbCl efflux measurements in transfected cells expressing Kir6.2/[Delta]F1388 SUR1 KATP channels. 

Phrase: "The effects of the [Delta"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "]F1388 mutation upon KATP channel activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "examined by 86RbCl efflux measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242485:measurements [Functional Concept]
   760   C0332128:Examined [Finding]

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Kir6.2/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 SUR1 KATP channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.45: The data indicate that the [Delta]F1388 mutation impairs KATP channel activity, consistent with the HI disease phenotype of probands possessing this mutation. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "impairs"

Phrase: "KATP channel activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "consistent with the HI disease phenotype of probands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "this mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.46: Extended haplotype analyses of kindreds that possess identical mutations suggest that at least two founder mutations for HI may exist within the Ashkenazi Jewish population. 

Phrase: "Extended haplotype analyses of kindreds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "that"

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "identical mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that at least two founder mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C2985435:Founder Mutation [Cell or Molecular Dysfunction]
   753   C0026882:Mutations [Genetic Function]
   753   C0205448:Two [Quantitative Concept]
   753   C0263541:Founder [Disease or Syndrome]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "may"

Phrase: "exist within the Ashkenazi Jewish population."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0022422:Jewish [Idea or Concept]
   753   C0032659:Population [Quantitative Concept]
   753   C0178443:Jewish [Population Group]
   753   C1257890:Population [Population Group]
   753   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.47: RESULTS SSCP analyses To define the molecular basis of HI in Ashkenazi Jews, DNA samples from 25 probands were screened for mutations within all 39 exons of the SUR1 gene and also, within flanking intron-exon boundaries by SSCP analyses. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "SSCP analyses To"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   823   C0796451:polymorphism analysis [Diagnostic Procedure]
   804   C0026377:Conformation [Spatial Concept]
   804   C0032529:Polymorphism [Genetic Function]
   804   C1704972:Strand [Spatial Concept]
   804   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1882417:Polymorphism [Qualitative Concept]
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]

Phrase: "define"

Phrase: "the molecular basis of HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1853126:MOLECULAR BASIS [Idea or Concept]
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "in Ashkenazi Jews,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337704:ashkenazi jews [Population Group]
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]

Phrase: "DNA samples from 25 probands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "screened for mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within all 39 exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the SUR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "also,"

Phrase: "within flanking intron-exon boundaries"

Phrase: "by SSCP analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0796451:polymorphism analysis [Diagnostic Procedure]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]
Processing 00000000.tx.48: Exons are numbered consecutively from the 5' end of the gene, with the two putative nucleotide-binding folds, NBF-1 and NBF-2, of the SUR1 protein encoded by exons 15-22 and 33-38, respectively (G. Gonzalez, L. Aguilar-Bryan and J. Bryan, GSDB accession #L78208) (10 ). 

Phrase: "Exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "consecutively from the 5' end of the gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1704837:END Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0444930:End [Spatial Concept]
   744   C2746065:End [Temporal Concept]

Phrase: "with the two putative nucleotide-binding folds,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0598153:nucleotide binding fold [Amino Acid Sequence]
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "NBF-1"

Phrase: "and"

Phrase: "NBF-2,"

Phrase: "of the SUR1 protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "encoded by exons 15-22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0679058:encoded [Mental Process]
   760   C2700640:Encoded [Activity]

Phrase: "and"

Phrase: "33-38,"

Phrase: "respectively"

Phrase: "(G. Gonzalez,"

Phrase: "L. Aguilar-Bryan"

Phrase: "and"

Phrase: "J. Bryan,"

Phrase: "GSDB accession #L78208"

Phrase: ")"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.49: Samples demonstrating electrophoretic mobility shifts were detected in some probands and/or control samples for exons 6, 12, 16, 18, 21, 27, 31, 33, 34, 35 and 39 (Figs 2 a and 3 a; data not shown). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "demonstrating"

Phrase: "electrophoretic mobility shifts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0333051:shifts [Functional Concept]
   793 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "detected in some probands"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C0702111:probands [Organism Attribute]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1948021:Proband [Family Group]

Phrase: "and/or"

Phrase: "control samples for exons 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "12,"

Phrase: "16,"

Phrase: "18,"

Phrase: "21,"

Phrase: "27,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "34,"

Phrase: "35"

Phrase: "and"

Phrase: "39"

Phrase: "(Figs 2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "a"

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.50: Mutations in the SUR1 gene in samples displaying such band shifts were identified by nucleotide sequence analyses of polymerase chain reaction (PCR) products amplified in independent reactions from genomic DNA samples. 

Phrase: "Mutations in the SUR1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "such band shifts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0175723:Band [Medical Device]
   861   C0333051:shifts [Functional Concept]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "identified by nucleotide sequence analyses of polymerase chain reaction (PCR) products"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   783   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   760   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   739   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0205396:Identified [Qualitative Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1514468:Products [Entity]
   739   C1519249:Sequence [Functional Concept]
   739   C1524075:Chain [Idea or Concept]
   739   C1550043:Identified [Finding]
   739   C1551388:Identified [Functional Concept]
   706   C0002778:Analysis [Laboratory Procedure]
   706   C0936012:Analysis [Research Activity]
   706   C1524024:analysis [Functional Concept]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "amplified in independent reactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]

Phrase: "from genomic DNA samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.51: A total of 14 different mutations were identified, including 12 putative polymorphisms (see below). 

Phrase: "A total of 14 different mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "12 putative polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.52: Figure 2. 

Phrase: "Figure 2."
Processing 00000000.tx.53: Identification of the exon 34 [Delta]F1388 mutation. 

Phrase: "Identification of the exon 34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.54: (a) SSCP analyses of seven individuals of Ashkenazi Jewish descent. 

Phrase: "(a)"

Phrase: "SSCP analyses"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   844   C0796451:polymorphism analysis [Diagnostic Procedure]
   812   C0026377:Conformation [Spatial Concept]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1704972:Strand [Spatial Concept]
   812   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1882417:Polymorphism [Qualitative Concept]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "of seven individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "of Ashkenazi Jewish descent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680043:descent [Family Group]
Processing 00000000.tx.55: Lanes 1, 2, 3, 5 and 6: unrelated probands; 

Phrase: "Lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: ":"

Phrase: "unrelated probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.56: lane 4: affected sib of the proband in lane 5; 

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "affected sib of the proband"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037047:Sib [Family Group]

Phrase: "in lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.57: lane 7: unaffected control individual. 

Phrase: "lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "unaffected control individual."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.58: Arrows indicate the position of shifted bands in individuals possessing the [Delta]F1388 mutation. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the position of shifted bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:Position [Spatial Concept]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.59: (ii) Nucleotide sequence analyses of exon 34 amplified by PCR from genomic DNA of individuals indicated in lanes 5 (patient) and 7 (normal) in (a). 

Phrase: "(ii"

Phrase: ")"

Phrase: "Nucleotide sequence analyses of exon 34"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "amplified by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "from genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "indicated in lanes 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   737   C1708639:Lane [Spatial Concept]

Phrase: "(patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: ")"

Phrase: "and"

Phrase: "7"

Phrase: "(normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "in ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.60: The nucleotide sequence shown is of the positive-sense strand. 

Phrase: "The nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is of the positive-sense strand."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1883001:Sense Strand [Functional Concept]
   753   C0036658:sense [Organ or Tissue Function]
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1704972:Strand [Spatial Concept]
   753   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.61: Although deletions of either nt 4162-4164 (ttc) or 4163-4165 (tct) may have occurred in the mutant allele, only the position of the ttc deletion is indicated for purposes of clarity. 

Phrase: "Although"

Phrase: "deletions of either nt 4162-4164"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1880274:Deletions [Activity]
   719 E C1442161:Deletion [Cell or Molecular Dysfunction]
   719 E C1511760:Deletion [Genetic Function]

Phrase: "(ttc)"

Phrase: "or"

Phrase: "4163-4165"

Phrase: "(tct)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0677634:TCT [Laboratory Procedure]

Phrase: "may"

Phrase: "have"

Phrase: "occurred in the mutant allele,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the position of the ttc deletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "is"

Phrase: "indicated for purposes of clarity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0486588:Clarity [Clinical Attribute]
   760   C1285529:purposes [Functional Concept]
   760   C1444656:Indicated [Finding]
   760   C3272888:Clarity [Laboratory Procedure]
Processing 00000000.tx.62: (c) RFLP analyses of a kindred possessing the [Delta]F1388 mutation. 

Phrase: "(c) RFLP analyses of a kindred possessing"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   799   C0200930:Restriction fragment length polymorphism analysis [Laboratory Procedure]
   743   C0796451:polymorphism analysis [Diagnostic Procedure]
   739   C0032529:Polymorphism [Genetic Function]
   739   C0332255:fragment [Functional Concept]
   739   C0443288:Restriction [Functional Concept]
   739   C1444754:Length [Quantitative Concept]
   739   C1706316:LENGTH [Research Activity]
   739   C1708096:Fragment [Qualitative Concept]
   739   C1882417:Polymorphism [Qualitative Concept]
   706   C0002778:Analysis [Laboratory Procedure]
   706   C0936012:Analysis [Research Activity]
   706   C1524024:analysis [Functional Concept]

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.63: PCR products encompassing exon 34 were amplified from genomic DNA of all family members and digested with BseRI for 2 h. 

Phrase: "PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "encompassing"

Phrase: "exon 34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "amplified from genomic DNA of all family members"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0086282:Family Members [Family Group]
   770   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0015576:Family [Family Group]
   744   C0017428:Genomic [Gene or Genome]
   744   C0680022:members [Population Group]
   744   C0887950:genomic [Biomedical Occupation or Discipline]
   744   C1704727:Family [Conceptual Entity]
   737 E C1611821:Family Member [Intellectual Product]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "digested with BseRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.64: Restriction digestion products were analyzed on a 3% NuSieve (3:1) agarose gel and visualized by staining with ethidium bromide. 

Phrase: "Restriction digestion products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed on a 3% NuSieve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0936012:Analyzed [Research Activity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "agarose gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1706746:Agarose Gel [Research Device]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0234621:Visualized [Functional Concept]
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "with ethidium bromide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.65: Lane 1: 123 bp marker DNA ladder (Gibco); 

Phrase: "Lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "123 bp marker DNA ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0336762:Ladder [Manufactured Object]

Phrase: "(Gibco"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.66: 2: undigested 274 bp exon 34 PCR product; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "undigested 274 bp exon 34 PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1514468:product [Entity]
   791   C1704444:Product [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.67: 3 and 4: maternal and paternal PCR products following digestion with BseRI, indicating the presence of the undigested wild-type (274 bp) fragment and mutant allele products (144 bp and 130 bp); 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: ":"

Phrase: "maternal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C2347083:Maternal [Family Group]
   944 E C0026591:Mother [Family Group]
   916 E C1826438:MATER [Gene or Genome]

Phrase: "and"

Phrase: "paternal PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "digestion with BseRI,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0012238:Digestion [Organism Function]
   790   C2349986:Digestion [Research Activity]
   734 E C0443277:Peptic [Functional Concept]

Phrase: "indicating"

Phrase: "the presence of the undigested wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(274 bp) fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "mutant allele products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "(144 bp"

Phrase: "and"

Phrase: "130 bp"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.68: 5 and 6: affected sibs homozygous for the [Delta]F1388 mutation. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6"

Phrase: ":"

Phrase: "affected sibs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037047:Sib [Family Group]

Phrase: "homozygous for the [Delta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "]F1388 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.69: Nucleotide sequence analyses of PCR products encompassing exon 34 from DNA samples displaying aberrant SSCP patterns revealed an in-frame deletion of three nucleotides (Fig. 2 a and b). 

Phrase: "Nucleotide sequence analyses of PCR products"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   770   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "encompassing"

Phrase: "exon 34 from DNA samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "aberrant SSCP patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0449774:Patterns [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an in-frame deletion of three nucleotides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.70: Although it is not possible to distinguish by nucleotide sequence analyses whether the nucleotides (nt) 4162-4164 (ttc) or 4163-4165 (tct) are deleted in the mutant allele (Fig. 2 b), both alternatives result in deletion of the codon for phenylalanine at amino acid position 1388 ([Delta]F1388) in NBF-2 and conservation of the adjacent downstream serine amino acid residue (G. Gonzalez, L. Aguilar-Bryan and J. Bryan, GSDB accession #L78208) (10 ). 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "not possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "distinguish by nucleotide sequence analyses"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   806   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "whether"

Phrase: "the nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(nt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "4162-4164"

Phrase: "(ttc)"

Phrase: "or"

Phrase: "4163-4165"

Phrase: "(tct)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0677634:TCT [Laboratory Procedure]

Phrase: "are"

Phrase: "deleted in the mutant allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1880274:Deleted [Activity]

Phrase: "(Fig. 2 b"

Phrase: ")"

Phrase: ","

Phrase: "both alternatives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1523987:Alternative [Conceptual Entity]

Phrase: "result in deletion of the codon"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0009221:Codon [Nucleotide Sequence]
   753   C1095825:Codon [Plant]
   753   C1274040:Result [Functional Concept]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1546471:Result [Idea or Concept]
   753   C1880274:Deletion [Activity]
   753   C2825142:Result [Finding]

Phrase: "for phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at amino acid position 1388"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: "("

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388"

Phrase: ")"

Phrase: "in NBF-2"

Phrase: "and"

Phrase: "conservation of the adjacent downstream serine amino acid residue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2347858:Conservation [Qualitative Concept]

Phrase: "(G. Gonzalez,"

Phrase: "L. Aguilar-Bryan"

Phrase: "and"

Phrase: "J. Bryan,"

Phrase: "GSDB accession #L78208"

Phrase: ")"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.71: Amino acid and nucleotide positions for the human SUR1 protein are numbered relative to the alternatively spliced form of the cDNA, encoding a protein of 1582 amino acids (G. Gonzalez, L. Aguilar-Bryan and J. Bryan, GSDB accession #L78208). 

Phrase: "Amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "nucleotide positions for the human SUR1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0733755:positions [Spatial Concept]

Phrase: "are"

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "relative to the alternatively spliced form of the cDNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a protein of 1582 amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(G. Gonzalez,"

Phrase: "L. Aguilar-Bryan"

Phrase: "and"

Phrase: "J. Bryan,"

Phrase: "GSDB accession #L78208"

Phrase: ")."
Processing 00000000.tx.72: Deletion of either nt 4162-4164 (ttc) or nt 4163-4165 (tct) creates a unique restriction enzyme recognition sequence for BseRI in exon 34 of the mutant allele, allowing identification of non-carriers and individuals homozygous or heterozygous for the [Delta]F1388 mutation. 

Phrase: "Deletion of either nt 4162-4164"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "(ttc)"

Phrase: "or"

Phrase: "nt 4163-4165"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(tct)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0677634:TCT [Laboratory Procedure]

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a unique restriction enzyme recognition sequence for BseRI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "in exon 34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the mutant allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "identification of non-carriers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "or"

Phrase: "heterozygous for the [Delta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygous [Organism Attribute]

Phrase: "]F1388 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.73: A representative mutation analysis profile for one pedigree is shown in Figure 2 c. 

Phrase: "A representative mutation analysis profile for one pedigree"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "shown in Figure 2 c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.74: Following digestion of the 274 bp PCR product with BseRI, probands homozygous for the [Delta]F1388 allele possessed fragments of 144 and 130 bp whereas both heterozygous parents had an undigested 274 bp fragment and two restriction fragments of 144 and 130 bp. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "digestion of the 274 bp PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0012238:Digestion [Organism Function]
   742   C2349986:Digestion [Research Activity]

Phrase: "with BseRI,"

Phrase: "probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "homozygous for the [Delta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "]F1388 allele possessed fragments of 144"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "130 bp"

Phrase: "whereas"

Phrase: "both heterozygous parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0030551:Parents [Family Group]
   827 E C2699423:Parent [Conceptual Entity]

Phrase: "had"

Phrase: "an undigested 274 bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "two restriction fragments of 144"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332255:fragments [Functional Concept]
   760   C0443288:Restriction [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "130 bp."
Processing 00000000.tx.75: Allelic frequencies for the [Delta]F1388 mutation were determined for HI and normal chromosomes by PCR amplification of exon 34 from all 25 probands and from 89 unaffected unrelated Ashkenazi Jews, followed by digestion of the resultant PCR products with BseRI. 

Phrase: "Allelic frequencies for the [Delta"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0017270:allelic frequency [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "determined for HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "and"

Phrase: "normal chromosomes by PCR amplification of exon 34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0008633:Chromosomes [Cell Component]
   716   C1516516:Chromosomal Amplification [Cell or Molecular Dysfunction]

Phrase: "from all 25 probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "and from 89 unaffected unrelated Ashkenazi Jews,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0337704:ashkenazi jews [Population Group]
   748   C0022389:Jews [Population Group]
   748   C0178443:jews [Population Group]
   748   C0445356:Unrelated [Finding]
   748   C1515981:And [Idea or Concept]
   748   C1704623:Unrelated [Qualitative Concept]
   748   C2986417:Unaffected [Conceptual Entity]

Phrase: "followed by digestion of the resultant PCR products"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0332283:Followed by [Temporal Concept]
           followed
   739   C0012238:Digestion [Organism Function]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1514468:Products [Entity]
   739   C1524075:Chain [Idea or Concept]
   739   C2349986:Digestion [Research Activity]
   706 E C1704444:Product [Quantitative Concept]
   706 E C1719822:Follow [Intellectual Product]

Phrase: "with BseRI."
Processing 00000000.tx.76: The [Delta]F1388 mutation was observed on nine of 48 (18.8%) HI alleles and was not detected in the 89 control DNA samples (data not shown). 

Phrase: "The [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed on nine of 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205455:Nine [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "(18.8%"

Phrase: ")"

Phrase: "HI alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected in the 89 control DNA samples"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243148:control [Qualitative Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: Eight probands were heterozygous and one proband, identical by descent for a region (D11S1901-D11S1310) encompassing the SUR1 locus on chromosome 11p15.1, was homozygous for this mutation (see Fig. 2 c). 

Phrase: "Eight probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "were"

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "and"

Phrase: "one proband,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1948021:Proband [Family Group]
   805 E C0702110:Propositus [Organism Attribute]
   777 E C0702111:probands [Organism Attribute]

Phrase: "identical by descent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "for a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "(D11S1901-D11S1310"

Phrase: ")"

Phrase: "encompassing"

Phrase: "the SUR1 locus on chromosome 11p15.1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "homozygous for this mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2 c)."
Processing 00000000.tx.78: Restriction fragment length polymorphism (RFLP) analyses of all immediate family members of the nine probands possessing the [Delta]F1388 mutation revealed co-segregation of this mutation with the HI disease phenotype in each kindred (Fig. 2 c; data not shown). 

Phrase: "Restriction fragment length polymorphism (RFLP) analyses of all immediate family members of the nine probands"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   762   C0200930:Restriction fragment length polymorphism analysis [Laboratory Procedure]
   734   C0032529:Polymorphism [Genetic Function]
   734   C0332255:fragment [Functional Concept]
   734   C0443288:Restriction [Functional Concept]
   734   C1444754:Length [Quantitative Concept]
   734   C1706316:LENGTH [Research Activity]
   734   C1708096:Fragment [Qualitative Concept]
   734   C1882417:Polymorphism [Qualitative Concept]
   731   C0796451:polymorphism analysis [Diagnostic Procedure]
   701   C0002778:Analysis [Laboratory Procedure]
   701   C0936012:Analysis [Research Activity]
   701   C1524024:analysis [Functional Concept]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "co-segregation of this mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "with the HI disease phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "in each kindred"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindred [Qualitative Concept]

Phrase: "(Fig. 2 c"

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: Figure 3. 

Phrase: "Figure 3."
Processing 00000000.tx.80: Identification of the 3992-9g -> a mutation. 

Phrase: "Identification of the 3992-9g -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: ">"

Phrase: "a mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.81: (a) SSCP analyses of six individuals of Ashkenazi Jewish descent. 

Phrase: "(a)"

Phrase: "SSCP analyses"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   844   C0796451:polymorphism analysis [Diagnostic Procedure]
   812   C0026377:Conformation [Spatial Concept]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1704972:Strand [Spatial Concept]
   812   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1882417:Polymorphism [Qualitative Concept]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "of six individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "of Ashkenazi Jewish descent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680043:descent [Family Group]
Processing 00000000.tx.82: Lanes 1, 2, 4 and 5: unrelated probands; 

Phrase: "Lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "unrelated probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.83: lane 3: heterozygous parent of the proband (lane 4); 

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "heterozygous parent of the proband"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030551:parent [Family Group]
   760   C2699423:Parent [Conceptual Entity]

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.84: lane 6: normal unrelated control. 

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "normal unrelated control."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2705716:normal control [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.85: Band shifts in DNA samples possessing the 3992-9g -> a mutation are indicated by an arrow. 

Phrase: "Band shifts in DNA samples"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0175723:Band [Medical Device]
   760   C0333051:shifts [Functional Concept]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]
   726 E C2347509:Shift [Phenomenon or Process]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "indicated by an arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.86: (b) Nucleotide sequence analyses of PCR products spanning exon 33 amplified from genomic DNA of individuals indicated in lanes 4 and 6 in (a). 

Phrase: "(b) Nucleotide sequence analyses of PCR products"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   764   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   708   C0002778:Analysis [Laboratory Procedure]
   708   C0936012:Analysis [Research Activity]
   708   C1524024:analysis [Functional Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "exon 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "amplified from genomic DNA of individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017428:Genomic [Gene or Genome]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "indicated in lanes 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   737   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "6 in ("

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.87: The nucleotide sequence shown is of the reverse complement. 

Phrase: "The nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is of the reverse complement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.88: Exonic and intronic sequences are shown in upper and lower case, respectively. 

Phrase: "Exonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "intronic sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "shown in upper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1282910:Upper [Spatial Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "lower case, respectively."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0441994:Lower [Spatial Concept]
   827   C0868928:Case [Functional Concept]
   827   C1548802:Lower [Body Location or Region]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C2003888:Lower [Activity]
   793 E C0205251:low [Qualitative Concept]
   793 E C1299352:Low [Qualitative Concept]
   793 E C1550472:low [Idea or Concept]
Processing 00000000.tx.89: (c) RFLP analyses of a kindred possessing the 3992-9g -> a mutation. 

Phrase: "(c) RFLP analyses of a kindred possessing"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   799   C0200930:Restriction fragment length polymorphism analysis [Laboratory Procedure]
   743   C0796451:polymorphism analysis [Diagnostic Procedure]
   739   C0032529:Polymorphism [Genetic Function]
   739   C0332255:fragment [Functional Concept]
   739   C0443288:Restriction [Functional Concept]
   739   C1444754:Length [Quantitative Concept]
   739   C1706316:LENGTH [Research Activity]
   739   C1708096:Fragment [Qualitative Concept]
   739   C1882417:Polymorphism [Qualitative Concept]
   706   C0002778:Analysis [Laboratory Procedure]
   706   C0936012:Analysis [Research Activity]
   706   C1524024:analysis [Functional Concept]

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.90: PCR products encompassing exon 33 from all available family members were amplified from genomic DNA and digested with NciI. 

Phrase: "PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "encompassing"

Phrase: "exon 33 from all available family members"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0086282:Family Members [Family Group]
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0015576:Family [Family Group]
   748   C0470187:Available [Functional Concept]
   748   C0680022:members [Population Group]
   748   C1704727:Family [Conceptual Entity]
   745 E C1611821:Family Member [Intellectual Product]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "were"

Phrase: "amplified from genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0017428:Genomic [Gene or Genome]
   770   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "digested with NciI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]
Processing 00000000.tx.91: Restriction digestion products were analyzed on a 3% NuSieve (3:1) agarose gel and visualized by staining with ethidium bromide. 

Phrase: "Restriction digestion products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed on a 3% NuSieve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0936012:Analyzed [Research Activity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "agarose gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1706746:Agarose Gel [Research Device]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0234621:Visualized [Functional Concept]
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "with ethidium bromide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.92: Lanes 1: 123 bp marker DNA ladder (Gibco); 

Phrase: "Lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ":"

Phrase: "123 bp marker DNA ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0336762:Ladder [Manufactured Object]

Phrase: "(Gibco"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.93: 2: undigested 258 bp exon 33 PCR product; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "undigested 258 bp exon 33 PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1514468:product [Entity]
   791   C1704444:Product [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.94: 3 and 4: PCR products amplified from paternal and maternal DNA follwing digestion with NciI, indicating the presence of the mutant (258 bp) fragment and wild-type allele digested into 168 bp and 90 bp fragments; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: ":"

Phrase: "PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "amplified from paternal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0337493:Paternal [Qualitative Concept]
   790   C2347452:Paternal [Family Group]

Phrase: "and"

Phrase: "maternal DNA follwing digestion with NciI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012238:Digestion [Organism Function]
   753   C2349986:Digestion [Research Activity]

Phrase: "indicating"

Phrase: "the presence of the mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(258 bp) fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "wild-type allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "digested into 168 bp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "90 bp fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.95: 5 and 8: unaffected carrier siblings; 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "8"

Phrase: ":"

Phrase: "unaffected carrier siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037047:Siblings [Family Group]
   793 E C1611273:Sibling [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.96: 6 and 7: affected siblings homozygous for the 3992-9g -> a mutation. 

Phrase: "6"

Phrase: "and"

Phrase: "7"

Phrase: ":"

Phrase: "affected siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037047:Siblings [Family Group]
   827 E C1611273:Sibling [Intellectual Product]

Phrase: "homozygous for the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: ">"

Phrase: "a mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.97: Three different band shifts were also detected by SSCP analysis of exon 33 in a subset of probands and/or control samples (Fig. 3 a; data not shown). 

Phrase: "Three different band shifts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0175723:Band [Medical Device]
   812   C0333051:shifts [Functional Concept]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   779 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "also"

Phrase: "detected by SSCP analysis of exon 33"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0796451:polymorphism analysis [Diagnostic Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0026377:Conformation [Spatial Concept]
   742   C0032529:Polymorphism [Genetic Function]
   742   C0442726:Detected [Finding]
   742   C0936012:Analysis [Research Activity]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1524024:analysis [Functional Concept]
   742   C1704972:Strand [Spatial Concept]
   742   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "and/or"

Phrase: "control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: Nucleotide sequence analyses of genomic DNA, amplified by PCR from samples displaying mobility shifts, identified two putative polymorphisms (see below) and a previously reported g -> a transition at position -9 of the 3' splice site of intron 32 (designated 3992-9g -> a, where nt 3992 is the first nucleotide of exon 33) (Fig. 3 b) (9 ). 

Phrase: "Nucleotide sequence analyses of genomic DNA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   820   C0162802:Sequence Analyses, DNA [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   767   C0200898:DNA analysis [Laboratory Procedure]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "amplified by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "from samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "mobility shifts,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333051:shifts [Functional Concept]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two putative polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "a previously reported g ->"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "a transition at position -9 of the 3' splice site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0599156:Transition [Cell or Molecular Dysfunction]
   739   C2700061:Transition [Activity]

Phrase: "of intron 32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "3992-9g -"

Phrase: ">"

Phrase: "a,"

Phrase: "where nt 3992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "the first nucleotide of exon 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "(Fig. 3 b) (9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.99: This mutation has been postulated to activate three cryptic RNA splice sites, resulting in frameshifts and a predicted truncation of the SUR1 molecule (9 ). 

Phrase: "This mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "three cryptic RNA splice sites,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   888   C1720838:Cryptic Splice Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   884   C0887916:RNA Splice Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205145:Sites [Spatial Concept]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "resulting in frameshifts"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332294:Resulting in [Functional Concept]
   790   C0678226:resulting [Functional Concept]
   756   C0079380:Frameshift [Cell or Molecular Dysfunction]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "a predicted truncation of the SUR1 molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1706395:Truncation [Cell or Molecular Dysfunction]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.100: A recognition sequence for the restriction endonuclease NciI is abolished by the 3992-9g -> a mutation so that mutant alleles retain an intact fragment of 258 bp upon digestion with this enzyme whereas wild-type alleles are digested into 168 and 90 bp fragments (Fig. 3 c). 

Phrase: "A recognition sequence for the restriction endonuclease NciI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "abolished by the 3992-9g -"

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that mutant alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "an intact fragment of 258 bp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "upon digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "with this enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "whereas"

Phrase: "wild-type alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Alleles [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "are"

Phrase: "digested into 168"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "90 bp fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig. 3 c)."
Processing 00000000.tx.101: Allelic frequencies for the 3992-9g -> a mutation, determined by RFLP analyses of 25 probands and 89 normal Ashkenazi individuals, indicated that the 3992-9g -> a mutation was the predominant mutation within SUR1 in the probands studied, occurring on 33 of 48 (68.8%) HI chromosomes compared with one of 178 (0.6%) chromosomes from control individuals (data not shown). 

Phrase: "Allelic frequencies for the 3992-9g -"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   773   C0017270:allelic frequency [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: ">"

Phrase: "a mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "determined by RFLP analyses of 25 probands"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   806   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   799   C0200930:Restriction fragment length polymorphism analysis [Laboratory Procedure]
   743   C0796451:polymorphism analysis [Diagnostic Procedure]
   739   C0032529:Polymorphism [Genetic Function]
   739   C0332255:fragment [Functional Concept]
   739   C0443288:Restriction [Functional Concept]
   739   C0702111:probands [Organism Attribute]
   739   C1444754:Length [Quantitative Concept]
   739   C1706316:LENGTH [Research Activity]
   739   C1708096:Fragment [Qualitative Concept]
   739   C1882417:Polymorphism [Qualitative Concept]
   706   C0002778:Analysis [Laboratory Procedure]
   706   C0936012:Analysis [Research Activity]
   706   C1524024:analysis [Functional Concept]
   706 E C1948021:Proband [Family Group]

Phrase: "and"

Phrase: "89 normal Ashkenazi individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "the predominant mutation within SUR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: ","

Phrase: "occurring on 33 of 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "(68.8%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: "HI chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "compared with one of 178"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205447:One [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "(0.6%"

Phrase: ")"

Phrase: "chromosomes from control individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0008633:Chromosomes [Cell Component]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.102: Of the 23 probands who possessed this mutation, 11 were homozygotes and 12 were heterozygotes. 

Phrase: "Of the 23 probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "who"

Phrase: "possessed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0850310:Possessed [Mental or Behavioral Dysfunction]
   966 E C3154893:Possess [Idea or Concept]

Phrase: "this mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "11"

Phrase: "were"

Phrase: "homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygotes [Organism Attribute]

Phrase: "and"

Phrase: "12"

Phrase: "were"

Phrase: "heterozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]
Processing 00000000.tx.103: Co-segregation of the 3992-9g -> a mutation with the HI disease phenotype was observed for 21 of 23 families by RFLP analyses of individual family members (data not shown). 

Phrase: "Co-segregation of the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0080141:segregation [Social Behavior]

Phrase: ">"

Phrase: "a mutation with the HI disease phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed for 21 of 23 families"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015576:Families [Family Group]
   753   C0450348:23 [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "by RFLP analyses"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   966   C0200930:Restriction fragment length polymorphism analysis [Laboratory Procedure]
   937   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   823   C0796451:polymorphism analysis [Diagnostic Procedure]
   804   C0032529:Polymorphism [Genetic Function]
   804   C0332255:fragment [Functional Concept]
   804   C0443288:Restriction [Functional Concept]
   804   C1444754:Length [Quantitative Concept]
   804   C1706316:LENGTH [Research Activity]
   804   C1708096:Fragment [Qualitative Concept]
   804   C1882417:Polymorphism [Qualitative Concept]
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]
   733 E C0205166:Long [Qualitative Concept]
   733 E C1522425:Longest [Qualitative Concept]
   733 E C1706317:Long [Qualitative Concept]

Phrase: "of individual family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: In one family, the proband homozygous for this mutation had two unaffected sibs who were haploidentical for the D11S861- D11S1310 interval encompassing the SUR1 locus (data not shown). 

Phrase: "In one family,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "homozygous for this mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "had"

Phrase: "two unaffected sibs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0037047:Sib [Family Group]

Phrase: "who"

Phrase: "were"

Phrase: "haploidentical for the D11S861- D11S1310 interval"

Phrase: "encompassing"

Phrase: "the SUR1 locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1708726:Locus [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: Although both sibs were large for gestational age, neither possessed any of the other clinical manifestations of HI (B. Glaser and H. Landau, pers. comm.). 

Phrase: "Although"

Phrase: "both sibs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0037047:Sib [Family Group]

Phrase: "were"

Phrase: "large for gestational age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0158915:Large for gestational age [Finding]
           large gestational age
   770   C0549177:Large [Quantitative Concept]

Phrase: "neither"

Phrase: "possessed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0850310:Possessed [Mental or Behavioral Dysfunction]
   966 E C3154893:Possess [Idea or Concept]

Phrase: "any of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552551:Any [Qualitative Concept]
   790   C3272371:ANY [Intellectual Product]

Phrase: "other clinical manifestations of HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   760   C0205319:manifestations [Functional Concept]

Phrase: "(B. Glaser"

Phrase: "and"

Phrase: "H. Landau,"

Phrase: "pers. comm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3639709:COMM [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: In a second family, assuming a recessive mode of inheritance for HI, the proband who was presumed to be a compound heterozygote for the 3992-9g -> a mutation and an unidentified mutation also had an unaffected sib who was haploidentical for all microsatellite markers within the D11S861-D11S1310 interval (data not shown). 

Phrase: "In a second family,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "assuming"

Phrase: "a recessive mode of inheritance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1708511:Mode of Inheritance [Functional Concept]
           Inheritance Mode
   760   C1513371:Mode [Functional Concept]
   760   C1705738:Mode [Quantitative Concept]
   760   C2347637:Mode [Quantitative Concept]
   760   C2348146:Mode [Quantitative Concept]

Phrase: "for HI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "who"

Phrase: "was"

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a compound heterozygote for the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019425:Heterozygote [Organism Attribute]

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "an unidentified mutation also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "an unaffected sib"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037047:Sib [Family Group]

Phrase: "who"

Phrase: "was"

Phrase: "haploidentical for all microsatellite markers"

Phrase: "within the D11S861-D11S1310 interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: Although the proband fulfilled the diagnostic criteria for HI, the possibility that defect(s) in insulin secretion in this patient are attributable to either (i) mutation(s) at another locus or (ii) a mutation at the SUR1 locus and a second mutation at a different locus cannot be excluded at present. 

Phrase: "Although"

Phrase: "the proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "fulfilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Fulfill [Idea or Concept]

Phrase: "the diagnostic criteria for HI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0679228:diagnostic criteria [Intellectual Product]
   760   C0243161:criteria [Intellectual Product]

Phrase: "the possibility"

Phrase: "that defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]

Phrase: "("

Phrase: "s) in insulin secretion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2603362:S' [Clinical Attribute]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in this patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "are"

Phrase: "attributable to either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596130:Attributable [Mental Process]

Phrase: "("

Phrase: "i"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ")"

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "s) at another locus or (ii"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1275771:S. II [Bacterium]
   753   C1708726:Locus [Gene or Genome]
   753   C2603362:S' [Clinical Attribute]

Phrase: ")"

Phrase: "a mutation at the SUR1 locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a second mutation at a different locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded at present."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   790   C1554077:Excluded [Idea or Concept]
   790   C2828389:Excluded [Activity]
   756 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.108: Together, the 3992-9g -> a and [Delta]F1388 mutations are associated with [approx]88% HI alleles in the patient cohort. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a"

Phrase: "and ["

Phrase: "Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "[approx"

Phrase: "]88% HI alleles in the patient cohort."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.109: Mutations were identified on both alleles for 19 of 25 (76.0%) probands, with 11 probands (44.0%) homozygous for the 3992-9g -> a mutation, one (4.0%) homozygous for the [Delta]F1388 mutation, seven (28.0%) were compound heterozygotes possessing both the 3992-9g -> a and [Delta]F1388 mutations and the remaining six (24.0%) probands were presumed to be compound heterozygotes for the 3992-9g -> a or [Delta]F1388 mutations and an unidentified mutation. 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "identified on both alleles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002085:Alleles [Gene or Genome]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "for 19"

Phrase: "of 25"

Phrase: "(76.0%"

Phrase: ")"

Phrase: "probands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "with 11 probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "(44.0%"

Phrase: ")"

Phrase: "homozygous for the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: ">"

Phrase: "a mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "one (4.0%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: ")"

Phrase: "homozygous for the [Delta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "]F1388 mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "(28.0%"

Phrase: ")"

Phrase: "were"

Phrase: "compound heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "both the 3992-9g -"

Phrase: ">"

Phrase: "a"

Phrase: "and ["

Phrase: "Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the remaining six"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205452:Six [Quantitative Concept]
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "(24.0%"

Phrase: ")"

Phrase: "probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "were"

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "compound heterozygotes for the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019425:Heterozygotes [Organism Attribute]

Phrase: ">"

Phrase: "a or [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439097:Delta [Intellectual Product]
   861   C1705241:Delta [Quantitative Concept]
   861   C3146239:Delta [Eukaryote]
   861   C3538806:DELTA [Spatial Concept]
   861   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "an unidentified mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.110: 86Rb+ efflux assays The functional consequences of the [Delta]F1388 mutation upon KATP channel activity were examined by measurement of 86Rb+ efflux in intact COSm6 cells co-transfected with the murine homologue of the KATP channel subunit Kir6.2 (13 ) and either wild-type hamster SUR1 or SUR1 containing the [Delta]F1388 mutation (designated [Delta]F1388SUR1). 

Phrase: "86Rb+ efflux assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "The functional consequences of the [Delta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "]F1388 mutation upon KATP channel activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "examined by measurement of 86Rb+ efflux"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242485:Measurement [Functional Concept]
   753   C0332128:Examined [Finding]

Phrase: "in intact COSm6 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0682538:intact cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with the murine homologue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026809:Murine [Mammal]
   753   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   753   C1334043:Homologue [Gene or Genome]

Phrase: "of the KATP channel subunit Kir6.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1416578:Kir6.2 [Gene or Genome]
   804   C0439799:Channel [Spatial Concept]
   804   C1706095:Channel [Conceptual Entity]
   804   C1711351:Subunit [Quantitative Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "either wild-type hamster SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   804   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "or"

Phrase: "SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1"

Phrase: ")."
Processing 00000000.tx.111: 86Rb+ efflux was assayed in transfected cells following incubation with (i) metabolic inhibitors (2-deoxy- D-glucose and oligomycin) which reduce intracellular ATP levels and increase ADP levels, resulting in opening of KATP channels, or (ii) diazoxide, an activator of KATP channels in islet [beta]-cells or (iii) glibenclamide, an inhibitor of KATP channel activity. 

Phrase: "86Rb+ efflux"

Phrase: "was"

Phrase: "assayed in transfected cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737 E C1269647:Cell [Cell]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation with"

Phrase: "("

Phrase: "i"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ")"

Phrase: "metabolic inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "oligomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028951:Oligomycin [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "which"

Phrase: "reduce"

Phrase: "intracellular ATP levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001480:Adenosine Triphosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0146894:triphosphate [Inorganic Chemical]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "increase ADP levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "resulting in opening of KATP channels,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332294:Resulting in [Functional Concept]
   790   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   753   C0175566:Opening [Spatial Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1882151:Opening [Spatial Concept]
   719   C0439799:Channel [Spatial Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719   C1706095:Channel [Conceptual Entity]
   719 E C2825142:Result [Finding]

Phrase: "or (ii"

Phrase: ")"

Phrase: "diazoxide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "an activator of KATP channels"

Phrase: "in islet"

Phrase: "[beta]-cells or (iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "glibenclamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "an inhibitor of KATP channel activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1153081:channel inhibitor activity [Molecular Function]
   753   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.112: In cells expressing wild-type Kir6.2/SUR1 KATP channels, 86Rb+ efflux was stimulated above basal levels by the presence of either diazoxide or metabolic inhibitors (Fig. 4 ). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type Kir6.2/SUR1 KATP channels,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0379878:Kir6.2 channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   760   C0439799:Channel [Spatial Concept]
   760   C1706095:Channel [Conceptual Entity]

Phrase: "86Rb+ efflux"

Phrase: "was"

Phrase: "stimulated above basal levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205112:Basal [Spatial Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1948023:Stimulated [Natural Phenomenon or Process]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "by the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of either diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   805 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "metabolic inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.113: The KATP channel activity elicited by metabolic inhibition in cells expressing wild-type Kir6.2/SUR1 KATP channels was sensitive to glibenclamide. 

Phrase: "The KATP channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "elicited by metabolic inhibition"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0021469:Metabolic Inhibition [Molecular Function]
           Inhibition
   833   C0449265:Elicited by [Qualitative Concept]
           elicited
   770   C0021467:Inhibition [Mental Process]
   770   C0311400:Metabolic [Functional Concept]
   770   C1524026:Metabolic [Cell Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C2707259:Metabolic [Clinical Attribute]
   770   C3463820:Inhibition [Activity]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type Kir6.2/SUR1 KATP channels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0379878:Kir6.2 channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   760   C0439799:Channel [Spatial Concept]
   760   C1706095:Channel [Conceptual Entity]

Phrase: "was"

Phrase: "sensitive to glibenclamide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.114: Untransfected COSm6 cells or cells transfected with a control plasmid expressing [beta]-galactosidase displayed no stimulation of basal 86Rb+ efflux levels by diazoxide and inhibition of efflux by metabolic inhibitors (Fig. 4 ; data not shown). 

Phrase: "Untransfected COSm6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with a control plasmid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "expressing"

Phrase: "[beta]-galactosidase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0005220:beta-Galactosidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "no stimulation of basal 86Rb+ efflux levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0445093:No stimulation [Functional Concept]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "inhibition of efflux"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "by metabolic inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: In contrast to cells expressing wild-type KATP channels, cells expressing Kir6.2/[Delta]F1388SUR1 channels displayed the same responses as untransfected control cells; 

Phrase: "In contrast to cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type KATP channels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Kir6.2/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1 channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the same responses as untransfected control cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.116: no stimulation by diazoxide and reduced efflux in the presence of metabolic inhibitors. 

Phrase: "no stimulation by diazoxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0445093:No stimulation [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "reduced efflux in the presence of metabolic inhibitors."
Processing 00000000.tx.117: Photolabeling of the 140 kDa SUR1 receptor in transfected cells, using 125I-glibenclamide, indicated that similar levels of SUR1 were expressed in cells co-transfected with Kir6.2/[Delta]F1388SUR1 or wild-type Kir6.2/SUR1 KATP channels (data not shown). 

Phrase: "Photolabeling of the 140 kDa SUR1 receptor"

Phrase: "in transfected cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "125I-glibenclamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that similar levels of SUR1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "expressed in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with Kir6.2/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C1416578:Kir6.2 [Gene or Genome]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1"

Phrase: "or"

Phrase: "wild-type Kir6.2/SUR1 KATP channels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0379878:Kir6.2 channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   760   C0439799:Channel [Spatial Concept]
   760   C1706095:Channel [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.118: Together, these data suggest that [Delta]F1388SUR1 is expressed in transfected cells but is unable to form a functional KATP channel with Kir6.2. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1"

Phrase: "is"

Phrase: "expressed in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a functional KATP channel with Kir6.2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0379878:Kir6.2 channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439799:Channel [Spatial Concept]
   748   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.119: Figure 4. 

Phrase: "Figure 4."
Processing 00000000.tx.120: Comparison of 86Rb+ efflux through wild-type SUR1 and [Delta]F1388SUR1 KATP channels. 

Phrase: "Comparison of 86Rb+ efflux"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "through wild-type SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   812   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "and ["

Phrase: "Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1 KATP channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.121: COSm6 cells were co-transfected with pCMV-Kir6.2 and either pECE-SUR1 (left panel) or pECE-[Delta]F1388SUR1 (right panel) and assayed for 86Rb+ efflux following incubation with either metabolic inhibitors (2-deoxy-D-glucose and oligomycin), which alter the intracellular ATP/ADP ratio, or diazoxide, which activates KATP channel activity. 

Phrase: "COSm6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with pCMV-Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1416578:Kir6.2 [Gene or Genome]

Phrase: "and"

Phrase: "either pECE-SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   827   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "pECE-"

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1"

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "assayed for 86Rb+ efflux"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation with either metabolic inhibitors"

Phrase: "(2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "oligomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028951:Oligomycin [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the intracellular ATP/ADP ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "or"

Phrase: "diazoxide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "KATP channel activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.122: Open squares indicate averaged basal efflux values from transfected and untransfected cells; 

Phrase: "Open squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: "indicate"

Phrase: "averaged basal efflux values from transfected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "untransfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.123: solid squares denote efflux in the presence of 2-deoxy-D-glucose (1 mM) and oligomycin (2.5 [mu]g/ml); 

Phrase: "solid squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: "denote"

Phrase: "efflux in the presence of 2-deoxy-"

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(1 mM)"

Phrase: "and"

Phrase: "oligomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028951:Oligomycin [Antibiotic,Organic Chemical]

Phrase: "(2.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "[mu]g/ml"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0439339:mU/mL [Quantitative Concept]
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
   734   C1532982:mU/g [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.124: solid circles represent efflux in the presence of diazoxide (300 [mu]M); 

Phrase: "solid circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "efflux in the presence of diazoxide"

Phrase: "(300"

Phrase: "[mu]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0347978:Mu [Intellectual Product]

Phrase: "M)"

Phrase: ";"
Processing 00000000.tx.125: open triangles (left panel) indicate efflux in the presence of metabolic inhibitors and glibenclamide (1 [mu]M) and open diamonds (right panel) represent control COSm6 cells incubated in the presence of 2-deoxy-D-glucose and oligomycin. 

Phrase: "open triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205119:triangles [Conceptual Entity]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "indicate"

Phrase: "efflux in the presence of metabolic inhibitors"

Phrase: "and"

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "[mu]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0347978:Mu [Intellectual Product]

Phrase: "M)"

Phrase: "and"

Phrase: "open diamonds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0057717:Diamonds [Element, Ion, or Isotope]
   827 E C1706341:Diamond [Qualitative Concept]

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "control COSm6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in the presence of 2-deoxy-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "oligomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028951:Oligomycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.126: Error bars indicate +- standard deviation. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "indicate"

Phrase: "+- standard deviation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0871420:Standard deviation [Quantitative Concept]
   861   C0012727:Deviation [Spatial Concept]
   861   C0205419:Deviation [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1705236:Deviation [Finding]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.127: Haplotype analyses To identify possible founder haplotypes associated with the [Delta]F1388 or 3992-9g -> a mutations, extended haplotypes were derived for HI and normal chromosomes in parents of the 25 Ashkenazi probands by typing all available individuals within each family for four microsatellite markers (D11S1397, D11S902, D11S921, D11S1890), which are linked to the HI locus (8 ,18 ,19 ). 

Phrase: "Haplotype analyses To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "identify"

Phrase: "possible founder haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "associated with the [Delta"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0439097:Delta [Intellectual Product]
   770   C1705241:Delta [Quantitative Concept]
   770   C3146239:Delta [Eukaryote]
   770   C3538806:DELTA [Spatial Concept]
   770   C3540585:DELTA [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "]F1388"

Phrase: "or"

Phrase: "3992-9g -"

Phrase: ">"

Phrase: "a mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "extended haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "derived for HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "normal chromosomes in parents of the 25 Ashkenazi probands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0008633:Chromosomes [Cell Component]

Phrase: "by typing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441704:Typing [Health Care Activity]
  1000   C0872404:typing [Occupational Activity]

Phrase: "all available individuals within each family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "for four microsatellite markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0005516:Marker [Clinical Attribute]

Phrase: "(D11S1397,"

Phrase: "D11S902,"

Phrase: "D11S921,"

Phrase: "D11S1890"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "linked to the HI locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020459:Hyperinsulinism [Disease or Syndrome]
   760   C1708726:Locus [Gene or Genome]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "(8 ,"

Phrase: "18 ,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.128: The relative order of these markers with respect to the SUR1 locus has been previously established as 11pter- D11S1397-(D11S902- SUR1- D11S921-D11S1890)-11pcen by genetic linkage (18 ,19 ), radiation hybrid (20 ) and physical (21 ) mapping. 

Phrase: "The relative order of these markers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]

Phrase: "with respect to the SUR1 locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1708726:Locus [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "established as 11pter- D11S1397-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443211:Established [Qualitative Concept]
   770   C1272684:Established [Qualitative Concept]

Phrase: "(D11S902- SUR1- D11S921-D11S1890"

Phrase: ")-"

Phrase: "11pcen by genetic linkage"

Phrase: "(18 ,"

Phrase: "19"

Phrase: ")"

Phrase: ","

Phrase: "radiation hybrid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0887811:Radiation Hybrid [Cell]
   861   C0020205:Hybrid [Organism]
   861   C0034519:Radiation [Natural Phenomenon or Process]
   861   C0560559:Radiation [Quantitative Concept]
   861   C0851346:Radiation [Natural Phenomenon or Process]
   861   C1522449:Radiation [Therapeutic or Preventive Procedure]
   861   C1524020:Radiation [Therapeutic or Preventive Procedure]
   861   C1524021:Radiation [Research Activity]

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "physical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031809:Physical [Health Care Activity]
  1000   C0205485:Physical [Functional Concept]
  1000   C1509143:Physical [Finding]

Phrase: "(21"

Phrase: ")"

Phrase: "mapping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283195:Mapping [Activity]
Processing 00000000.tx.129: For 21 of these families, the D11S902-D11S921 haplotypes have been described previously (8 ). 

Phrase: "For 21"

Phrase: "of these families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "the D11S902-D11S921 haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.130: Complete haplotypes were constructed for 47 of 48 HI chromosomes and for 47 of 50 normal chromosomes. 

Phrase: "Complete haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "constructed for 47 of 48 HI chromosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0008633:Chromosomes [Cell Component]
   748   C0020459:Hyperinsulinism [Disease or Syndrome]
   714   C2827421:Construct [Classification]

Phrase: "and for 47 of 50 normal chromosomes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0008633:Chromosomes [Cell Component]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.131: Subgroups were determined by combining haplotypes that differ by <= 2 bp at a single locus on the assumption that such differences are more likely to represent CA repeat slippage than different mutation events (22 ). 

Phrase: "Subgroups"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1079230:subgroups [Virus]
   966 E C1515021:Subgroup [Classification]

Phrase: "were"

Phrase: "determined by combining haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018591:Haplotypes [Organism Attribute]
   737   C0336789:Combine [Manufactured Object]

Phrase: "that"

Phrase: "differ by"

Phrase: "<"

Phrase: "= 2 bp at a single locus"

Phrase: "on the assumption"

Phrase: "that"

Phrase: "such differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "CA repeat slippage than different mutation events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883041:SLIPPAGE [Phenomenon or Process]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.132: No recombination was observed between the HI locus and any of the four microsatellite marker loci (data not shown). 

Phrase: "No recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034865:Recombination [Genetic Function]

Phrase: "was"

Phrase: "observed between the HI locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020459:Hyperinsulinism [Disease or Syndrome]
   760   C1441672:Observed [Functional Concept]
   760   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "any of the four microsatellite marker loci"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1519302:Microsatellite Marker [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           Microsatellite
   748   C0005516:Marker [Clinical Attribute]
   748   C0205450:Four [Quantitative Concept]
   748   C1552551:Any [Qualitative Concept]
   748   C3272371:ANY [Intellectual Product]
   714   C1708726:Locus [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: Table 1 shows the haplotypes present on Ashkenazi HI chromosomes and their corresponding frequencies on normal chromosomes. 

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "present on Ashkenazi HI chromosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008633:Chromosomes [Cell Component]
   760   C0020459:Hyperinsulinism [Disease or Syndrome]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "their corresponding frequencies on normal chromosomes."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.134: Mutations within SUR1 identified on HI chromosomes are also indicated for each haplotype. 

Phrase: "Mutations within SUR1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified on HI chromosomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0008633:Chromosomes [Cell Component]
   770   C0020459:Hyperinsulinism [Disease or Syndrome]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "are"

Phrase: "also"

Phrase: "indicated for each haplotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018591:Haplotype [Organism Attribute]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.135: A total of 35 different haplotypes were detected, with 11 present on HI chromosomes (Table 1 ). 

Phrase: "A total of 35 different haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "with 11 present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "on HI chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.136: A single haplotype, F, was predominant on HI chromosomes, accounting for 25 of 47 (53.2%) disease chromosomes and three of 47 (6.4%) normal chromosomes. 

Phrase: "A single haplotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "was"

Phrase: "predominant on HI chromosomes,"

Phrase: "accounting for 25 of 47"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0000938:Accounting [Occupational Activity]
   726 E C1551359:account [Idea or Concept]
   726 E C2741673:Account # [Clinical Attribute]
   726 E C2981730:Account [Classification]

Phrase: "(53.2%"

Phrase: ")"

Phrase: "disease chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "and"

Phrase: "three of 47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205449:Three [Quantitative Concept]

Phrase: "(6.4%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442748:6/4 [Finding]

Phrase: ")"

Phrase: "normal chromosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]
Processing 00000000.tx.137: The three most frequent F subgroups, F.I, F.II and F.IV, which together account for 48.9% HI chromosomes, were not detected on non-HI chromosomes. 

Phrase: "The three most frequent F subgroups,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1079230:subgroups [Virus]
   771 E C1515021:Subgroup [Classification]

Phrase: "F.I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F.II"

Phrase: "and"

Phrase: "F.IV,"

Phrase: "which together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "account for 48.9% HI chromosomes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0008672:9 chromosome [Cell Component]
   753   C0008633:Chromosomes [Cell Component]
   753   C0020459:Hyperinsulinism [Disease or Syndrome]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected on non-HI chromosomes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0008633:Chromosomes [Cell Component]
   760   C0020459:Hyperinsulinism [Disease or Syndrome]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1518422:Non [Functional Concept]
Processing 00000000.tx.138: Two other frequent haplotypes, H and K, were detected on 10.6% and 19.1% of HI chromosomes, respectively, with corresponding frequencies on normal chromosomes of 2.1% and 10.6%. 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other frequent haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "were"

Phrase: "detected on 10.6%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0439187:/10^6 [Quantitative Concept]
   833   C1881839:10^6 [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "19.1% of HI chromosomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0008651:Chromosome 1 [Cell Component]
   781   C0008661:19 chromosome [Cell Component]
   760   C0008633:Chromosomes [Cell Component]
   760   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "respectively,"

Phrase: "with corresponding frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "on normal chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "of 2.1%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "10.6%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439187:/10^6 [Quantitative Concept]
  1000   C1881839:10^6 [Quantitative Concept]
Processing 00000000.tx.139: Together, haplotypes F, H and K account for 83.0% of the HI chromosomes and 19.1% normal chromosomes of the parents studied. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "haplotypes F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "K account for 83.0% of the HI chromosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1551359:account [Idea or Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]

Phrase: "and"

Phrase: "19.1% normal chromosomes of the parents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0008651:Chromosome 1 [Cell Component]
   757   C0008661:19 chromosome [Cell Component]
   748   C0008633:Chromosomes [Cell Component]

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.140: All other haplotypes were rare, occurring on one of 47 (2.1%) HI chromosomes. 

Phrase: "All"

Phrase: "other haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "rare,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "occurring on one of 47"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205447:One [Quantitative Concept]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "(2.1%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "HI chromosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]
Processing 00000000.tx.141: Of the 34 HI chromosomes bearing the 3992-9g -> a mutation, the majority were represented by the F (73.5%) haplotype and less frequently, by haplotypes H (14.7%), G (2.9%), I (2.9%) and J (2.9%). 

Phrase: "Of the 34 HI chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "represented by the F (73.5%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0439133:(f) [Intellectual Product]
   753   C1553038:[f] [Quantitative Concept]
   719   C1882932:Represent [Activity]

Phrase: ")"

Phrase: "haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "and"

Phrase: "less frequently,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332183:Frequently [Temporal Concept]
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "by haplotypes H (14.7%"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   861   C0593972:14 7 [Quantitative Concept]
   812   C0018591:Haplotypes [Organism Attribute]
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "G (2.9%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "I (2.9%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "and"

Phrase: "J (2.9%"

Phrase: ")."
Processing 00000000.tx.142: In contrast, the [Delta]F1388 mutation was associated exclusively with haplotype K (sub- haplotypes K.I, K.II). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "exclusively with haplotype K (sub- haplotypes K.I,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0018591:Haplotype [Organism Attribute]
           Haplotypes
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0542339:Sub- [Spatial Concept]
   744   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1264637:SUB [Quantitative Concept]
   744   C1708601:K' [Quantitative Concept]

Phrase: "K.II"

Phrase: ")."
Processing 00000000.tx.143: Neither of these mutations were detected on normal chromosomes bearing the F, H, I, J or K haplotypes. 

Phrase: "Neither of these mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0026882:Mutations [Genetic Function]
   770   C3274651:Neither [Qualitative Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "detected on normal chromosomes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0008633:Chromosomes [Cell Component]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J"

Phrase: "or"

Phrase: "K haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.144: These data are consistent with the presence of at least two founder chromosomes for HI in Ashkenazi Jews. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the presence of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "at least two founder chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008633:Chromosomes [Cell Component]

Phrase: "for HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "in Ashkenazi Jews."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337704:ashkenazi jews [Population Group]
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]
Processing 00000000.tx.145: Table 1 Association between haplotypes on HI chromosomes and SUR1 mutations Polymorphisms within the SUR1 gene In addition to the SSCP variants described above for exons 33 and 34, band shifts were also detected for some probands and/or control samples on SSCP for exons 6, 12, 16, 18, 21, 27, 31, 33, 34, 35 and 39 (data not shown). 

Phrase: "Table 1 Association between haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "on HI chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]

Phrase: "and"

Phrase: "SUR1 mutations Polymorphisms within the SUR1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0678951:gene polymorphisms [Genetic Function]
   742   C0032529:polymorphisms [Genetic Function]
   708 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "In addition to the SSCP variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above for exons 33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1282910:Above [Spatial Concept]
   770   C1552828:above [Idea or Concept]

Phrase: "and"

Phrase: "34,"

Phrase: "band shifts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0175723:Band [Medical Device]
   861   C0333051:shifts [Functional Concept]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "also"

Phrase: "detected for some probands"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C0702111:probands [Organism Attribute]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1948021:Proband [Family Group]

Phrase: "and/or"

Phrase: "control samples on SSCP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "for exons 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "12,"

Phrase: "16,"

Phrase: "18,"

Phrase: "21,"

Phrase: "27,"

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "33,"

Phrase: "34,"

Phrase: "35"

Phrase: "and"

Phrase: "39"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: Nucleotide sequence analyses revealed a total of 12 different point mutations within the SUR1 gene which were classified as polymorphisms on the basis that they: (i) do not modify the amino acid sequence of the protein; 

Phrase: "Nucleotide sequence analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0004793:Nucleotide Sequence [Nucleotide Sequence]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a total of 12 different point mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]

Phrase: "within the SUR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "which"

Phrase: "were"

Phrase: "classified as polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0008902:Classified [Classification]
   790   C0032529:polymorphisms [Genetic Function]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "on the basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1527178:Basis [Functional Concept]
  1000   C1874451:Basis [Pharmacologic Substance]

Phrase: "that"

Phrase: "they"

Phrase: ":"

Phrase: "("

Phrase: "i"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ")"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the amino acid sequence of the protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   879   C0920679:aminoacid sequence of protein [Amino Acid Sequence]
   814   C0002518:Amino Acid Sequence [Amino Acid Sequence]
           Protein Sequence
   804   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0202406:Acid [Laboratory Procedure]
   748   C1519249:Sequence [Functional Concept]

Phrase: ";"
Processing 00000000.tx.147: or (ii) result in conservative amino acid substitutions in apparently non-highly conserved residues of the protein; 

Phrase: "or (ii"

Phrase: ")"

Phrase: "result in conservative amino acid substitutions"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   719   C1555721:Substitution [Idea or Concept]
   719   C1706204:Substitution [Activity]

Phrase: "in apparently non-highly conserved residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.148: or (iii) are present on normal chromosomes from the control Ashkenazi population (Table 2 ). 

Phrase: "or (iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "present on normal chromosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "from the control Ashkenazi population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0032662:control population [Occupation or Discipline]
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.149: To determine whether these polymorphisms created potential novel 5' or 3' splice sites, Shapiro/Senapathy consensus values (23 ) were calculated for positions -3 to +6 for possible 5' splice site sequences (containing GT) and for positions -14 to +1 for potential 3' splice site sequences (containing AG). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "these polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "potential novel 5'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205314:Novel [Temporal Concept]
   827   C0679622:novel [Intellectual Product]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "or"

Phrase: "3' splice sites,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887918:Splice Sites, 3' [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "Shapiro/Senapathy consensus values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "calculated for positions -3 to +6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0444686:Calculated [Functional Concept]
   753   C0733755:positions [Spatial Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]

Phrase: "for possible 5' splice site sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "(containing GT)"

Phrase: "and for positions -14 to +1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0733755:positions [Spatial Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "for potential 3' splice site sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "(containing AG"

Phrase: ")."
Processing 00000000.tx.150: Consensus values were calculated for all subsequences encompassing the putative polymorphism and varied from a minimum value of 0.214 (nt 4717g -> a) to a maximum of 0.731 (nt 1686t -> c) for possible 5' splice sites, and from 0.302 (nt 4123-25c -> t) to 0.829 (nt 3822g -> a) for 3' splice site consensus values. 

Phrase: "Consensus values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated for all subsequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]

Phrase: "encompassing"

Phrase: "the putative polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "varied from a minimum value of 0.214"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1522609:Value [Quantitative Concept]
   744   C1524031:Minimum [Qualitative Concept]
   744   C1552614:minimum [Idea or Concept]
   744   C2826545:MINIMUM [Quantitative Concept]

Phrase: "(nt 4717g -"

Phrase: "> a) to a maximum of 0.731"

Phrase: "(nt 1686t -"

Phrase: "> c) for possible 5' splice sites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1553033:[c] [Quantitative Concept]

Phrase: "and from 0.302"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(nt 4123-25c -"

Phrase: "> t) to 0.829"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2603360:T' [Clinical Attribute]

Phrase: "(nt 3822g -"

Phrase: "> a) for 3' splice site consensus values."
Processing 00000000.tx.151: However, in each case the consensus values for the mutated sites were lower than values calculated for the normal site (data not shown), suggesting that novel 5' or 3' splice sites are unlikely to be created by the polymorphisms identified here. 

Phrase: "However,"

Phrase: "in each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the consensus values for the mutated sites"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "lower than values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "calculated for the normal site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0205145:Site [Spatial Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1515974:Site [Body Location or Region]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2825164:Site [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that novel 5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205314:Novel [Temporal Concept]
   861   C0679622:novel [Intellectual Product]

Phrase: "or"

Phrase: "3' splice sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887918:Splice Sites, 3' [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "be"

Phrase: "created by the polymorphisms"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C1707531:Created By [Qualitative Concept]
   770   C0032529:polymorphisms [Genetic Function]
   770   C1706214:Created [Activity]
   737 E C1882417:Polymorphism [Qualitative Concept]
   737 E C3244320:create [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "here."
Processing 00000000.tx.152: Nonetheless, the possibility that some of the identified polymorphisms either augment or ameliorate the deleterious effects of familial hyperinsulinism mutations upon KATP channel activity and insulin secretion cannot be excluded at present. 

Phrase: "Nonetheless,"

Phrase: "the possibility"

Phrase: "that"

Phrase: "some of the identified polymorphisms either"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0032529:polymorphisms [Genetic Function]
   753   C0205392:Some [Quantitative Concept]
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C3540770:Some [Intellectual Product]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "or"

Phrase: "ameliorate"

Phrase: "the deleterious effects of familial hyperinsulinism mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "upon KATP channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded at present."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   790   C1554077:Excluded [Idea or Concept]
   790   C2828389:Excluded [Activity]
   756 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.153: Table 2 Polymorphisms within the SUR1 geneaNucleotide and codon positions are according to the full-length human SUR1 cDNA sequence incorporating the alternative spliced form of exon 17 (GenBank accession no L78208; L78224).bTm designates putative transmembrane domain.cMutation was detected on HI and/or normal chromosomes. 

Phrase: "Table 2 Polymorphisms within the SUR1 geneaNucleotide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "codon positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "are according to the full-length human SUR1 cDNA sequence"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   753   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   753   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   751   C0058595:DNA receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0004793:Sequence [Nucleotide Sequence]
   736   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   736   C0086418:Human [Human]
   736   C0162327:Sequence [Nucleotide Sequence]
   736   C0443225:Full [Qualitative Concept]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   736   C0680240:according [Social Behavior]
   736   C1444754:Length [Quantitative Concept]
   736   C1519249:Sequence [Functional Concept]
   736   C1551058:Are [Quantitative Concept]
   736   C1706316:LENGTH [Research Activity]
   736   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "incorporating"

Phrase: "the alternative spliced form of exon 17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "(GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no L78208"

Phrase: "; L78224"

Phrase: ").bTm"

Phrase: "designates"

Phrase: "putative transmembrane domain.cMutation"

Phrase: "was"

Phrase: "detected on HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "normal chromosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosomes [Cell Component]
Processing 00000000.tx.154: DISCUSSION The sulfonylurea receptor (SUR1) is involved in nucleotide regulation of KATP channel activity and is, therefore, a central component in the mechanism of glucose-regulated insulin secretion in pancreatic islet [beta]-cells (13 ,14 ). 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "The sulfonylurea receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "(SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: ")"

Phrase: "is"

Phrase: "involved in nucleotide regulation of KATP channel activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1153410:channel activity [Molecular Function]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0439799:Channel [Spatial Concept]
   744   C0441655:Activity [Activity]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1561536:*Activity [Idea or Concept]
   744   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: ","

Phrase: "therefore,"

Phrase: "a central component in the mechanism of glucose-regulated insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0449432:Component [Manufactured Object]
   738   C1705248:Component [Conceptual Entity]

Phrase: "in pancreatic islet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "[beta]-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(13 ,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.155: In this study, 25 HI patients of Ashkenazi Jewish descent were screened for mutations in the SUR1 gene and specific haplotypes associated with identified mutations were defined. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "25 HI patients of Ashkenazi Jewish descent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "screened for mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0026882:Mutations [Genetic Function]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the SUR1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "specific haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "associated with identified mutations"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026882:Mutations [Genetic Function]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "were"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.156: Two common mutations associated with HI in this population were identified, a novel deletion of F1388 in NBF-2 and a previously described point mutation at position -9 of the 3' splice site of intron 32 (9 ). 

Phrase: "Two common mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with HI"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0020459:Hyperinsulinism [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in this population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "a novel deletion of F1388"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "in NBF-2"

Phrase: "and"

Phrase: "a previously described point mutation at position -9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   767   C2924612:A point [Body Location or Region]
   744   C0026882:Mutation [Genetic Function]
   744   C1552961:Point [Quantitative Concept]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C2347617:point [Quantitative Concept]

Phrase: "of the 3' splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887918:3' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "of intron 32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.157: The 3992-9g -> a mutation, which is the most prevalent mutation in the SUR1 gene in Ashkenazis with HI, has also been previously detected in one proband of Saudi Arabian origin (9 ). 

Phrase: "The 3992-9g -"

Phrase: ">"

Phrase: "a mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "is"

Phrase: "the most prevalent mutation in the SUR1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0596611:Gene Mutation [Genetic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Ashkenazis"

Phrase: "with HI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "previously"

Phrase: "detected in one proband of Saudi Arabian origin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0079946:origin [Classification]
   744   C0205447:One [Quantitative Concept]
   744   C0238686:ARABIAN [Finding]
   744   C0439659:Origin [Temporal Concept]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1550512:origin [Intellectual Product]
   744   C1948021:Proband [Family Group]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.158: In contrast, the [Delta]F1388 mutation, which accounted for 19% HI alleles, was not observed in RFLP analyses of 50 non-Ashkenazi probands of various ethnic origins and may, therefore, be associated predominantly with HI in Ashkenazi Jews (A. Nestorowicz, unpublished data). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "accounted for 19% HI alleles,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002085:Alleles [Gene or Genome]
   760   C0020459:Hyperinsulinism [Disease or Syndrome]
   726   C1551359:account [Idea or Concept]
   726   C2741673:Account # [Clinical Attribute]
   726   C2981730:Account [Classification]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in RFLP analyses of 50 non-Ashkenazi probands"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   777   C0200930:Restriction fragment length polymorphism analysis [Laboratory Procedure]
   736   C0032529:Polymorphism [Genetic Function]
   736   C0332255:fragment [Functional Concept]
   736   C0443288:Restriction [Functional Concept]
   736   C0702111:probands [Organism Attribute]
   736   C0796451:polymorphism analysis [Diagnostic Procedure]
   736   C1441672:Observed [Functional Concept]
   736   C1444754:Length [Quantitative Concept]
   736   C1518422:Non [Functional Concept]
   736   C1706316:LENGTH [Research Activity]
   736   C1708096:Fragment [Qualitative Concept]
   736   C1882417:Polymorphism [Qualitative Concept]
   703   C0002778:Analysis [Laboratory Procedure]
   703   C0936012:Analysis [Research Activity]
   703   C1524024:analysis [Functional Concept]
   703 E C1948021:Proband [Family Group]

Phrase: "of various ethnic origins"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   901   C0015031:Ethnic Origins [Population Group]
   827   C0079946:origins [Classification]
   827   C0439659:Origins [Temporal Concept]
   793 E C1550512:origin [Intellectual Product]
   755 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   755 E C0314603:Genetic [Functional Concept]
   743 E C0205313:Original [Idea or Concept]
   743 E C2347409:Original [Occupational Activity]
   734 E C0005615:Birth [Organism Function]
   734 E C0035150:Reproduction [Organism Function]
   734 E C1550722:birth [Idea or Concept]
   734 E C3245487:birth [Intellectual Product]
   721 E C0454729:Natal [Geographic Area]
   721 E C0559522:Genital [Body System]
   721 E C0598240:originality [Mental Process]
   721 E C1546649:Genital [Intellectual Product]
   721 E C1550642:Genital [Body Substance]

Phrase: "and"

Phrase: "may"

Phrase: ","

Phrase: "therefore,"

Phrase: "be"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "predominantly with HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "in Ashkenazi Jews"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337704:ashkenazi jews [Population Group]
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]

Phrase: "(A. Nestorowicz,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.159: To date, only four mutations in the SUR1 gene have been reported. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "only four mutations in the SUR1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.160: In addition to the 3992-9g -> a and [Delta]F1388 mutations described here, we previously decribed a missense mutation (G1479R) in exon 37 in a proband of Sephardic Jewish origin (17 ), and a g -> a transition at position -1 of the 5' splice site of intron 35 was reported for seven probands of Saudi Arabian origin and one proband of German descent (9 ). 

Phrase: "In addition to the 3992-9g -"

Phrase: ">"

Phrase: "a"

Phrase: "and ["

Phrase: "Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here,"

Phrase: "we previously decribed"

Phrase: "a missense mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599155:Missense Mutation [Genetic Function]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(G1479R"

Phrase: ")"

Phrase: "in exon 37"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in a proband"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "of Sephardic Jewish origin"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   827   C0079946:origin [Classification]
   827   C0439659:Origin [Temporal Concept]
   827   C1550512:origin [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   743 E C0005615:Birth [Organism Function]
   743 E C0035150:Reproduction [Organism Function]
   743 E C1550722:birth [Idea or Concept]
   743 E C3245487:birth [Intellectual Product]
   727 E C0454729:Natal [Geographic Area]
   727 E C0559522:Genital [Body System]
   727 E C0598240:originality [Mental Process]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a g -> a transition at position -1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0599156:Transition [Cell or Molecular Dysfunction]
   748   C2700061:Transition [Activity]

Phrase: "of the 5' splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "of intron 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "reported for seven probands of Saudi Arabian origin"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   744   C0079946:origin [Classification]
   744   C0205453:Seven [Quantitative Concept]
   744   C0238686:ARABIAN [Finding]
   744   C0439659:Origin [Temporal Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C0702111:probands [Organism Attribute]
   744   C1550512:origin [Intellectual Product]
   744   C3496591:Reported [Clinical Attribute]
   714   C2919603:Original report [Intellectual Product]
   711 E C1948021:Proband [Family Group]
   711 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "one proband of German descent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1948021:Proband [Family Group]
   704 E C0702110:Propositus [Organism Attribute]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.161: However, neither of these additional mutations were detected, either by RFLP or SSCP analyses of exons 35 and 37, in the 25 Ashkenazi Jewish families studied here (data not shown). 

Phrase: "However,"

Phrase: "neither of these additional mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0026882:Mutations [Genetic Function]
   760   C1524062:Additional [Functional Concept]
   760   C3274651:Neither [Qualitative Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "either by RFLP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   753   C0032529:Polymorphism [Genetic Function]
   753   C0332255:fragment [Functional Concept]
   753   C0443288:Restriction [Functional Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C1708096:Fragment [Qualitative Concept]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "or"

Phrase: "SSCP analyses of exons 35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0796451:polymorphism analysis [Diagnostic Procedure]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "37,"

Phrase: "in the 25 Ashkenazi Jewish families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: The allelic homogeneity described here for HI in Ashkenazi Jews presumably reflects the relative isolation of this population (24 ) and has also been observed for several other autosomal recessive disorders in Ashkenazis, including Canavan disease (25 ,26 ), Gaucher disease (27 ), Fanconi anemia (28 ) and glycogenesis VII (29 ). 

Phrase: "The allelic homogeneity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881065:Homogeneity [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here for HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "in Ashkenazi Jews presumably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0337704:ashkenazi jews [Population Group]
   827   C0022389:Jews [Population Group]
   827   C0178443:jews [Population Group]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the relative isolation of this population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "observed for several"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "other autosomal recessive disorders in Ashkenazis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012634:Disorders [Disease or Syndrome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Canavan disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0206307:Canavan Disease [Disease or Syndrome]
  1000   C1412591:Canavan disease [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(25 ,"

Phrase: "26"

Phrase: ")"

Phrase: ","

Phrase: "Gaucher disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0017205:Gaucher Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "Fanconi anemia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0015625:Fanconi Anemia [Disease or Syndrome]
  1000   C3469521:FANCONI ANEMIA [Disease or Syndrome]
   861   C0002871:Anaemia [Disease or Syndrome]
   861   C1000483:Anemia [Plant]
   789 E C0857322:anaemic [Finding]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "glycogenesis VII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445385:VII [Intellectual Product]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.163: At present, it is unclear whether the 3992-9g -> a mutation has a causal role in the disease process or is a polymorphism highly associated with a disease causing mutation located elsewhere, either within the SUR1 gene or a nearby locus. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unclear"

Phrase: "whether"

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "a causal role in the disease process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "is"

Phrase: "a polymorphism highly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with a disease causing mutation"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0243083:associated disease [Pathologic Function]
   773   C1314792:disease cause [Functional Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0026882:Mutation [Genetic Function]
   753   C0678227:Causing [Functional Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   719 E C0015127:cause [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1524003:Cause [Conceptual Entity]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "located"

Phrase: "elsewhere,"

Phrase: "either within the SUR1 gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1335671:Receptor Gene [Gene or Genome]
   790   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "or"

Phrase: "a nearby locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.164: The effect(s) of the 3992-9g -> a mutation upon RNA splicing have been examined by transfection of a human glioblastoma cell line (SNB19) with mini-gene constructs containing the exon 33 and flanking exons of SUR1 inserted downstream from a RSV promoter (9 ). 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "s) of the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2603362:S' [Clinical Attribute]

Phrase: ">"

Phrase: "a mutation upon RNA splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "examined by transfection of a human glioblastoma cell line"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   784   C0682523:Human Cell Line [Cell]
   764   C0007600:Cell Line [Cell]
   762   C0427861:cell human [Laboratory or Test Result]
   742   C0007634:Cell [Cell]
   742   C0017636:Glioblastoma [Neoplastic Process]
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   742   C0086418:Human [Human]
   742   C0205132:Line [Spatial Concept]
   742   C0332128:Examined [Finding]
   742   C1269647:Cell [Cell]
   742   C1550648:Line [Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "(SNB19"

Phrase: ")"

Phrase: "with mini-gene constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the exon 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "flanking exons of SUR1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "inserted downstream from a RSV promoter"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441587:Inserted [Health Care Activity]
   753   C0522506:Downstream [Spatial Concept]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.165: Comparison of cDNA products from wild-type and mutant constructs revealed that activation of three separate 3' cryptic splice sites occurred in constructs containing the 3992-9g -> a mutation, resulting in a 7 bp addition or deletions of 20 or 30 bp. 

Phrase: "Comparison of cDNA products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "from wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that activation of three separate 3' cryptic splice sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1879547:Activation [Activity]

Phrase: "occurred in constructs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]
   756   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "resulting in a 7 bp addition"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0332294:Resulting in [Functional Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1883712:Addition [Functional Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "or"

Phrase: "deletions of 20"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1880274:Deletions [Activity]
   756 E C1442161:Deletion [Cell or Molecular Dysfunction]
   756 E C1511760:Deletion [Genetic Function]

Phrase: "or"

Phrase: "30 bp."
Processing 00000000.tx.166: Consequent frameshifts associated with these additions/deletions are predicted to result in deletion of the entire NBF-2 domain (Fig. 1 ) (9 ). 

Phrase: "Consequent frameshifts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0079380:Frameshift [Cell or Molecular Dysfunction]

Phrase: "associated with these additions/deletions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1880274:Deletions [Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C1883712:Addition [Functional Concept]

Phrase: "are"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in deletion of the entire NBF-2 domain"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0439751:Entire [Quantitative Concept]
   742   C0444667:Entire [Quantitative Concept]
   742   C1274040:Result [Functional Concept]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1546471:Result [Idea or Concept]
   742   C1880274:Deletion [Activity]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C2825142:Result [Finding]
   742   C3541951:Domain [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.167: Although specific role(s) of NBF-2 remain to be elucidated, site-directed mutagenesis studies of NBF-2 in which G1479 was replaced with R have shown that MgADP stimulation of KATP channel activity occurs through binding in this domain (17 ). 

Phrase: "Although"

Phrase: "specific role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "("

Phrase: "s) of NBF-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C2722359:S-2 [Organic Chemical,Pharmacologic Substance]
   770   C2603362:S' [Clinical Attribute]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated"

Phrase: ","

Phrase: "site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "studies of NBF-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "in which G1479"

Phrase: "was"

Phrase: "replaced with R"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0205090:R- [Spatial Concept]
   790   C0559956:Replaced [Functional Concept]
   790   C0684010:R. [Professional or Occupational Group]
   790   C1299987:replaced [Functional Concept]
   790   C2603358:R' [Clinical Attribute]
   756 E C1554078:Replace [Idea or Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that MgADP stimulation of KATP channel activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "occurs through binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "in this domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.168: Deletion of NBF-2 in 3992-9g -> a alleles may, therefore, not only prevent binding of ATP to NBF-2 but may also abolish responsiveness of SUR1 to MgADP. 

Phrase: "Deletion of NBF-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "in 3992-9g -"

Phrase: ">"

Phrase: "a alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "may"

Phrase: ","

Phrase: "therefore,"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "binding of ATP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0001480:Adenosine Triphosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   770   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0146894:triphosphate [Inorganic Chemical]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to NBF-2"

Phrase: "but"

Phrase: "may"

Phrase: "also"

Phrase: "abolish"

Phrase: "responsiveness of SUR1"

Phrase: "to MgADP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024468:MgADP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.169: Unresponsiveness to MgADP is predicted to result in a net reduction of channel activity at any ADP/ATP ratio, a hypothesis consistent with the loss of regulation of glucose-induced insulin secretion observed in the HI disease phenotype (17 ). 

Phrase: "Unresponsiveness to MgADP"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0241526:Unresponsiveness [Finding]
   718 E C0205269:Unresponsive [Functional Concept]
   718 E C0237284:Unresponsive [Finding]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in a net reduction of channel activity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C1153410:channel activity [Molecular Function]
   767   C2267000:Reduction Activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0439799:Channel [Spatial Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C0441655:Activity [Activity]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C1706095:Channel [Conceptual Entity]
   744   C2825142:Result [Finding]

Phrase: "at any ADP/ATP ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "a hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "consistent with the loss of regulation of glucose-induced insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "observed in the HI disease phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0012634:Disease [Disease or Syndrome]
   753   C0020459:Hyperinsulinism [Disease or Syndrome]
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]
   753   C1441672:Observed [Functional Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.170: Although cryptic spice site activation was demonstrated in transfected glioblastoma (SNB19) cells (9 ) it is unknown whether such aberrant RNA splicing of 3992-9g -> a mutant alleles occurs in islet [beta]-cells in vivo in the HI patients studied here. 

Phrase: "Although"

Phrase: "cryptic spice site activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "demonstrated in transfected glioblastoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017636:Glioblastoma [Neoplastic Process]

Phrase: "(SNB19"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(9"

Phrase: ")"

Phrase: "it"

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "whether"

Phrase: "such aberrant RNA splicing of 3992-9g -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0035687:RNA Splicing [Genetic Function]
           Splicing
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C2610186:splicing [Genetic Function]

Phrase: ">"

Phrase: "a mutant alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "occurs in islet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "[beta]-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in vivo in the HI patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here."
Processing 00000000.tx.171: Formal proof of cryptic splice site utilization will require isolation and nucleotide sequence analyses of SUR1 cDNA from affected probands possessing the 3992-9g -> a allele. 

Phrase: "Formal proof of cryptic splice site utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0556981:% proof [Quantitative Concept]

Phrase: "will"

Phrase: "require"

Phrase: "isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "nucleotide sequence analyses of SUR1 cDNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0162802:Sequence Analyses, DNA [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   750   C0200898:DNA analysis [Laboratory Procedure]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "from affected probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.172: Intrafamilial variation in disease phenotype was observed for one family in which the proband, who was homozygous for the 3992-9g -> a mutation, had two unaffected haploidentical sibs (data not shown). 

Phrase: "Intrafamilial variation in disease phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C2675094:Intrafamilial variation [Finding]
   760   C0205419:Variation [Qualitative Concept]

Phrase: "was"

Phrase: "observed for one family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015576:Family [Family Group]
   770   C0205447:One [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1704727:Family [Conceptual Entity]

Phrase: "in which"

Phrase: "the proband,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1948021:Proband [Family Group]
   944 E C0702110:Propositus [Organism Attribute]
   916 E C0702111:probands [Organism Attribute]

Phrase: "who"

Phrase: "was"

Phrase: "homozygous for the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: ">"

Phrase: "a mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "two unaffected haploidentical sibs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0037047:Sib [Family Group]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.173: However, both unaffected haploidentical sibs were large for gestational age (H. Landau and B. Glaser, unpublished data) and it is possible that these children exhibit(ed) subtle defects in regulation of glucose-induced insulin secretion. 

Phrase: "However,"

Phrase: "both unaffected haploidentical sibs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0037047:Sib [Family Group]

Phrase: "were"

Phrase: "large for gestational age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0158915:Large for gestational age [Finding]
           large gestational age
   770   C0549177:Large [Quantitative Concept]

Phrase: "(H. Landau"

Phrase: "and"

Phrase: "B. Glaser,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "these children"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Children [Age Group]
  1000   C0680063:Children [Family Group]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "(ed) subtle defects in regulation of glucose-induced insulin secretion."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0243067:defects [Functional Concept]
   706 E C1457869:Defect [Functional Concept]
   706 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.174: Such variation in phenotypic expression has also been described for a number of other autosomal recessive disorders including Gaucher disease (27 ). 

Phrase: "Such variation in phenotypic expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1836717:Phenotypic variation [Finding]
   760   C0205419:Variation [Qualitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "described for a number of other autosomal recessive disorders"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0441748:Autosomal recessive [Intellectual Product]
   760   C0449811:Number of autosome [Quantitative Concept]
           autosomes number
   742   C0012634:Disorders [Disease or Syndrome]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0596142:autosomal [Cell Component]
   742   C1552738:described [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Gaucher disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0017205:Gaucher Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.175: The mechanism(s) underlying this variable phenotypic expression of HI is unknown. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s)"

Phrase: "underlying"

Phrase: "this variable phenotypic expression of HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1863108:Variable phenotypic expression [Finding]
   790   C0031437:Phenotypic expression [Organism Attribute]
   783   C1868500:Variable expression [Finding]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.176: Clinical heterogeneity may be due to the effects of modifier genes (genetic background), metabolic interferences and/or exogenous factors that modulate the expression of the HI phenotype. 

Phrase: "Clinical heterogeneity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850620:Clinical heterogeneity [Finding]
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "may"

Phrase: "be due to the effects of modifier genes"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0678226:Due to [Functional Concept]
           due
   770   C3178895:Genes, Modifier [Gene or Genome]
   750   C0681891:effect modifier [Functional Concept]
   744   C0017337:Genes [Gene or Genome]
   744   C0205349:Modifier [Qualitative Concept]
   744   C1280500:effects [Qualitative Concept]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]
   744   C3542952:Modifier [Intellectual Product]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "(genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: ")"

Phrase: ","

Phrase: "metabolic interferences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521102:Interference [Qualitative Concept]

Phrase: "and/or"

Phrase: "exogenous factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516998:Exogenous Factors [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the expression of the HI phenotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.177: Alternately, if cryptic splice site utilization does occur in 3992-9g -> a mutant alleles in islet [beta]-cells in vivo, it is feasible that some individuals may express variable proportions of wild-type transcript sufficient to maintain phenotypically normal regulation of insulin secretion. 

Phrase: "Alternately,"

Phrase: "if"

Phrase: "cryptic splice site utilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0042153:utilization [Functional Concept]
   756   C1720838:Splice Site, Cryptic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "does"

Phrase: "occur in 3992-9g -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: ">"

Phrase: "a mutant alleles in islet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]

Phrase: "[beta]-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "it"

Phrase: "is"

Phrase: "feasible"

Phrase: "that"

Phrase: "some individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "may"

Phrase: "express"

Phrase: "variable proportions of wild-type transcript sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1709707:Proportion [Quantitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "phenotypically normal regulation of insulin secretion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1325895:regulation of insulin secretion [Cell Function]
   820   C1523071:regulation of secretion [Cell Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.178: A second common mutation identified in the Ashkenazi probands was deletion of the codon for F1388. 

Phrase: "A second common mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in the Ashkenazi probands"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205396:Identified [Qualitative Concept]
   760   C0702111:probands [Organism Attribute]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726 E C1948021:Proband [Family Group]

Phrase: "was"

Phrase: "deletion of the codon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "for F1388."
Processing 00000000.tx.179: 86Rb+ efflux measurements on intact cells expressing either Kir6.2/wild-type SUR1 or Kir6.2/[Delta]F1388SUR1 KATP channels revealed that channel activity was impaired by the [Delta]F1388 mutation (Fig. 4 ). 

Phrase: "86Rb+ efflux measurements on intact cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:measurements [Functional Concept]

Phrase: "expressing"

Phrase: "either Kir6.2/wild-type SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   795   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "or"

Phrase: "Kir6.2/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1 KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1153410:channel activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "impaired by the [Delta"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0221099:Impaired [Functional Concept]
   770   C0439097:Delta [Intellectual Product]
   770   C0684336:Impaired [Pathologic Function]
   770   C1705241:Delta [Quantitative Concept]
   770   C3146239:Delta [Eukaryote]
   770   C3538806:DELTA [Spatial Concept]
   770   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.180: Both metabolic inhibition and addition of diazoxide increased efflux in COSm6 cells expressing wild-type KATP channels whereas cells expressing Kir6.2/[Delta]F1388SUR1 channels were unresponsive to diazoxide and, similar to untransfected COSm6 control cells, showed reduced efflux in the presence of metabolic inhibitors. 

Phrase: "Both metabolic inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0021469:Metabolic Inhibition [Molecular Function]
           Inhibition
   861   C0021467:Inhibition [Mental Process]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "addition of diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "efflux in COSm6 cells"

Phrase: "expressing"

Phrase: "wild-type KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "whereas"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Kir6.2/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1 channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "were"

Phrase: "unresponsive to diazoxide"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205269:Unresponsive [Functional Concept]
   790   C0237284:Unresponsive [Finding]
   718 E C0241526:Unresponsiveness [Finding]

Phrase: "and"

Phrase: ","

Phrase: "similar to untransfected COSm6 control cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "reduced efflux in the presence of metabolic inhibitors."
Processing 00000000.tx.181: These data were obtained for intact cells and thus, are predicted to be representative of the activity of the mutant [Delta]F1388 KATP channel in pancreatic [beta]-cells. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "obtained for intact cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   816   C0682538:intact cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "thus,"

Phrase: "are"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "representative of the activity of the mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882932:Representative [Activity]

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 KATP channel in pancreatic [beta]-cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439799:Channel [Spatial Concept]
   748   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.182: However, we have not yet resolved whether the [Delta]F1388 KATP channel is completely inactive or is unable to respond to changes in MgADP, as demonstrated for other mutations in NBF-2 (17 ). 

Phrase: "However,"

Phrase: "we"

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "resolved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]

Phrase: "whether"

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 KATP channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "completely inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205254:Inactive [Qualitative Concept]

Phrase: "or"

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "respond to changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in MgADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024468:MgADP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "demonstrated for other mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in NBF-2"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.183: Amino acid alignments of SUR1 NBF-2 with other members of the ABC-superfamily indicates that residue 1388 is usually non-polar in nature but that the primary structure is not strictly conserved, with some members of this protein family containing L (cystic fibrosis transmembrane conductance regulator; CFTR), T (P-glycoprotein multidrug resistance protein family; MDR) or V(MDR) at the homologous position (30 ). 

Phrase: "Amino acid alignments of SUR1 NBF-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1706765:Alignment [Quantitative Concept]

Phrase: "with other members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the ABC-superfamily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883220:Superfamily [Conceptual Entity]

Phrase: "indicates"

Phrase: "that residue 1388"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "is"

Phrase: "usually non-polar in nature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0813983:polar [Quantitative Concept]
   760   C1518422:Non [Functional Concept]

Phrase: "but"

Phrase: "that"

Phrase: "the primary structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "not strictly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "conserved"

Phrase: ","

Phrase: "with some members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680022:members [Population Group]
   966 E C2698041:Member [Professional or Occupational Group]

Phrase: "of this protein family containing L (cystic fibrosis transmembrane conductance regulator"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   873   C0056889:Cystic Fibrosis Transmembrane Conductance Regulator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C1413365:CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR [Gene or Genome]
   807   C0010674:Cystic Fibrosis [Disease or Syndrome]
   791   C0016059:Fibrosis [Pathologic Function]
   791   C0182953:REGULATOR [Medical Device]
   791   C0205207:Cystic [Qualitative Concept]
   791   C1167322:transmembrane [Cell Component]
   791   C1704734:Regulator [Medical Device]
   791   C1704735:Regulator [Conceptual Entity]
   791   C2752508:transmembrane [Cell Component]
   720 E C0010709:Cyst [Disease or Syndrome]
   720 E C0334129:Fibrotic [Functional Concept]
   720 E C0686883:Cyst [Eukaryote]

Phrase: "; CFTR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056889:CFTR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413365:CFTR [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "T (P-glycoprotein multidrug resistance protein family"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   818   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0015576:Family [Family Group]
   795   C1704727:Family [Conceptual Entity]
   724 E C0241888:Familial [Functional Concept]
   710   C0103013:T-protein [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0170844:T Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1152257:T-protein [Molecular Function]

Phrase: "; MDR)"

Phrase: "or"

Phrase: "V(MDR) at the homologous position"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.184: Amino acid residue 1388 is located two residues downstream from the Walker A consensus sequence in NBF-2 and resides in a flexible cytoplasmic loop predicted to protrude from the core-nucleotide binding fold (Fig. 1 ) (10 -12 ,30 ). 

Phrase: "Amino acid residue 1388"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C1709915:Residue [Conceptual Entity]
   812   C1882936:RESIDUE [Phenomenon or Process]
   741 E C1609982:Residual [Qualitative Concept]

Phrase: "is"

Phrase: "located"

Phrase: "two residues downstream from the Walker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "A consensus sequence in NBF-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0079160:Consensus Sequence [Nucleotide Sequence]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0376298:Consensus [Social Behavior]
   753   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "resides in a flexible cytoplasmic loop"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0010834:Cytoplasmic [Cell Component]
   753   C0419518:Loop [Medical Device]
   753   C0443220:Flexible [Qualitative Concept]
   753   C0445022:Loop [Spatial Concept]
   753   C0521449:Cytoplasmic [Body Location or Region]
   753   C2982691:Reside [Activity]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protrude from the core-nucleotide binding fold"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0598153:nucleotide binding fold [Amino Acid Sequence]
   778   C1148916:nucleotide binding [Molecular Function]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0332462:Fold [Spatial Concept]
   748   C0444669:Core [Spatial Concept]
   748   C1145667:Binding [Activity]
   748   C1167518:core [Cell Component]
   748   C1167622:Binding [Molecular Function]
   748   C1706352:Core [Medical Device]
   748   C1880834:FOLD [Phenomenon or Process]
   748   C1882467:Core [Manufactured Object]
   748   C3274653:Core [Body Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(10 -12 ,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.185: A conserved sequence (linker) motif located within this loop has been proposed for other members of the ABC protein family to couple, presumably via a conformational change(s), the energy of ATP hydrolysis to transport or activity of the protein (30 ). 

Phrase: "A conserved sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0009802:Conserved Sequence [Nucleotide Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "(linker"

Phrase: ")"

Phrase: "motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514562:Motif [Amino Acid Sequence]

Phrase: "located within this loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0419518:Loop [Medical Device]
   770   C0445022:Loop [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed for other members of the ABC protein family to"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0086282:Family Members [Family Group]
   741 E C1611821:Family Member [Intellectual Product]
   739   C0015576:Family [Family Group]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0680022:members [Population Group]
   739   C1441414:PROPOSED [Idea or Concept]
   739   C1553874:Proposed [Qualitative Concept]
   739   C1578820:Proposed [Idea or Concept]
   739   C1704727:Family [Conceptual Entity]
   706 E C2698041:Member [Professional or Occupational Group]

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: ","

Phrase: "presumably via a conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0301641:Conformational change [Molecular Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "the energy of ATP hydrolysis to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0424589:Energy [Finding]
   748   C0542479:Energy [Natural Phenomenon or Process]
   748   C1442080:Energy [Quantitative Concept]

Phrase: "transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "or"

Phrase: "activity of the protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1537044:protein activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.186: Three-dimensional modeling of a number of ABC proteins has shown that the core nucleotide-binding fold composed of Walker A and B motifs has a strict requirement for a particular conformation rather than primary structure to maintain binding and hydrolysis of ATP (11 ,31 ). 

Phrase: "Three-dimensional modeling of a number of ABC proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the core nucleotide-binding fold"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0598153:nucleotide binding fold [Amino Acid Sequence]
   861   C1148916:nucleotide binding [Molecular Function]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C0332462:Fold [Spatial Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "composed of Walker A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043016:Walker [Medical Device]

Phrase: "and"

Phrase: "B motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "has"

Phrase: "a strict requirement for a particular conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514873:Requirement [Functional Concept]

Phrase: "rather than"

Phrase: "primary structure to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   827   C0678594:Structure [Spatial Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "hydrolysis of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "(11 ,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.187: It is possible that deletion of F1388 disrupts the requisite tertiary structure of the nucleotide-binding pocket, perhaps preventing binding of ATP or ADP and/or alters the conformation and function(s) associated with the conserved cytoplasmic linker motif in SUR1. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that deletion of F1388"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the requisite tertiary structure of the nucleotide-binding pocket,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205372:Tertiary [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]

Phrase: "perhaps preventing binding of ATP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "and/or"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "("

Phrase: "s)"

Phrase: "associated with the conserved cytoplasmic linker motif"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0521449:Cytoplasmic [Body Location or Region]
   748   C1514562:Motif [Amino Acid Sequence]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in SUR1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   861   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536898:Sulfonylurea [Pharmacologic Substance]
Processing 00000000.tx.188: Patch-clamp experiments on cells co-transfected with Kir6.2 and [Delta]F1388SUR1 cDNA constructs may provide further information regarding the effect(s) of the [Delta]F1388 mutation upon the properties of the KATP channel. 

Phrase: "Patch-clamp experiments on cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "co-transfected with Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C1416578:Kir6.2 [Gene or Genome]

Phrase: "and ["

Phrase: "Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1 cDNA constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0012931:DNA Construct [Nucleic Acid, Nucleoside, or Nucleotide]
   779   C2827421:Construct [Classification]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "regarding"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "s) of the [Delta"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0439097:Delta [Intellectual Product]
   770   C1705241:Delta [Quantitative Concept]
   770   C2603362:S' [Clinical Attribute]
   770   C3146239:Delta [Eukaryote]
   770   C3538806:DELTA [Spatial Concept]
   770   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation upon the properties of the KATP channel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.189: Further studies are also needed to determine whether the [Delta]F1388 mutation disrupts post-translational processing of the SUR1 protein, as has been described for deletions of certain amino acids within the cytoplasmic loop of NBF-1 in CFTR (32 ,33 ). 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "also"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "post-translational processing of the SUR1 protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   815   C0033666:Post-Translational Protein Processing [Molecular Function]
           protein processing
   789   C1449566:Protein Processing, Translational [Molecular Function]
   767   C0449935:Post-processing [Intellectual Product]
   744   C1709694:Processing [Activity]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "described for deletions of certain amino acids"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   748   C1552738:described [Idea or Concept]
   748   C1880274:Deletions [Activity]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]
   714 E C1442161:Deletion [Cell or Molecular Dysfunction]
   714 E C1511760:Deletion [Genetic Function]

Phrase: "within the cytoplasmic loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "of NBF-1"

Phrase: "in CFTR (32 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0056889:CFTR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413365:CFTR [Gene or Genome]

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.190: Extended haplotype analyses revealed associations between the [Delta]F1388 and 3992-9g -> a mutations in SUR1 and specific haplotypes (Table 1 ). 

Phrase: "Extended haplotype analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "associations between the [Delta"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0004083:Associations [Mental Process]
   737 E C0439849:Association [Qualitative Concept]
   737 E C0596306:Association [Phenomenon or Process]
   737 E C0699792:association [Social Behavior]

Phrase: "]F1388"

Phrase: "and"

Phrase: "3992-9g -"

Phrase: ">"

Phrase: "a mutations in SUR1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "specific haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.191: Although only a small number of probands with the [Delta]F1388 mutation were identified, the data suggest that this mutation may be associated exclusively with the group K haplotype, a finding consistent with a single origin of this mutation. 

Phrase: "Although"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small number of probands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "with the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "exclusively with the group K haplotype,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0441845:Group K [Intellectual Product]
   753   C0018591:Haplotype [Organism Attribute]
   753   C0441833:Group [Idea or Concept]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1708601:K' [Quantitative Concept]

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "consistent with a single origin of this mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.192: In contrast to the [Delta]F1388 mutation, the 3992-9g -> a mutation was observed in the context of five (F, G, H, I, J) different (i.e. haplotypes that differ by >2 bp at one or more markers) haplotypes, with the majority of alleles carrying this mutation represented by haplotypes F and H. 

Phrase: "In contrast to the [Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the 3992-9g -"

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed in the context of five"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205451:Five [Quantitative Concept]
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]
   753   C1441672:Observed [Functional Concept]

Phrase: "(F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J)"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "("

Phrase: "i.e. haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018591:Haplotypes [Organism Attribute]
   827   C0205396:Identified [Qualitative Concept]
   827   C1550043:Identified [Finding]
   827   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "differ by"

Phrase: ">2 bp at one"

Phrase: "or"

Phrase: "more markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: "haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "with the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "represented by haplotypes F"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0018591:Haplotypes [Organism Attribute]
   770   C0439133:(f) [Intellectual Product]
   770   C1553038:[f] [Quantitative Concept]
   737   C1882932:Represent [Activity]

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.193: It is possible that these haplotypes represent independent origins of the 3992-9g -> a mutation and/or that this mutation is ancient, so that multiple recombination events with normal haplotypes may have resulted in variant haplotypes. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "these haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "independent origins of the 3992-9g -"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0079946:origins [Classification]
   753   C0439659:Origins [Temporal Concept]
   719 E C1550512:origin [Intellectual Product]

Phrase: ">"

Phrase: "a mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and/or"

Phrase: "that"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "ancient, so"

Phrase: "that multiple recombination events with normal haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441471:Events [Event]
   748   C3541888:Events [Classification]

Phrase: "may"

Phrase: "have"

Phrase: "resulted in variant haplotypes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018591:Haplotypes [Organism Attribute]
   770   C0205419:Variant [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.194: As 12 polymorphisms were detected within the SUR1 gene, construction of haplotypes using these intragenic RFLP markers as well as intragenic microsatellite markers, may provide further insight into the origins of these chromosomes in Ashkenazi Jews. 

Phrase: "As 12 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "detected within the SUR1 gene,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1335671:Receptor Gene [Gene or Genome]
   790   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   753   C0442726:Detected [Finding]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "construction of haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these intragenic RFLP markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0005516:Marker [Clinical Attribute]
   734   C0035268:Restriction fragment length polymorphism [Clinical Attribute]

Phrase: "as well as"

Phrase: "intragenic microsatellite markers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0005516:Marker [Clinical Attribute]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further insight into the origins of these chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:Insight [Mental Process]

Phrase: "in Ashkenazi Jews."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337704:ashkenazi jews [Population Group]
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]
Processing 00000000.tx.195: An additional five distinct haplotypes (A-E) were observed on single HI chromosomes for which no mutations were defined within the 39 exons of the SUR1 gene. 

Phrase: "An additional five distinct haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "(A-E)"

Phrase: "were"

Phrase: "observed on single HI chromosomes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008633:Chromosomes [Cell Component]
   760   C0020459:Hyperinsulinism [Disease or Syndrome]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "for which"

Phrase: "no mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "defined within the 39 exons of the SUR1 gene."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1335671:Receptor Gene [Gene or Genome]
   760   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   739   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0017337:Gene [Gene or Genome]
   739   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1704788:Defined [Conceptual Entity]
   739   C3536898:Sulfonylurea [Pharmacologic Substance]
   739   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.196: These haplotypes may represent separate mutational events or rearrangements of more common haplotypes by an ancestral recombination event. 

Phrase: "These haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "separate mutational events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "or"

Phrase: "rearrangements of more common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511695:Rearrangements [Genetic Function]

Phrase: "by an ancestral recombination event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441471:Event [Event]
Processing 00000000.tx.197: Assuming that 2 bp variation are more likely to represent CA repeat slippage than different mutation events (22 ), we estimate that there may be in the order of five additional mutations in this Ashkenazi patient cohort that remain to be identified. 

Phrase: "Assuming"

Phrase: "that 2 bp variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]

Phrase: "are"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "CA repeat slippage than different mutation events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883041:SLIPPAGE [Phenomenon or Process]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "that there"

Phrase: "may"

Phrase: "be in the order of five additional mutations"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0026882:Mutations [Genetic Function]
   744   C0205451:Five [Quantitative Concept]
   744   C1524062:Additional [Functional Concept]
   744   C1705175:Order [Intellectual Product]
   744   C1705176:Order [Qualitative Concept]
   744   C1705177:Order [Classification]
   744   C1705178:Order [Activity]
   744   C1882348:Order [Qualitative Concept]
   744   C2987476:Be [Conceptual Entity]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in this Ashkenazi patient cohort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599755:Cohort [Population Group]

Phrase: "that"

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.198: These mutations may be present within the exon sequences or flanking intron-exon boundaries screened here but were undetected by SSCP analyses or may be located either within intronic sequences and/or the 5' or 3' untranslated regions of the SUR1 gene which have not yet been analyzed. 

Phrase: "These mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "present within the exon sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "flanking intron-exon boundaries"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "here"

Phrase: "but"

Phrase: "were"

Phrase: "undetected by SSCP analyses"

Phrase: "or"

Phrase: "may"

Phrase: "be"

Phrase: "located"

Phrase: "either within intronic sequences"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "and/or"

Phrase: "the 5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "3' untranslated regions of the SUR1 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0600600:3' Untranslated Regions [Biologically Active Substance,Nucleotide Sequence]
   770   C0600680:Untranslated Regions [Nucleic Acid, Nucleoside, or Nucleotide]
   750   C1883633:3' Region [Nucleotide Sequence]
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]

Phrase: "which"

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.199: In summary, we have established that HI in Ashkenazi Jews is associated with two frequent mutations within the SUR1 gene. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that HI in Ashkenazi Jews"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "is"

Phrase: "associated with two frequent mutations"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0026882:Mutations [Genetic Function]
   760   C0205448:Two [Quantitative Concept]
   760   C0332183:Frequent [Temporal Concept]
   745   C3178846:Mutation Frequencies [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "within the SUR1 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
Processing 00000000.tx.200: Identification of additional mutations in HI and characterization of their effects upon the structure and properties of the islet [beta]-cell KATP channel may provide further insight into the structure-function relationship of the SUR1 protein, the mechanism of insulin exocytosis in islet [beta]-cells and the molecular and cellular mechanisms underlying familial hyperinsulinism. 

Phrase: "Identification of additional mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "in HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "and"

Phrase: "characterization of their effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "upon the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "properties of the islet"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0871161:properties [Qualitative Concept]
   770   C1292721:properties [Functional Concept]
   737 E C1882134:Property [Conceptual Entity]
   737 E C2347695:Property [Entity]

Phrase: "[beta]-cell KATP channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439799:Channel [Spatial Concept]
   812   C1706095:Channel [Conceptual Entity]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further insight into the structure-function relationship of the SUR1 protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0233820:Insight, function [Mental Process]
           Insight

Phrase: "the mechanism of insulin exocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "in islet"

Phrase: "[beta]-cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "familial hyperinsulinism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2931834:Hyperinsulinism, familial [Disease or Syndrome]
   861   C0020459:Hyperinsulinism [Disease or Syndrome]
Processing 00000000.tx.201: Table 3 . Oligonucleotide sequences, annealing temperatures and PCR product sizes for SSCP analysis of SUR1 MATERIALS AND METHODS Families A total of 25 Ashkenazi Jewish families were ascertained from Israel and the United States. 

Phrase: "Table 3 . Oligonucleotide sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "annealing temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]

Phrase: "and"

Phrase: "PCR product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "sizes for SSCP analysis of SUR1 MATERIALS"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0796451:polymorphism analysis [Diagnostic Procedure]
   760   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0026377:Conformation [Spatial Concept]
   739   C0032529:Polymorphism [Genetic Function]
   739   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   739   C0456389:SIZES [Spatial Concept]
   739   C0520510:Materials [Substance]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1704972:Strand [Spatial Concept]
   739   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C1882417:Polymorphism [Qualitative Concept]
   739   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "AND"

Phrase: "METHODS Families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "A total of 25 Ashkenazi Jewish families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "ascertained from Israel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0022271:Israel [Geographic Area]

Phrase: "and"

Phrase: "the United States."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0041703:United States [Geographic Area]
   861   C1301808:states [Geographic Area]
   827   C0166872:unite [Biomedical or Dental Material]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]
Processing 00000000.tx.202: Twenty-one of these families have been described previously (8 ) and an additional four families were recruited from Israel for this study. 

Phrase: "Twenty-one of these families"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015576:Families [Family Group]
   760   C0205447:One [Quantitative Concept]
   760   C0724000:twenty [Organic Chemical,Pharmacologic Substance]
   760   C1704727:Family [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(8"

Phrase: ")"

Phrase: "and"

Phrase: "an additional four families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "were"

Phrase: "recruited from Israel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0022271:Israel [Geographic Area]

Phrase: "for this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.203: Consanguinity was present in three families on the panel in which the parents within each family were related to a common distant ancestor (8 ). 

Phrase: "Consanguinity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009789:Consanguinity [Finding]
  1000   C1266852:consanguinity [Family Group]

Phrase: "was"

Phrase: "present in three families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "on the panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "in which"

Phrase: "the parents within each family"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0030551:Parents [Family Group]
   726 E C2699423:Parent [Conceptual Entity]

Phrase: "were"

Phrase: "related to a common distant ancestor"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0205214:Common [Quantitative Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0443203:Distant [Spatial Concept]
   753   C0445223:Related [Finding]
   753   C0870134:Ancestor [Family Group]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.204: Clinical diagnosis of HI was based on the following criteria (2 ,34 ,35 ): hypoglycemia with increased glucose utilization in infants that are large for gestational age and the combination of inappropriately elevated serum insulin levels, low plasma ketones and brisk response to glucagon injection. 

Phrase: "Clinical diagnosis of HI"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332140:Diagnosis, clinical [Qualitative Concept]
   770   C0011900:Diagnosis [Finding]
   770   C0205210:Clinical [Qualitative Concept]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "based on the following criteria"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0243161:criteria [Intellectual Product]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(2 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "34 ,"

Phrase: "35"

Phrase: ")"

Phrase: ":"

Phrase: "hypoglycemia with increased glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020615:Hypoglycaemia [Disease or Syndrome]

Phrase: "in infants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021270:Infants [Age Group]

Phrase: "that"

Phrase: "are"

Phrase: "large for gestational age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0158915:Large for gestational age [Finding]
           large gestational age
   770   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "the combination of inappropriately elevated serum insulin levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205195:Combination [Qualitative Concept]
   744   C1947911:Combination [Physical Object]

Phrase: "low plasma ketones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022634:Ketones [Organic Chemical]

Phrase: "and"

Phrase: "brisk response to glucagon injection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]
Processing 00000000.tx.205: For this study, probands were classified as Ashkenazi Jewish when both parents were descended from eastern European ancestors (Germany, Czechoslovakia, Poland, Romania, Hungary, Ukraine, Russia or the Baltic States). 

Phrase: "For this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "were"

Phrase: "classified as Ashkenazi Jewish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008902:Classified [Classification]
   770   C0022422:Jewish [Idea or Concept]
   770   C0178443:Jewish [Population Group]

Phrase: "when"

Phrase: "both parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0030551:Parents [Family Group]
   966 E C2699423:Parent [Conceptual Entity]

Phrase: "were"

Phrase: "descended from eastern European ancestors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0239309:Eastern European [Population Group]
   760   C0205386:descended [Qualitative Concept]
   760   C0239307:European [Population Group]
   760   C0870134:Ancestors [Family Group]
   760   C1535514:European [Population Group]
   760   C1707877:Eastern [Spatial Concept]

Phrase: "(Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "Czechoslovakia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010872:Czechoslovakia [Geographic Area]
   928 E C0239160:CZECHOSLOVAKIAN [Finding]

Phrase: "Poland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032356:Poland [Geographic Area]

Phrase: "Romania,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035826:Romania [Geographic Area]
   928 E C2919684:Romanian [Population Group]

Phrase: "Hungary,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020174:Hungary [Geographic Area]

Phrase: "Ukraine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041580:Ukraine [Geographic Area]

Phrase: "Russia"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0035970:Russia [Geographic Area]
   928 E C0035967:RUSSIAN [Language]
   928 E C0337816:Russian [Population Group]

Phrase: "or"

Phrase: "the Baltic States"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0004715:Baltic States [Geographic Area]
           baltic
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: ")."
Processing 00000000.tx.206: Genomic DNA from probands and their families was isolated from Epstein-Barr virus (EBV)-transformed lymphoblasts or from peripheral blood lymphocytes using standard procedures. 

Phrase: "Genomic DNA from probands"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0017428:Genomic [Gene or Genome]
   770   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "their families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "was"

Phrase: "isolated from Epstein-Barr virus (EBV)-transformed lymphoblasts"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   814   C0014644:Epstein-Barr Virus [Virus]
   748   C0042776:Virus [Virus]
   748   C0205409:Isolated [Functional Concept]
   748   C0229613:Lymphoblasts [Cell]
   748   C0319157:virus [Virus]
   748   C1167770:Lymphoblasts [Laboratory Procedure]
   748   C1396851:Epstein [Disease or Syndrome]
   748   C1510411:Transformed [Pathologic Function]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or from peripheral blood lymphocytes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   828   C1518997:Peripheral Blood Lymphocyte [Cell]
   806   C0229664:peripheral blood [Body Substance]
           Blood
   790   C0024264:Blood lymphocyte [Cell]
           Lymphocytes
   765 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0205100:Peripheral [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard procedures."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.207: Genomic DNA from 89 unrelated, normal Ashkenazi Jewish individuals was kindly supplied by Dr D. 

Phrase: "Genomic DNA from 89 unrelated, normal Ashkenazi Jewish individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0017428:Genomic [Gene or Genome]
   742   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "kindly"

Phrase: "supplied by Dr D."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   770   C0031831:DR [Professional or Occupational Group]
   770   C1707664:DR [Biomedical or Dental Material]
   770   C1999230:Supplied [Activity]
   770   C2348314:Dr. [Conceptual Entity]
   770   C3540849:DR [Idea or Concept]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.208: Abliovitz (Department of Genetics, Hadassah Hospital, Jerusalem). 

Phrase: "Abliovitz"

Phrase: "(Department of Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587466:Genetics department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Hadassah Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Jerusalem"

Phrase: ")."
Processing 00000000.tx.209: SSCP analysis For SSCP analysis, individual exons and adjacent intron-exon boundaries were amplified by the polymerase chain reaction (PCR). 

Phrase: "SSCP analysis For SSCP analysis,"

Phrase: "individual exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "adjacent intron-exon boundaries"

Phrase: "were"

Phrase: "amplified by the polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]

Phrase: "(PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.210: Oligonucleotide sequences for SSCP were complementary to flanking intronic sequences (G. Gonzalez, L. Aguilar-Bryan and J. Bryan, GSDB accession nos L78208- L78222, L78224-L78243, L78254, L78255) and were designed to generate PCR products of 110-366 bp. 

Phrase: "Oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences for SSCP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0026377:Conformation [Spatial Concept]
   760   C0032529:Polymorphism [Genetic Function]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C1704972:Strand [Spatial Concept]
   760   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "complementary to flanking intronic sequences"

Phrase: "(G. Gonzalez,"

Phrase: "L. Aguilar-Bryan"

Phrase: "and"

Phrase: "J. Bryan,"

Phrase: "GSDB accession nos L78208- L78222,"

Phrase: "L78224-L78243,"

Phrase: "L78254,"

Phrase: "L78255"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "PCR products of 110-366 bp."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.211: Primer sequences and annealing temperatures for amplification of each exon are listed in Table 3 . Exons are numbered in consecutive order from the 5' end of the gene. 

Phrase: "Primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "annealing temperatures for amplification of each exon"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0039476:Temperatures [Quantitative Concept]
   714 E C0005903:temperature [Organism Attribute]

Phrase: "are"

Phrase: "listed in Table 3 . Exons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   726   C0745732:List [Conceptual Entity]
   726   C3272378:LIST [Intellectual Product]

Phrase: "are"

Phrase: "numbered in consecutive order"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0449788:numbered [Quantitative Concept]
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1707491:Consecutive [Qualitative Concept]
   770   C1882348:Order [Qualitative Concept]
   737 E C0237753:*Number [Quantitative Concept]

Phrase: "from the 5' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "of the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.212: For exon 25, the 366 bp PCR product was digested with the restriction endonuclease RsaI prior to electrophoresis through non-denaturing gels. 

Phrase: "For exon 25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the 366 bp PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1514468:product [Entity]
   799   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "digested with the restriction endonuclease RsaI"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0012906:Restriction Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0059212:Rsa I endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0443288:Restriction [Functional Concept]
   753   C0868946:digested [Physiologic Function]

Phrase: "prior to electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "through non-denaturing gels."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]
Processing 00000000.tx.213: Genomic DNA (50 ng) was amplified by PCR in a 10 [mu]l reaction containing: 10 pmol each primer, 0.2 mM each dNTP, 1.5 mM MgCl2, 10 mM Tris-HCl (pH 8.0), 50 mM KCl, 1.0 U Taq DNA polymerase (Gibco) and 1 [mu]Ci [[alpha]-32P]-dCTP. 

Phrase: "Genomic DNA (50 ng)"

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "in a 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "[mu]l reaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   734   C0439342:mU/L [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: ":"

Phrase: "10 pmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "each primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "0.2 mM"

Phrase: "each dNTP,"

Phrase: "1.5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 mM Tris-HCl (pH 8.0"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "50 mM KCl,"

Phrase: "1.0 U Taq DNA polymerase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
   861   C2257065:Taq DNA polymerase [Genetic Function]
   827   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Gibco"

Phrase: ")"

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "[mu]Ci [[alpha"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "]-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-dCTP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.214: For amplification of exon 1, the reaction mix included 5% formamide. 

Phrase: "For amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "of exon 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the reaction mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205430:Mix [Functional Concept]
   861   C1421951:MIX [Gene or Genome]
   861   C1720722:Mix [Qualitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "5% formamide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016568:formamide [Organic Chemical]
Processing 00000000.tx.215: Amplification conditions were an initial denaturation at 94oC (4 min); 

Phrase: "Amplification conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "an initial denaturation at 94oC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0301642:Denaturation [Molecular Function]

Phrase: "(4 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.216: followed by 30 cycles of 94oC (1 min), optimal annealing temperature (1 min) and 72oC (1 min). 

Phrase: "followed by 30 cycles of 94oC"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332283:Followed by [Temporal Concept]
           followed
   719   C1511572:Cycle [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(1 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "optimal annealing temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "(1 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "72oC"

Phrase: "(1 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.217: Amplified samples were diluted two-fold with formamide buffer (95% formamide, 10 mM EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol), denatured at 94oC for 5 min and chilled on ice prior to electrophoresis. 

Phrase: "Amplified samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "two-fold with formamide buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "(95% formamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016568:formamide [Organic Chemical]

Phrase: "10 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1% bromophenol blue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006247:Bromophenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]

Phrase: "0.1% xylene cyanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0377925:xylene cyanol [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "denatured at 94oC"

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "chilled on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0085593:Chill [Sign or Symptom]

Phrase: "prior to electrophoresis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]
Processing 00000000.tx.218: PCR products were analyzed on gels containing a 1/4 dilution of GeneAmp gel matrix (Perkin-Elmer) and 0.5*Tris-borate-EDTA (TBE), with or without 10% glycerol. 

Phrase: "PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "analyzed on gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017243:Gels [Biomedical or Dental Material]
   790   C0936012:Analyzed [Research Activity]
   756 E C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a 1/4 dilution of GeneAmp gel matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079240:Dilution [Laboratory Procedure]
   744   C1948037:Dilution [Functional Concept]

Phrase: "(Perkin-Elmer"

Phrase: ")"

Phrase: "and"

Phrase: "0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "*Tris-borate-EDTA (TBE),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0006007:Borate [Chemical Viewed Structurally]
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "with"

Phrase: "or without 10% glycerol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.219: Electrophoresis was done at 10-30 W for 5-12 h, at 4oC or room temperature (RT) and gels were exposed to Kodak X-OMAT film for autoradiography. 

Phrase: "Electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "was"

Phrase: "done at 10-30 W"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]

Phrase: "for 5-12 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "at 4oC"

Phrase: "or"

Phrase: "room temperature (RT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "exposed to Kodak X-OMAT film"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0086296:Film [Manufactured Object]
   753   C1561571:film [Biomedical or Dental Material]
   753   C1561572:film [Substance]

Phrase: "for autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.220: Identification of mutations Nucleotide sequence analyses to identify mutations were done on patient samples exhibiting shifted bands relative to control samples on SSCP. 

Phrase: "Identification of mutations Nucleotide sequence analyses to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "identify"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "done on patient samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030705:*^patient [Patient or Disabled Group]
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "shifted bands relative to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0175723:Bands [Medical Device]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "samples on SSCP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.221: Genomic DNA was amplified by PCR with primers used for SSCP analysis (Table 3 ). 

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "with primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used for SSCP analysis"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0796451:polymorphism analysis [Diagnostic Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0026377:Conformation [Spatial Concept]
   753   C0032529:Polymorphism [Genetic Function]
   753   C0936012:Analysis [Research Activity]
   753   C1273517:used [Finding]
   753   C1524024:analysis [Functional Concept]
   753   C1704972:Strand [Spatial Concept]
   753   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1882417:Polymorphism [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.222: The resultant PCR products were excised from 2% low melting temperature (LMP) agarose gels, purified and directly sequenced by double-stranded DNA cycle sequencing (Perkin-Elmer) according to the manufacturer's instructions. 

Phrase: "The resultant PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "excised from 2% low melting temperature"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   783   C0009264:Low temperature [Natural Phenomenon or Process]
   753   C0005903:temperature [Organism Attribute]
   753   C0039476:*Temperature [Quantitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C0599882:Melting [Natural Phenomenon or Process]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   719 E C0050572:MELT [Therapeutic or Preventive Procedure]
   719 E C1540179:MELT [Gene or Genome]

Phrase: "(LMP) agarose gels,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "sequenced by double-stranded DNA cycle sequencing"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0162326:DNA sequencing [Nucleotide Sequence]
           DNA Sequence
           Sequence
   774   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205173:Double [Functional Concept]
   748   C1511572:Cycle [Temporal Concept]
   748   C1553778:Sequencing [Intellectual Product]
   748   C1561491:Sequencing [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   743   C1979882:Double strand [Qualitative Concept]
   714   C0004793:Sequence [Nucleotide Sequence]
   714   C0162327:Sequence [Nucleotide Sequence]
   714   C1519249:Sequence [Functional Concept]

Phrase: "(Perkin-Elmer"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.223: Both strands of the PCR product were sequenced using PCR amplification primers end-labeled with 32P. 

Phrase: "Both"

Phrase: "strands of the PCR product"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1514468:product [Entity]
   748   C1524075:Chain [Idea or Concept]
   748   C1704444:Product [Quantitative Concept]
   748   C1704972:Strand [Spatial Concept]
   748   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR amplification primers end-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0444930:End [Spatial Concept]
   799   C2746065:End [Temporal Concept]
   743 E C0205088:Terminal [Temporal Concept]
   743 E C1705314:Terminal [Manufactured Object]
   743 E C1705315:Terminal [Spatial Concept]

Phrase: "labeled with 32P."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1553631:32p [Medical Device]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.224: For mutations that created or abolished restriction endonuclease sites, the presence of the mutation was verified by restriction endonuclease digestion of PCR products with appropriate enzymes. 

Phrase: "For mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "or"

Phrase: "abolished restriction endonuclease sites,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   858   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "the presence of the mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "verified by restriction endonuclease digestion of PCR products"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0012906:Restriction Endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0012238:Digestion [Organism Function]
   739   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C0443288:Restriction [Functional Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1514468:Products [Entity]
   739   C1524075:Chain [Idea or Concept]
   739   C1711411:Verified [Functional Concept]
   739   C2349986:Digestion [Research Activity]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "with appropriate enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.225: To confirm the presence of the 3992-9g -> a and [Delta]F1388 mutations, genomic DNA was amplified using SSCP primers (Table 3 ) and the resultant PCR products were digested for 2 h with NciI or BseRI, respectively. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of the 3992-9g -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ">"

Phrase: "a"

Phrase: "and ["

Phrase: "Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388 mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SSCP primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "the resultant PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "digested for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0868946:digested [Physiologic Function]

Phrase: "with NciI"

Phrase: "or"

Phrase: "BseRI,"

Phrase: "respectively."
Processing 00000000.tx.226: Restriction digestion products were analyzed by electrophoresis on 3% NuSieve (3:1) (FMC BioProducts) agarose gels and were visualized by staining with ethidium bromide. 

Phrase: "Restriction digestion products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "on 3% NuSieve"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(FMC BioProducts"

Phrase: ")"

Phrase: "agarose gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1706746:Agarose Gel [Research Device]
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "were"

Phrase: "visualized by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0234621:Visualized [Functional Concept]
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "with ethidium bromide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.227: Haplotype analysis All available individuals within each family were genotyped with the four di- and tetranucleotide repeat polymorphic markers D11S1397, D11S902, D11S921 and D11S1890. 

Phrase: "Haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "All available individuals within each family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "were"

Phrase: "genotyped with the four di-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205450:Four [Quantitative Concept]
   760   C3538902:DI [Gene or Genome]
   760   C3541881:DI [Idea or Concept]
   726   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "tetranucleotide"

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "polymorphic markers D11S1397,"

Phrase: "D11S902,"

Phrase: "D11S921"

Phrase: "and"

Phrase: "D11S1890."
Processing 00000000.tx.228: D11S1397 is distal to the SUR1 locus but the relative order of D11S902- SUR1-D11S921-D11S1890 is unknown (18 -21 ). 

Phrase: "D11S1397"

Phrase: "is"

Phrase: "distal to the SUR1 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205108:Distal [Spatial Concept]

Phrase: "but"

Phrase: "the relative order of D11S902- SUR1-D11S921-D11S1890"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C1705175:Order [Intellectual Product]
   742   C1705176:Order [Qualitative Concept]
   742   C1705177:Order [Classification]
   742   C1705178:Order [Activity]
   742   C1882348:Order [Qualitative Concept]

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "(18 -21"

Phrase: ")."
Processing 00000000.tx.229: Haplotypes for 21 of these families at the D11S902 and D11S921 loci have been described previously (8 ). 

Phrase: "Haplotypes for 21 of these families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018591:Haplotypes [Organism Attribute]

Phrase: "at the D11S902"

Phrase: "and"

Phrase: "D11S921 loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.230: Oligonucleotide sequences and PCR amplification conditions for all microsatellite markers were obtained from Genome Data Base. 

Phrase: "Oligonucleotide sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "PCR amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1524075:Chain [Idea or Concept]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "conditions for all microsatellite markers"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           Microsatellite
   760   C0012634:condition [Disease or Syndrome]
   760   C0348080:Condition [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]
   726   C0005516:Marker [Clinical Attribute]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "were"

Phrase: "obtained from Genome Data Base."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0872346:genome database [Intellectual Product]
   806   C0242356:Database [Intellectual Product]
   806   C0993637:Data Base [Intellectual Product]
   760   C0002055:base [Inorganic Chemical]
   760   C0017428:Genome [Gene or Genome]
   760   C0178499:Base [Chemical Viewed Functionally]
   760   C1301820:Obtained [Functional Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1880279:Base [Biomedical or Dental Material]
   760   C2338314:Genome [Conceptual Entity]
   760   C3245479:data [Medical Device]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.231: Haplotypes were derived for parental chromosomes by inferring phase from their genotypes and those of their children: in 22 families there were at least two children, providing unequivocal haplotypes and in three families only one child was available for haplotype analyses. 

Phrase: "Haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "derived for parental chromosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008633:Chromosomes [Cell Component]
   770   C0030551:Parental [Family Group]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "by inferring phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "from their genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "those of their children"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0008059:Children [Age Group]
   770   C0680063:Children [Family Group]

Phrase: ":"

Phrase: "in 22 families there"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "were at least two children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0008059:Children [Age Group]
   760   C0205448:Two [Quantitative Concept]
   760   C0680063:Children [Family Group]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "unequivocal haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "and in three families only one child"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C0029039:Only Child [Family Group]
   748   C0008059:Child [Age Group]
   748   C0015576:Families [Family Group]
   748   C0205171:Only [Quantitative Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0205449:Three [Quantitative Concept]
   748   C0680063:CHILD [Family Group]
   748   C1515981:And [Idea or Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C1720467:Only [Intellectual Product]

Phrase: "was"

Phrase: "available for haplotype analyses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]
Processing 00000000.tx.232: All haplotypes were constructed to minimize recombinants. 

Phrase: "All haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "recombinants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:Recombinants [Organism]
Processing 00000000.tx.233: For consanguineous marriages where the parental HI chromosomes were identical by descent (IBD), only one parental disease chromosome was included in the analyses. 

Phrase: "For consanguineous marriages where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024841:Marriages [Finding]

Phrase: "the parental HI chromosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008633:Chromosomes [Cell Component]

Phrase: "were"

Phrase: "identical by descent (IBD),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "only one parental disease chromosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0008633:Chromosome [Cell Component]

Phrase: "was"

Phrase: "included in the analyses."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332257:included [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.234: Control allele distributions were drawn from the non-carrier chromosomes within the same families. 

Phrase: "Control allele distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0037775:Distributions [Spatial Concept]
   793 E C0520511:distribution [Idea or Concept]
   793 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "drawn from the non-carrier chromosomes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C2986416:Noncarrier [Conceptual Entity]
   753   C0007294:Carrier [Finding]
   753   C0008633:Chromosomes [Cell Component]
   753   C0560175:Carrier [Finding]
   753   C1518422:Non [Functional Concept]
   753   C1706209:Carrier [Medical Device]
   753   C3273162:Carrier [Intellectual Product]
   719   C0013113:Draw [Intellectual Product]

Phrase: "within the same families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.235: Plasmid constructions Construction of the plasmids (i) pCMV-Kir6.2, expressing full-length murine Kir6.2, generously provided by Dr Susumu Seino (Chiba University, Japan) and (ii) pECE-SUR1 expressing full-length hamster SUR1 cDNA, have been described in detail elsewhere (10 ,13 ). 

Phrase: "Plasmid constructions Construction of the plasmids"

Phrase: "("

Phrase: "i"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ")"

Phrase: "pCMV-Kir6.2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1416578:Kir6.2 [Gene or Genome]

Phrase: "expressing"

Phrase: "full-length murine Kir6.2,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   875   C0806636:Length 2 [Quantitative Concept]
   840   C1416578:Kir6.2 [Gene or Genome]
   804   C0026809:Murine [Mammal]
   804   C0443225:Full [Qualitative Concept]
   804   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   804   C1444754:Length [Quantitative Concept]
   804   C1706316:LENGTH [Research Activity]
   733 E C0205166:Long [Qualitative Concept]
   733 E C1522425:Longest [Qualitative Concept]
   733 E C1706317:Long [Qualitative Concept]

Phrase: "generously"

Phrase: "provided by Dr Susumu Seino"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "(Chiba University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "pECE-SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   827   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "expressing"

Phrase: "full-length hamster SUR1 cDNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "have"

Phrase: "been"

Phrase: "described in detail elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(10 ,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.236: F1388 was deleted from wild-type hamster SUR1 using an overlap PCR strategy. 

Phrase: "F1388"

Phrase: "was"

Phrase: "deleted from wild-type hamster SUR1"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0324936:Wild hamster, NOS [Mammal]
   748   C0018557:Hamster [Mammal]
   748   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1547052:*Type [Quantitative Concept]
   748   C1880274:Deleted [Activity]
   748   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an overlap PCR strategy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0679199:strategy [Mental Process]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.237: Briefly, complementary mutant oligonucleotides missing the phenylalanine codon (F) codon and two flanking primers were synthesized. 

Phrase: "Briefly,"

Phrase: "complementary mutant oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "the phenylalanine codon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "(F) codon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "two flanking primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "synthesized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]
Processing 00000000.tx.238: The outside primers flanked unique restriction sites in the pECE-SUR1 plasmid. 

Phrase: "The outside primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "flanked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0230171:Flank [Body Location or Region]

Phrase: "unique restriction sites in the pECE-SUR1 plasmid."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   762   C0005456:RECEPTOR SITES [Receptor]
   742   C0205145:Sites [Spatial Concept]
   742   C0443288:Restriction [Functional Concept]
   731   C1882940:Restriction Site [Nucleotide Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.239: Two PCR products with a 20 bp overlap spanning the desired deletion were amplified using (i) the forward mutant primer (5'-AGTCCTCCTCCCTGGCCTTTTTCCG-3') with the downstream outside reverse primer (5'-CGTAGAGGATCCAGACATGA-3') and (ii) the forward outside primer (5'-GT- CATCTCCTATGTCACACC-3') and the reverse mutant primer (5'-AAAGGCCAGGGAGGAGGACTTCCCG-3'), respectively. 

Phrase: "Two PCR products with a 20 bp overlap"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1514468:Products [Entity]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the desired deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "were"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "("

Phrase: "i"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ")"

Phrase: "the forward mutant primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1953382:Forward primer [Cell]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-AGTCCTCCTCCCTGGCCTTTTTCCG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "with the downstream outside reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-CGTAGAGGATCCAGACATGA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "the forward outside primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1953382:Forward primer [Cell]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-GT- CATCTCCTATGTCACACC-3'"

Phrase: ")"

Phrase: "and"

Phrase: "the reverse mutant primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5'-AAAGGCCAGGGAGGAGGACTTCCCG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.240: Amplification was done with Taq DNA polymerase (Perkin-Elmer) for 30 cycles of 94oC for 1 min, 55oC for 1 min and 72oC for 1 min. 

Phrase: "Amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "done with Taq DNA polymerase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
   862   C2257065:Taq DNA polymerase [Genetic Function]
   806   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1272695:Done [Qualitative Concept]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C2746065:Done [Temporal Concept]

Phrase: "(Perkin-Elmer"

Phrase: ")"

Phrase: "for 30 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "of 94oC"

Phrase: "for 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "55oC for 1 min"

Phrase: "and"

Phrase: "72oC for 1 min."
Processing 00000000.tx.241: The two resultant PCR products were purified by agarose gel electrophoresis, mixed and re-amplified using only the forward and reverse outside primers. 

Phrase: "The two resultant PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C1514468:Products [Entity]
   766 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "purified by agarose gel electrophoresis,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]
   760   C1998793:Purified [Functional Concept]

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "re-amplified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "outside primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.242: The PCR product was digested with the restriction enzymes EcoRI and NotI, purified by agarose gel electrophoresis and subcloned using standard methodology into pECE-SUR1 (10 ) following digestion with EcoRI and NotI. 

Phrase: "The PCR product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "digested with the restriction enzymes EcoRI"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]
   753   C0443288:Restriction [Functional Concept]
   753   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "NotI,"

Phrase: "purified by agarose gel electrophoresis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]
   760   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "subcloned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1883178:Subclone [Cell]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard methodology into pECE-SUR1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0969625:methodology [Intellectual Product]
   753   C3266812:Methodology [Idea or Concept]

Phrase: "(10"

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "digestion with EcoRI"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0012238:Digestion [Organism Function]
   790   C2349986:Digestion [Research Activity]
   734 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "NotI."
Processing 00000000.tx.243: The region amplified by PCR was sequenced to ensure no additional mutations were introduced during amplification. 

Phrase: "The region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "amplified by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "was"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "no additional mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "introduced during amplification."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1517480:Amplification [Molecular Biology Research Technique]
   790   C1521871:Amplification [Phenomenon or Process]
   790   C1705759:Amplification [Cell or Molecular Dysfunction]
   756   C1292748:introduce [Functional Concept]
Processing 00000000.tx.244: The resulting plasmid is designated pECE- [Delta]F1388SUR1. 

Phrase: "The resulting plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "pECE-"

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1."
Processing 00000000.tx.245: Cell culture, 86Rb+ efflux and 125I-glibenclamide photolabeling COSm6 cells were maintained in Dulbecco's modified Eagle's medium with high glucose (DMEM-HG) and supplemented with 10% fetal calf serum (FCS). 

Phrase: "Cell culture,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "86Rb+ efflux"

Phrase: "and"

Phrase: "125I-glibenclamide photolabeling COSm6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C0024501:Maintain [Activity]

Phrase: "with high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(DMEM-HG)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "supplemented with 10% fetal calf serum (FCS)."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.246: Cells were co-transfected with pCMV-Kir6.2 (5 [mu]g) and either pECE-SUR1 (5 [mu]g) or pECE-[Delta]F1388SUR1 (5 [mu]g) using DEAE-dextran as described previously (13 ). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with pCMV-Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1416578:Kir6.2 [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[mu]g)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532982:mU/g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "either pECE-SUR1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   827   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[mu]g)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532982:mU/g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "or"

Phrase: "pECE-"

Phrase: "[Delta"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439097:Delta [Intellectual Product]
  1000   C1705241:Delta [Quantitative Concept]
  1000   C3146239:Delta [Eukaryote]
  1000   C3538806:DELTA [Spatial Concept]
  1000   C3540585:DELTA [Gene or Genome]

Phrase: "]F1388SUR1"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[mu]g)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532982:mU/g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DEAE-dextran"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011051:DEAE-Dextran [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   861   C0046079:DEAE [Organic Chemical,Pharmacologic Substance]
   861   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.247: Co-transfected cells were incubated for 12-24 h with 86RbCl and assayed for efflux in the presence or absence of diazoxide, metabolic inhibitors (oligomycin and 2-deoxy-D-glucose) and glibenclamide as described in detail elsewhere (10 ,13 ). 

Phrase: "Co-transfected"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 12-24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 86RbCl"

Phrase: "and"

Phrase: "assayed for efflux"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of diazoxide,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "metabolic inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(oligomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028951:Oligomycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in detail elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(10 ,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.248: Co-transfected cells were photolabeled with 125I-glibenclamide as described previously (10 ,13 ). 

Phrase: "Co-transfected"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "photolabeled with 125I-glibenclamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017628:Glibenclamide [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10 ,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.249: ACKNOWLEDGMENTS We are grateful to the patients and their families for participating in this study. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to the patients"

Phrase: "and"

Phrase: "their families for participating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Families [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "in this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.250: This work was supported in part by N.I.H. grants DK16746 (M.A.P.), RR-00240 (C.A.S.) and DK44311 (J.B.), by Grants #194164 (M.A.P.) and #195008 (J.B.) from the Juvenile Diabetes Foundation, by a Mentor-Based Fellowship Award from the American Diabetes Association (A.N., M.A.P.), Grant #93/00191/2 from the United States-Israel Binational Science Foundation (B.G., M.A.P.), Grant # 2677 from the Israel Ministry of Health (B.G.), and by grants from the Houston Endowment and American Diabetes Association (L.A.B.). 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by N.I.H. grants DK16746"

Phrase: "(M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "RR-00240"

Phrase: "(C.A.S."

Phrase: ")"

Phrase: "and"

Phrase: "DK44311"

Phrase: "(J."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "by Grants #194164"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018173:Grants [Quantitative Concept]
   827 E C1548284:Grant [Idea or Concept]

Phrase: "(M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "P.)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and #"

Phrase: "195008"

Phrase: "(J."

Phrase: "B.) from the Juvenile Diabetes Foundation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347469:/B [Quantitative Concept]

Phrase: "by a Mentor-Based Fellowship Award"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0004446:Award [Manufactured Object]

Phrase: "from the American Diabetes Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(A.N., M.A."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Grant #93/00191/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018173:Grant [Quantitative Concept]
   812   C1548284:Grant [Idea or Concept]

Phrase: "from the United States-Israel Binational Science Foundation"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   799   C0016617:Foundation [Organization]
   716 E C0002055:base [Inorganic Chemical]
   716 E C0178499:Base [Chemical Viewed Functionally]
   716 E C1626935:Bases [Quantitative Concept]
   716 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(B.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Grant # 2677 from the Israel Ministry of Health"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0018173:Grant [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0022271:Israel [Geographic Area]
   744   C1548284:Grant [Idea or Concept]

Phrase: "(B.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and by grants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Houston Endowment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014265:Endowment [Quantitative Concept]

Phrase: "and"

Phrase: "American Diabetes Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(L.A.B."

Phrase: ")."
Processing 00000000.tx.251: REFERENCES 1 Landau, H. and Schiller, M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Landau,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Schiller,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.252: (1991) Persistent hyperinsulinemic hypoglycemia of infancy and childhood. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Persistent hyperinsulinemic hypoglycemia of infancy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027773:Persistent Hyperinsulinemic Hypoglycemia of Infancy [Disease or Syndrome]
  1000   C2931834:Persistent hyperinsulinaemic hypoglycaemia of infancy [Disease or Syndrome]
           Persistent Hyperinsulinemic Hypoglycemia
   862   C1456352:Hypoglycaemia of infancy [Pathologic Function]
   862   C2931833:HYPERINSULINEMIC HYPOGLYCEMIA, PERSISTENT [Disease or Syndrome]
   806   C1864903:Hyperinsulinemic hypoglycemia [Finding]
   760   C0020615:Hypoglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "childhood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231335:Childhood [Temporal Concept]
Processing 00000000.tx.253: In Schiller, M. 

Phrase: "In Schiller,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.254: (ed.), Pediatric Surgery of the Liver, Pancreas, and Spleen. 

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Pediatric Surgery of the Liver,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0279077:Paediatric surgery [Biomedical Occupation or Discipline]
   806   C1609625:Pediatric Surgery [Intellectual Product]
   806   C3241973:Pediatric Surgery [Therapeutic or Preventive Procedure]
   797   C0193373:liver surgery [Therapeutic or Preventive Procedure]
   760   C0038894:Surgery [Biomedical Occupation or Discipline]
   760   C0038895:surgery [Functional Concept]
   760   C0543467:Surgery [Health Care Activity]

Phrase: "Pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Spleen."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037993:Spleen [Body Part, Organ, or Organ Component]
  1000   C0771377:SPLEEN [Tissue]
  1000   C1278932:Spleen [Body Part, Organ, or Organ Component]
Processing 00000000.tx.255: W.B. 

Phrase: "W.B."
Processing 00000000.tx.256: Saunders Co., Philadelphia, pp. 

Phrase: "Saunders Co.,"

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "pp."
Processing 00000000.tx.257: 187-201. 

Phrase: "187-201."
Processing 00000000.tx.258: 2 Stanley, C. 

Phrase: "2 Stanley,"

Phrase: "C."
Processing 00000000.tx.259: A. and Baker, L. 

Phrase: "A."

Phrase: "and"

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.260: (1976) Hyperinsulinism in infants and children: diagnosis and therapy. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Hyperinsulinism in infants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "and"

Phrase: "children"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Children [Age Group]
  1000   C0680063:Children [Family Group]

Phrase: ":"

Phrase: "diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "therapy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]
Processing 00000000.tx.261: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.262: Pediatr., 23, 315-355. 

Phrase: "Pediatr.,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "315-355."
Processing 00000000.tx.263: 3 Woo, D., Scopes, J. 

Phrase: "3 Woo,"

Phrase: "D."

Phrase: ","

Phrase: "Scopes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710028:Scope [Conceptual Entity]

Phrase: "J."
Processing 00000000.tx.264: W. and Polak, J. 

Phrase: "W."

Phrase: "and"

Phrase: "Polak,"

Phrase: "J."
Processing 00000000.tx.265: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.266: (1976) Idiopathic hypoglycemia in sibs with morphologic evidence of nesidioblastosis of the pancreas. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Idiopathic hypoglycemia in sibs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020615:Hypoglycaemia [Disease or Syndrome]

Phrase: "with morphologic evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "of nesidioblastosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027773:Nesidioblastosis [Disease or Syndrome]

Phrase: "of the pancreas."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.267: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.268: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.269: Child., 51, 528-531. 

Phrase: "Child.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Child [Age Group]
  1000   C0680063:CHILD [Family Group]

Phrase: "51,"

Phrase: "528-531."
Processing 00000000.tx.270: 4 Bruining, G. 

Phrase: "4 Bruining,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.271: J. 

Phrase: "J."
Processing 00000000.tx.272: (1990) Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Recent advances in hyperinsulinism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0725066:Advance [Medical Device]

Phrase: "and"

Phrase: "the pathogenesis of diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.273: Curr. 

Phrase: "Curr."
Processing 00000000.tx.274: Opinion. 

Phrase: "Opinion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]
Processing 00000000.tx.275: Pediatr., 2, 758-765. 

Phrase: "Pediatr.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "758-765."
Processing 00000000.tx.276: 5 Mathew, P. 

Phrase: "5 Mathew,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.277: M., Young, J. 

Phrase: "M."

Phrase: ","

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "J."
Processing 00000000.tx.278: M., Abu-Osba, Y. 

Phrase: "M."

Phrase: ","

Phrase: "Abu-Osba,"

Phrase: "Y."
Processing 00000000.tx.279: K., Mulhern, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mulhern,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.280: D., Hammoudi, S., Hamdan, J. 

Phrase: "D."

Phrase: ","

Phrase: "Hammoudi,"

Phrase: "S."

Phrase: ","

Phrase: "Hamdan,"

Phrase: "J."
Processing 00000000.tx.281: A. and Sa'di, A. 

Phrase: "A."

Phrase: "and"

Phrase: "Sa'di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "A."
Processing 00000000.tx.282: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.283: (1988) Persistent neonatal hyperinsulinism. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Persistent neonatal hyperinsulinism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2931834:Neonatal Hyperinsulinism [Disease or Syndrome]
   827   C0020459:Hyperinsulinism [Disease or Syndrome]
Processing 00000000.tx.284: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.285: Pediatr., 27, 148-151. 

Phrase: "Pediatr.,"

Phrase: "27,"

Phrase: "148-151."
Processing 00000000.tx.286: 6 Glaser, B., Chiu, K. 

Phrase: "6 Glaser,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chiu,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.287: C., Anker, R., Nestorowicz, A., Landau, H., Ben-Bassat, H., Shlomai, Z., Kaiser, N., Thornton, P. 

Phrase: "C., Anker,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nestorowicz,"

Phrase: "A.,"

Phrase: "Landau,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ben-Bassat,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shlomai,"

Phrase: "Z.,"

Phrase: "Kaiser,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Thornton,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.288: S., Stanley, C. 

Phrase: "S."

Phrase: ","

Phrase: "Stanley,"

Phrase: "C."
Processing 00000000.tx.289: A., Spielmen, R. 

Phrase: "A.,"

Phrase: "Spielmen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.290: S., Gogolin-Ewens, K., Cerasi, E., Baker, L., Rice, J., Donis-Keller, H. and Permutt, M. 

Phrase: "S."

Phrase: ","

Phrase: "Gogolin-Ewens,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Cerasi,"

Phrase: "E.,"

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "J.,"

Phrase: "Donis-Keller,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Permutt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.291: A. 

Phrase: "A."
Processing 00000000.tx.292: (1994) Familial hyperinsulinism maps to chromosome 11p14-15.1, 30cM centromeric to the insulin gene. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Familial hyperinsulinism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2931834:Hyperinsulinism, familial [Disease or Syndrome]
   861   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "maps to chromosome 11p14-15.1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0008651:Chromosome 1 [Cell Component]
   783   C0008657:15 chromosome [Cell Component]
   783   C0814036:chromosome map [Intellectual Product]
   783   C1424473:MAP-1 [Gene or Genome]
   753   C0008633:Chromosome [Cell Component]
   753   C0024779:Map [Manufactured Object]
   753   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1706473:Map [Conceptual Entity]

Phrase: "30cM"

Phrase: "centromeric to the insulin gene."
Processing 00000000.tx.293: Nature Genet., 7, 185-188. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "185-188."
Processing 00000000.tx.294: 7 Thomas, P. 

Phrase: "7 Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.295: M., Cote, G. 

Phrase: "M."

Phrase: ","

Phrase: "Cote,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.296: J., Hallman, D. 

Phrase: "J.,"

Phrase: "Hallman,"

Phrase: "D."
Processing 00000000.tx.297: M. and Mathew, P. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mathew,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.298: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.299: (1995) Homozygosity mapping, to chromosome 11p, of the gene for familial persistent hyperinsulinemic hypoglycemia of infancy. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Homozygosity mapping,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1283195:Mapping [Activity]

Phrase: "to chromosome 11p,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327812:chromosome 11p [Gene or Genome]

Phrase: "of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "for familial persistent hyperinsulinemic hypoglycemia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C2931833:HYPERINSULINEMIC HYPOGLYCEMIA, PERSISTENT [Disease or Syndrome]
   923   C2931834:Persistent Hyperinsulinemic Hypoglycemia [Disease or Syndrome]
   861   C1864903:Hyperinsulinemic hypoglycemia [Finding]
   812   C0020615:Hypoglycaemia [Disease or Syndrome]
   741 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "of infancy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231330:Infancy [Temporal Concept]
Processing 00000000.tx.300: Am. 

Phrase: "Am."
Processing 00000000.tx.301: J. 

Phrase: "J."
Processing 00000000.tx.302: Hum. 

Phrase: "Hum."
Processing 00000000.tx.303: Genet., 56, 416-421. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "56,"

Phrase: "416-421."
Processing 00000000.tx.304: 8 Glaser, B., Chiu, K. 

Phrase: "8 Glaser,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chiu,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.305: C., Liu, L., Anker, R., Nestorowicz, A., Cox, N. 

Phrase: "C., Liu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Anker,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nestorowicz,"

Phrase: "A.,"

Phrase: "Cox,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.306: J., Landau, H., Kaiser, N., Thornton, P. 

Phrase: "J.,"

Phrase: "Landau,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kaiser,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Thornton,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.307: S., Stanley, C. 

Phrase: "S."

Phrase: ","

Phrase: "Stanley,"

Phrase: "C."
Processing 00000000.tx.308: A., Cerasi, E., Baker, L., Donis-Keller, H. and Permutt., M. 

Phrase: "A.,"

Phrase: "Cerasi,"

Phrase: "E.,"

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Donis-Keller,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Permutt.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.309: A. 

Phrase: "A."
Processing 00000000.tx.310: (1995) Recombinant mapping of the familial hyperinsulinism gene to an 0.8 cM region on chromosome 11p15.1 and demonstration of a founder effect in Ashkenazi Jews. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Recombinant mapping of the familial hyperinsulinism gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0008630:Gene Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   748   C1283195:Mapping [Activity]

Phrase: "to an 0.8 cM region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "on chromosome 11p15.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0008651:Chromosome 1 [Cell Component]
   901   C1520365:11p15.1 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C1520364:11p15 [Cell Component]

Phrase: "and"

Phrase: "demonstration of a founder effect"

Phrase: "in Ashkenazi Jews."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337704:ashkenazi jews [Population Group]
   861   C0022389:Jews [Population Group]
   861   C0178443:jews [Population Group]
Processing 00000000.tx.311: Hum. 

Phrase: "Hum."
Processing 00000000.tx.312: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.313: Genet., 4, 879-886. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "879-886."
Processing 00000000.tx.314: 9 Thomas, P. 

Phrase: "9 Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.315: M., Cote, G. 

Phrase: "M."

Phrase: ","

Phrase: "Cote,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.316: J., Wohlik, N., Haddad, B., Mathew, P. 

Phrase: "J.,"

Phrase: "Wohlik,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Haddad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Mathew,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.317: M., Rabl, W., Aguilar-Bryan, L., Gagel, R. 

Phrase: "M."

Phrase: ","

Phrase: "Rabl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539754:RABL [Gene or Genome]

Phrase: "W.,"

Phrase: "Aguilar-Bryan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gagel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.318: F. and Bryan, J. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Bryan,"

Phrase: "J."
Processing 00000000.tx.319: (1995) Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mutations in the sulfonylurea receptor gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in familial persistent hyperinsulinemic hypoglycemia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C2931833:HYPERINSULINEMIC HYPOGLYCEMIA, PERSISTENT [Disease or Syndrome]
   923   C2931834:Persistent Hyperinsulinemic Hypoglycemia [Disease or Syndrome]
   861   C1864903:Hyperinsulinemic hypoglycemia [Finding]
   812   C0020615:Hypoglycaemia [Disease or Syndrome]
   741 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "of infancy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231330:Infancy [Temporal Concept]
Processing 00000000.tx.320: Science, 268, 426-429. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "268,"

Phrase: "426-429."
Processing 00000000.tx.321: MEDLINE Abstract 10 Aguilar-Bryan, L., Nichols, C. 

Phrase: "MEDLINE Abstract 10 Aguilar-Bryan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nichols,"

Phrase: "C."
Processing 00000000.tx.322: G., Wechsler, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wechsler,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.323: W., Clement IV, J. 

Phrase: "W., Clement IV,"

Phrase: "J."
Processing 00000000.tx.324: P., Boyd III, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Boyd III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.325: E., Gonzlez, G., Herrera-Sosa, H., Nguy, K., Bryan, J. and Nelson, D. 

Phrase: "E.,"

Phrase: "Gonzlez,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Herrera-Sosa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nguy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bryan,"

Phrase: "J."

Phrase: "and"

Phrase: "Nelson,"

Phrase: "D."
Processing 00000000.tx.326: (1995) Cloning of the [beta]-cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cloning of the [beta]-cell high-affinity sulfonylurea receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0009013:cell cloning [Cell]
   742   C0009015:Cloning [Research Activity]
   716   C1412082:SULFONYLUREA RECEPTOR, BETA-CELL HIGH-AFFINITY [Gene or Genome]

Phrase: ":"

Phrase: "A regulator of insulin secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0182953:REGULATOR [Medical Device]
   760   C1704734:Regulator [Medical Device]
   760   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.327: Science, 268, 423-426. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "268,"

Phrase: "423-426."
Processing 00000000.tx.328: MEDLINE Abstract 11 Hyde, S. 

Phrase: "MEDLINE Abstract 11 Hyde,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.329: C., Emsley, P., Hartshorn, M. 

Phrase: "C., Emsley,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hartshorn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.330: J., Mimmack, M. 

Phrase: "J.,"

Phrase: "Mimmack,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: M., Gileadi, U., Pearce, S. 

Phrase: "M."

Phrase: ","

Phrase: "Gileadi,"

Phrase: "U.,"

Phrase: "Pearce,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.332: R., Gallagher, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gallagher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.333: P., Gill, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gill,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017558:Gill [Body Part, Organ, or Organ Component]
  1000   C1552935:gill [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.334: R., Hubbard, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hubbard,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.335: E. and Higgins, C. 

Phrase: "E."

Phrase: "and"

Phrase: "Higgins,"

Phrase: "C."
Processing 00000000.tx.336: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.337: (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multi-drug resistance and bacterial transport. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Structural model of ATP-binding proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0026349:Structural Model [Manufactured Object]
   748   C3161035:Model [Intellectual Product]

Phrase: "associated with cystic fibrosis,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0010674:Cystic Fibrosis [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0016059:Fibrosis [Pathologic Function]
   770   C0205207:Cystic [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "multi-drug resistance"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
  1000   C0242640:Multi-Drug Resistance [Organism Attribute]
   901   C0013203:Drug resistance [Biologic Function]
   827   C0013227:Drug [Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C0439064:Multi [Quantitative Concept]
   827   C1254351:Drug [Pharmacologic Substance]
   827   C1514892:Resistance [Physiologic Function]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "and"

Phrase: "bacterial transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
Processing 00000000.tx.338: Nature, 346, 362-365. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "346,"

Phrase: "362-365."
Processing 00000000.tx.339: MEDLINE Abstract 12 Mimura, C. 

Phrase: "MEDLINE Abstract 12 Mimura,"

Phrase: "C."
Processing 00000000.tx.340: S., Holbrook, S. 

Phrase: "S."

Phrase: ","

Phrase: "Holbrook,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.341: R. and Ames, G. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Ames,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.342: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.343: (1991) Structural model of the nucleotide-binding conserved component of periplasmic permeases. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Structural model of the nucleotide-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0026349:Structural Model [Manufactured Object]
   760   C3161035:Model [Intellectual Product]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "conserved component of periplasmic permeases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.344: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.345: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.346: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.347: USA, 88, 84-88. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "88,"

Phrase: "84-88."
Processing 00000000.tx.348: 13 Inagaki, N., Gonoi, T., Clement IV, J. 

Phrase: "13 Inagaki,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Gonoi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Clement IV,"

Phrase: "J."
Processing 00000000.tx.349: P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S. and Bryan, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Namba,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Inazawa,"

Phrase: "J.,"

Phrase: "Gonzalez,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aguilar-Bryan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Seino,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Bryan,"

Phrase: "J."
Processing 00000000.tx.350: (1995) Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Reconstitution of IKATP"

Phrase: ":"

Phrase: "An inward rectifier subunit plus the sulfonylurea receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.351: Science, 270, 1166-1170. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "270,"

Phrase: "1166-1170."
Processing 00000000.tx.352: MEDLINE Abstract 14 Ashcroft, F. 

Phrase: "MEDLINE Abstract 14 Ashcroft,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.353: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.354: (1988) Adenosine triphosphate-sensitive K+ channels. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Adenosine triphosphate-sensitive K+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.355: Annu. 

Phrase: "Annu."
Processing 00000000.tx.356: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.357: Neurosci., 11, 97-118. 

Phrase: "Neurosci.,"

Phrase: "11,"

Phrase: "97-118."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.358: 15 Dunne, M. 

Phrase: "15 Dunne,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.359: J., Kane, C., Squires, P. 

Phrase: "J.,"

Phrase: "Kane,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Squires,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: E., James, R. 

Phrase: "E.,"

Phrase: "James,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.361: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.362: L., Johnson, P. 

Phrase: "L., Johnson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.363: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.364: V. and Lindley, K. 

Phrase: "V."

Phrase: "and"

Phrase: "Lindley,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.365: J. 

Phrase: "J."
Processing 00000000.tx.366: (1995) Persistent neonatal hyperinsulinemic hypoglycemia in humans involves a defect in pancreatic B-cell K-channels. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Persistent neonatal hyperinsulinemic hypoglycemia in humans"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C2931833:HYPERINSULINEMIC HYPOGLYCEMIA, PERSISTENT [Disease or Syndrome]
   820   C2931834:Persistent Hyperinsulinemic Hypoglycemia [Disease or Syndrome]
   790   C1864903:Hyperinsulinemic hypoglycemia [Finding]
   783   C0158986:Neonatal hypoglycaemia [Pathologic Function]
   753   C0020615:Hypoglycaemia [Disease or Syndrome]

Phrase: "involves"

Phrase: "a defect in pancreatic B-cell K-channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1457869:Defect [Functional Concept]
   744   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.367: Diabetologia, 38, A15. 

Phrase: "Diabetologia,"

Phrase: "38,"

Phrase: "A15."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1540087:A15 [Gene or Genome]
  1000   C1548680:A15 [Intellectual Product]
Processing 00000000.tx.368: 16 Philipson, L. 

Phrase: "16 Philipson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.369: H., Worley III J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Worley III J."
Processing 00000000.tx.370: F., Roe, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Roe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.371: W., Mittal, A., Kuznetsov, A., Blair, N. 

Phrase: "W., Mittal,"

Phrase: "A.,"

Phrase: "Kuznetsov,"

Phrase: "A.,"

Phrase: "Blair,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.372: T., Ghai, K., McIntyre, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ghai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "McIntyre,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: S., Lancaster, M. 

Phrase: "S."

Phrase: ","

Phrase: "Lancaster,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.374: E. and Dukes, I. 

Phrase: "E."

Phrase: "and"

Phrase: "Dukes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1512090:Dukes [Classification]
   966 E C1446468:Duke [Laboratory Procedure]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.375: D. 

Phrase: "D."
Processing 00000000.tx.376: (1996) Absence of glucose-regulated KATP current in pancreatic [beta]-cells of PHHI. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Absence of glucose-regulated KATP current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "in pancreatic [beta]-cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "of PHHI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2931834:PHHI [Disease or Syndrome]
Processing 00000000.tx.377: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.378: J., 70, A361. 

Phrase: "J.,"

Phrase: "70,"

Phrase: "A361."
Processing 00000000.tx.379: 17 Nichols, C. 

Phrase: "17 Nichols,"

Phrase: "C."
Processing 00000000.tx.380: G., Shyng, S-L., Nestorowicz, A., Glaser, B., Clement IV, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Shyng,"

Phrase: "S-L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Nestorowicz,"

Phrase: "A.,"

Phrase: "Glaser,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Clement IV,"

Phrase: "J."
Processing 00000000.tx.381: P., Gonzalez, G., Aguilar-Bryan, L., Permutt, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gonzalez,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aguilar-Bryan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Permutt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.382: A. and Bryan, J. 

Phrase: "A."

Phrase: "and"

Phrase: "Bryan,"

Phrase: "J."
Processing 00000000.tx.383: (1996) Adenosine diphosphate as an intracellular regulator of insulin secretion. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Adenosine diphosphate as an intracellular regulator of insulin secretion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0001459:Adenosine Diphosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C0523452:Adenosine Diphosphate [Laboratory Procedure]
   742   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   742   C0034320:diphosphate [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.384: Science, 272, 1785-1787. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "272,"

Phrase: "1785-1787."
Processing 00000000.tx.385: MEDLINE Abstract 18 Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. and Weissenbach, J. 

Phrase: "MEDLINE Abstract 18 Gyapay,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Morissette,"

Phrase: "J.,"

Phrase: "Vignal,"

Phrase: "A.,"

Phrase: "Dib,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fizames,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Millasseau,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marc,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0379885:MARC [Amino Acid, Peptide, or Protein]
  1000   C1332692:MARC [Gene or Genome]
  1000   C1704902:MARC [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Bernardi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lathrop,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Weissenbach,"

Phrase: "J."
Processing 00000000.tx.386: (1994) The 1993-1994 Gnthon human genetic linkage map. 

Phrase: "(1994"

Phrase: ")"

Phrase: "The 1993-1994 Gnthon human genetic linkage map."
Meta Candidates (Total=22; Excluded=13; Pruned=0; Remaining=9)
   845   C0678932:genetic linkage map [Intellectual Product]
   829   C0814036:genetic map [Intellectual Product]
   818   C0023745:genetic linkage [Molecular Function]
           linkage
   795   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   795   C0024779:Map [Manufactured Object]
   795   C0314603:Genetic [Functional Concept]
   795   C1706473:Map [Conceptual Entity]
   790   C0086418:Human - origin [Human]
   740 E C0005615:Birth [Organism Function]
   740 E C0035150:Reproduction [Organism Function]
   740 E C0079946:origin [Classification]
   740 E C0439659:Origin [Temporal Concept]
   740 E C1550512:origin [Intellectual Product]
   740 E C1550722:birth [Idea or Concept]
   740 E C3245487:birth [Intellectual Product]
   712 E C0454729:Natal [Geographic Area]
   712 E C0559522:Genital [Body System]
   712 E C1546649:Genital [Intellectual Product]
   712 E C1550642:Genital [Body Substance]
   703 E C0205313:Original [Idea or Concept]
   703 E C2347409:Original [Occupational Activity]
Processing 00000000.tx.387: Nature Genet., 7, 246-339. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "246-339."
Processing 00000000.tx.388: 19 Litt, M., Kramer, P., Kort, E., Cox, S., Root, D., White, R., Weissenbach, J., Donis-Keller, H., Gatti, R., Weber, J., Nakamura, Y., Julier, C., Hayashi, K., Spurr, N., Dean, M., Mandel, J., Kidd, K., Kruse, T., Retief, A., Bale, A., Meo, T., Vergnaud, G., Warren, S. and Willard, F. 

Phrase: "19 Litt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346650:LITT [Therapeutic or Preventive Procedure]

Phrase: "M."

Phrase: ","

Phrase: "Kramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331847:Kramer [Health Care Related Organization]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kort,"

Phrase: "E.,"

Phrase: "Cox,"

Phrase: "S."

Phrase: ","

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Weissenbach,"

Phrase: "J.,"

Phrase: "Donis-Keller,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gatti,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "J.,"

Phrase: "Nakamura,"

Phrase: "Y.,"

Phrase: "Julier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Spurr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0285253:spurr [Organic Chemical]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Dean,"

Phrase: "M."

Phrase: ","

Phrase: "Mandel,"

Phrase: "J.,"

Phrase: "Kidd,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kruse,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Retief,"

Phrase: "A.,"

Phrase: "Bale,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680724:bail [Governmental or Regulatory Activity]
  1000   C2826220:BALE [Quantitative Concept]

Phrase: "A.,"

Phrase: "Meo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Vergnaud,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Warren,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Willard,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.389: (1995) The CEPH consortium linkage map of human chromosome 11. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The CEPH consortium linkage map of human chromosome 11."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0814036:chromosome map [Intellectual Product]
   742   C0024779:Map [Manufactured Object]
   742   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.390: Genomics, 27, 101-112. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "27,"

Phrase: "101-112."
Processing 00000000.tx.391: MEDLINE Abstract 20 James, M. 

Phrase: "MEDLINE Abstract 20 James,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.392: R., Richard 3rd, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Richard 3rd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205437:3rd [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.393: W., Schott, J. 

Phrase: "W., Schott,"

Phrase: "J."
Processing 00000000.tx.394: J., Yousry, C., Clark, K., Bell, J., Terwilliger, J. 

Phrase: "J.,"

Phrase: "Yousry,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "J.,"

Phrase: "Terwilliger,"

Phrase: "J."
Processing 00000000.tx.395: D., Hazan, J., Dubay, C. and Vignal, A. 

Phrase: "D."

Phrase: ","

Phrase: "Hazan,"

Phrase: "J.,"

Phrase: "Dubay,"

Phrase: "C."

Phrase: "and"

Phrase: "Vignal,"

Phrase: "A."
Processing 00000000.tx.396: (1994) A radiation hybrid map of 506 STS markers spanning human chromosome 11. 

Phrase: "(1994"

Phrase: ")"

Phrase: "A radiation hybrid map of 506 STS markers"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C1253949:Radiation Hybrid Map [Intellectual Product]
   770   C0887811:Radiation Hybrid [Cell]
   744   C0020205:Hybrid [Organism]
   744   C0024779:Map [Manufactured Object]
   744   C0034519:Radiation [Natural Phenomenon or Process]
   744   C0560559:Radiation [Quantitative Concept]
   744   C0851346:Radiation [Natural Phenomenon or Process]
   744   C1522449:Radiation [Therapeutic or Preventive Procedure]
   744   C1524020:Radiation [Therapeutic or Preventive Procedure]
   744   C1524021:Radiation [Research Activity]
   744   C1706473:Map [Conceptual Entity]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "human chromosome 11."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0008643:Human Chromosome [Cell Component]
   901   C0008653:Chromosome 11 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.397: Nature Genet., 8, 70-76. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "70-76."
Processing 00000000.tx.398: 21 Ayyagari, R., Nestorowicz, A., Li, Y., Chandrasekharappa, S., Chinault, C., van Tuinen, P., Smith, R. 

Phrase: "21 Ayyagari,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nestorowicz,"

Phrase: "A.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.,"

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Chinault,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "van Tuinen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: J. 

Phrase: "J."
Processing 00000000.tx.400: H., Hejtmancik, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hejtmancik,"

Phrase: "J."
Processing 00000000.tx.401: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.402: H. and Permutt, M. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Permutt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: A. 

Phrase: "A."
Processing 00000000.tx.404: (1996) Construction of a YAC contig encompassing the Usher syndrome Type IC and familial hyperinsulinism loci on chromosome 11p14-15.1. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Construction of a YAC contig"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "encompassing"

Phrase: "the Usher syndrome Type IC"

Phrase: "and"

Phrase: "familial hyperinsulinism loci on chromosome 11p14-15.1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.405: Genome Res., 6, 504-514. 

Phrase: "Genome Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "6,"

Phrase: "504-514."
Processing 00000000.tx.406: 22 Weber, J. 

Phrase: "22 Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:weber [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.407: L. and Wong, C. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C."
Processing 00000000.tx.408: (1993) Mutation of human short tandem repeats. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mutation of human short tandem repeats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.409: Hum. 

Phrase: "Hum."
Processing 00000000.tx.410: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.411: Genet., 2, 1123-1128. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "1123-1128."
Processing 00000000.tx.412: 23 Shapiro, M. 

Phrase: "23 Shapiro,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.413: B. and Senepathy, P. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Senepathy,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.414: (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. 

Phrase: "(1987"

Phrase: ")"

Phrase: "RNA splice junctions of different classes of eukaryotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0205144:Junction [Spatial Concept]
   711   C1706311:Junction [Medical Device]

Phrase: ":"

Phrase: "sequence statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038215:Statistics [Occupation or Discipline]
   861   C0600673:Statistics [Intellectual Product]
   827 E C2348149:Statistic [Quantitative Concept]
   827 E C2828391:Statistic [Quantitative Concept]

Phrase: "and"

Phrase: "functional implications in gene expression."
Processing 00000000.tx.415: Nucleic Acids Res. 

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.416: 15, 7155-7174. 

Phrase: "15,"

Phrase: "7155-7174."
Processing 00000000.tx.417: 24 Jorde, L. 

Phrase: "24 Jorde,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.418: (1992) Genetic diseases in the Ashkenazi population: Evolutionary considerations. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Genetic diseases in the Ashkenazi population"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C2316203:Genetic diseases [Finding]
   790   C2924406:Genetic diseases [Laboratory Procedure]
   783   C0017404:genetic population [Occupation or Discipline]
   756 E C0019247:Genetic disease [Disease or Syndrome]
   753   C0012634:Diseases [Disease or Syndrome]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]

Phrase: ":"

Phrase: "Evolutionary considerations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:considerations [Finding]
Processing 00000000.tx.419: In Bonne-Tamir, B. and Adam, A. 

Phrase: "In Bonne-Tamir,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Adam,"

Phrase: "A."
Processing 00000000.tx.420: (eds), Genetic Diversity among Jews: Diseases and Markers at the DNA level. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Genetic Diversity among Jews"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   833   C0042333:Genetic Diversity [Natural Phenomenon or Process]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C1880371:Diversity [Qualitative Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: ":"

Phrase: "Diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Markers at the DNA level."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0012872:Markers, DNA [Nucleotide Sequence]
   726   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.421: Oxford University Press, New York, pp. 

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "pp."
Processing 00000000.tx.422: 305-318. 

Phrase: "305-318."
Processing 00000000.tx.423: 25 Kaul, R., Gao. 

Phrase: "25 Kaul,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gao."
Processing 00000000.tx.424: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: A., Balamurugan, K. and Matalon, R. 

Phrase: "A.,"

Phrase: "Balamurugan,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Matalon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.426: (1993) Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cloning of the human aspartoacylase cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0525049:Human Cloning [Research Activity]
   748   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "a common missense mutation in Canavan disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0599155:Missense Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.427: Nature Genet., 5, 118-123. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "118-123."
Processing 00000000.tx.428: 26 Kaul, R., Gao. 

Phrase: "26 Kaul,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gao."
Processing 00000000.tx.429: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: A., Balamurugan, K., Petrosky, A., Michals, K. and Matalon, R. 

Phrase: "A.,"

Phrase: "Balamurugan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Petrosky,"

Phrase: "A.,"

Phrase: "Michals,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Matalon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.431: (1994) Canavan disease: Mutations among Jewish and non-Jewish patients. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Canavan disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0206307:Canavan Disease [Disease or Syndrome]
  1000   C1412591:Canavan disease [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "Mutations among Jewish"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "non-Jewish patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1829939:{Non-patient} [Clinical Attribute]
   827   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.432: Am. 

Phrase: "Am."
Processing 00000000.tx.433: J. 

Phrase: "J."
Processing 00000000.tx.434: Hum. 

Phrase: "Hum."
Processing 00000000.tx.435: Genet., 55, 34-41. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "34-41."
Processing 00000000.tx.436: 27 Beutler, E. 

Phrase: "27 Beutler,"

Phrase: "E."
Processing 00000000.tx.437: (1993) Gaucher disease as a paradigm of current issues regarding single gene mutations of humans. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gaucher disease as a paradigm of current issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017205:Gaucher Disease [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]

Phrase: "regarding"

Phrase: "single gene mutations of humans."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0596611:gene mutations [Genetic Function]
   797   C0314604:gene humans [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.438: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.439: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.440: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.441: USA, 90, 5384-5390. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "5384-5390."
Processing 00000000.tx.442: 28 Whitney, M. 

Phrase: "28 Whitney,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.443: A., Saito, H., Jakobs, P. 

Phrase: "A.,"

Phrase: "Saito,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jakobs,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.444: M., Gibson, R. 

Phrase: "M."

Phrase: ","

Phrase: "Gibson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.445: A., Moses, R. 

Phrase: "A.,"

Phrase: "Moses,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.446: E. and Grompe, M. 

Phrase: "E."

Phrase: "and"

Phrase: "Grompe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.447: (1993) A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews. 

Phrase: "(1993"

Phrase: ")"

Phrase: "A common mutation in the FACC gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Fanconi anaemia in Ashkenazi Jews."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0015625:Fanconi Anemia [Disease or Syndrome]
   806   C3469521:FANCONI ANEMIA [Disease or Syndrome]
   760   C0002871:Anaemia [Disease or Syndrome]
   760   C1000483:Anemia [Plant]
Processing 00000000.tx.448: Nature Genet., 4, 202-205. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "202-205."
Processing 00000000.tx.449: 29 Sherman, J. 

Phrase: "29 Sherman,"

Phrase: "J."
Processing 00000000.tx.450: B., Raben, N., Nicastri, C., Argov, Z., Nakajima, H., Adams, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Raben,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Nicastri,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Argov,"

Phrase: "Z.,"

Phrase: "Nakajima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "E."
Processing 00000000.tx.451: M., Eng, C. 

Phrase: "M."

Phrase: ","

Phrase: "Eng,"

Phrase: "C."
Processing 00000000.tx.452: M., Cowan, T. 

Phrase: "M."

Phrase: ","

Phrase: "Cowan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.453: M. and Plotz, P. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Plotz,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.454: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.455: (1994) Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII- and their population frequency. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Common mutations in the phosphofructokinase-M gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Ashkenazi Jewish patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "with glycogenesis VII-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445385:VII [Intellectual Product]

Phrase: "and"

Phrase: "their population frequency."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0017270:Population Frequency [Quantitative Concept]
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]
Processing 00000000.tx.456: Am. 

Phrase: "Am."
Processing 00000000.tx.457: J. 

Phrase: "J."
Processing 00000000.tx.458: Hum. 

Phrase: "Hum."
Processing 00000000.tx.459: Genet., 55, 305-313. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "305-313."
Processing 00000000.tx.460: 30 Higgins, C. 

Phrase: "30 Higgins,"

Phrase: "C."
Processing 00000000.tx.461: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.462: (1992) ABC transporters: From microorganisms to man. 

Phrase: "(1992"

Phrase: ")"

Phrase: "ABC transporters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242738:ABC Transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2984318:ABC transporters [Functional Concept]
   861   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "From microorganisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0445623:Microorganisms [Organism]
   966 E C2827713:Microorganism [Intellectual Product]

Phrase: "to man."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024554:MAN [Finding]
  1000   C0025266:Man [Population Group]
  1000   C0086418:Man [Human]
Processing 00000000.tx.463: Annu. 

Phrase: "Annu."
Processing 00000000.tx.464: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.465: Cell Biol., 8, 67-113. 

Phrase: "Cell Biol.,"

Phrase: "8,"

Phrase: "67-113."
Processing 00000000.tx.466: 31 Shen, H., Yao, B-Y. and Mueller, D. 

Phrase: "31 Shen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yao,"

Phrase: "B-Y."

Phrase: "and"

Phrase: "Mueller,"

Phrase: "D."
Processing 00000000.tx.467: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.468: (1994) Primary structural constraints of P-loop of mitochondrial F1-ATPase from yeast. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Primary structural constraints of P-loop of mitochondrial F1-ATPase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C0443288:Constraint [Functional Concept]
   706   C2986806:Constraint [Occupational Activity]

Phrase: "from yeast."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.469: J. 

Phrase: "J."
Processing 00000000.tx.470: Biol. 

Phrase: "Biol."
Processing 00000000.tx.471: Chem., 269, 9424-9428. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "269,"

Phrase: "9424-9428."
Processing 00000000.tx.472: 32 Cheng, S. 

Phrase: "32 Cheng,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.473: H., Gregory, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gregory,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.474: J., Marshall, J., Paul, S., Souza, D. 

Phrase: "J.,"

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "J.,"

Phrase: "Paul,"

Phrase: "S."

Phrase: ","

Phrase: "Souza,"

Phrase: "D."
Processing 00000000.tx.475: W., White, G. 

Phrase: "W., White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.476: A., O'Riordan, C. 

Phrase: "A.,"

Phrase: "O'Riordan,"

Phrase: "C."
Processing 00000000.tx.477: R. and Smith, A. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.478: E. 

Phrase: "E."
Processing 00000000.tx.479: (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Defective intracellular transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599814:Intracellular Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "processing of CFTR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "the molecular basis of most cystic fibrosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1853126:MOLECULAR BASIS [Idea or Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.480: Cell, 63, 827-834. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "63,"

Phrase: "827-834."
Processing 00000000.tx.481: MEDLINE Abstract 33 Gregory, R. 

Phrase: "MEDLINE Abstract 33 Gregory,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.482: J., Rich, D. 

Phrase: "J.,"

Phrase: "Rich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699759:Rich [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.483: P., Cheng, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cheng,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.484: H., Souza, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Souza,"

Phrase: "D."
Processing 00000000.tx.485: W., Paul, S., Manavalan, P., Anderson, M. 

Phrase: "W., Paul,"

Phrase: "S."

Phrase: ","

Phrase: "Manavalan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Anderson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.486: P., Welsh, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Welsh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.487: J. and Smith, A. 

Phrase: "J."

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.488: E. 

Phrase: "E."
Processing 00000000.tx.489: (1991) Maturation and function of cystic fibrosis transmembrane regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "function of cystic fibrosis transmembrane regulator variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "mutations in putative nucleotide-binding domains 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.490: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.491: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.492: Biol., 11, 3886-3893. 

Phrase: "Biol.,"

Phrase: "11,"

Phrase: "3886-3893."
Processing 00000000.tx.493: 34 Landau, H., Perlman, M., Meyer, S., Isacsohn, M., Krausz, M., Mayan, H., Lijovetzky, G. and Schiller, M. 

Phrase: "34 Landau,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Perlman,"

Phrase: "M."

Phrase: ","

Phrase: "Meyer,"

Phrase: "S."

Phrase: ","

Phrase: "Isacsohn,"

Phrase: "M."

Phrase: ","

Phrase: "Krausz,"

Phrase: "M."

Phrase: ","

Phrase: "Mayan,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lijovetzky,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Schiller,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: (1982) Persistent neonatal hypoglycemia due to hyperinsulinism: medical aspects. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Persistent neonatal hypoglycemia due to hyperinsulinism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0158986:Neonatal hypoglycaemia [Pathologic Function]
   783   C2931834:Neonatal Hyperinsulinism [Disease or Syndrome]
   753   C0020615:Hypoglycaemia [Disease or Syndrome]
   753   C1552240:Neonatal [Professional or Occupational Group]
   753   C1552264:Neonatal [Professional or Occupational Group]
   753   C2939425:Neonatal [Temporal Concept]

Phrase: ":"

Phrase: "medical aspects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.495: Pediatr., 70, 440-446. 

Phrase: "Pediatr.,"

Phrase: "70,"

Phrase: "440-446."
Processing 00000000.tx.496: 35 Aynsley-Green, A., Polak, J. 

Phrase: "35 Aynsley-Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332583:Green [Qualitative Concept]

Phrase: "A.,"

Phrase: "Polak,"

Phrase: "J."
Processing 00000000.tx.497: M., Bloom, S. 

Phrase: "M."

Phrase: ","

Phrase: "Bloom,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.498: R., Gough, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gough,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.499: H., Keeling, J., Ashcroft, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Keeling,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441591:Keeling [Therapeutic or Preventive Procedure]

Phrase: "J.,"

Phrase: "Ashcroft,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.500: J. 

Phrase: "J."
Processing 00000000.tx.501: H., Turner, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.502: C. and Baum, J. 

Phrase: "C."

Phrase: "and"

Phrase: "Baum,"

Phrase: "J."
Processing 00000000.tx.503: D. 

Phrase: "D."
Processing 00000000.tx.504: (1981) Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycemia. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Nesidioblastosis of the pancreas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C0027773:Nesidioblastosis of Pancreas [Disease or Syndrome]
           Pancreas Nesidioblastosis
           Nesidioblastosis
   881   C2931834:NESIDIOBLASTOSIS OF PANCREAS [Disease or Syndrome]

Phrase: ":"

Phrase: "definition of the syndrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1550452:definition [Idea or Concept]
   770   C1704788:Definition [Conceptual Entity]
   770   C3539107:Definition [Intellectual Product]

Phrase: "and"

Phrase: "the management of the severe neonatal hyperinsulinaemic hypoglycemia."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0150254:Hypoglycaemia management [Therapeutic or Preventive Procedure]
   744   C0001554:Management [Occupational Activity]
   744   C0376636:management [Health Care Activity]
   744   C1273870:Management [Occupational Activity]
   744   C3273539:Management [Occupation or Discipline]
Processing 00000000.tx.505: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.506: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.507: Child., 56, 496-508. 

Phrase: "Child.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Child [Age Group]
  1000   C0680063:CHILD [Family Group]

Phrase: "56,"

Phrase: "496-508."
Processing 00000000.tx.508: *To whom correspondence should be addressed +Present address: The Children's Hospital, Temple St, Dublin, Ireland This page is maintained by OUP admin. 

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "+Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "The Children's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0020017:Children's hospital [Health Care Related Organization]
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Temple St,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Dublin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454777:Dublin [Geographic Area]

Phrase: "Ireland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022067:Ireland [Geographic Area]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "maintained by OUP admin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
Processing 00000000.tx.509: Last updated Thu Oct 31 15:28:51 GMT 1996. 

Phrase: "Last updated Thu Oct 31 15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0039677:THU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0039958:THU [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0450355:31 [Intellectual Product]
   799   C1517741:Last [Qualitative Concept]
   766   C1519814:Update [Temporal Concept]

Phrase: ":"

Phrase: "28"

Phrase: ":"

Phrase: "51 GMT 1996."
Processing 00000000.tx.510: Part of the OUP Journals World Wide Web service.

Phrase: "Part of the OUP Journals World Wide Web service."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.511: Copyright Oxford University Press, 1996

Phrase: "Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "1996"

